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ABSTRACT
Membrane repair can be modulated by the association of an S100A10 dimer
with the calcium- and phospholipid-binding protein annexin A2. This heterotetrameric
complex has the ability to form larger multiprotein assemblies such as those with the
enlargeosome protein AHNAK and members of the transmembrane ferlin family. The
main goals of this thesis were to design, synthesize and characterize a molecule that
would facilitate assembly of larger S100 multiprotein complexes, investigate the
arrangement of the proteins, stoichiometry and affinity of AHNAK for the S100A10annexin A2 complex and identify structural details of the ternary complex formed
between S100A10, annexin A2 and AHNAK.
Successful expression, purification and characterization of two S100-target
peptide hybrid proteins comprised of S100A10 and S100B linked in tandem to annexin
A2 (residues 1-15) (referred to as A10A2) and CapZ (TRTK12) (referred to as BT12),
respectively, was achieved. Different protease cleavage sites were incorporated into the
linkers of the hybrid proteins. Since in situ proteolytic cleavage showed the linker did not
perturb the structures of the S100A10-annexin A2 or S100B-TRTK12 complexes, this
approach was used as a scaffold for larger S100 complexes.
Peptide array experiments identified the regions of interaction within the Cterminus of AHNAK. Of the eight consensus regions observed, one of the sequences of
AHNAK (AHNAK5) which showed the strongest interaction was used as a synthetic
peptide to identify the binding region(s), stoichiometry and affinity with the A10A2
complex.

Using

NMR,

fluorescence
iii

and

non-denaturing

electrospray

mass

spectrometries, a novel asymmetric arrangement between a single AHNAK5 peptide and
the A10A2 dimer having an affinity near 3 nM was identified.
The binding region of AHNAK5 on A10A2 was determined by NMR
spectroscopy and X-ray crystallography. X-ray crystallography of the A10A2-AHNAK5
complex showed that the backbone structure of A10A2-AHNAK5 is similar to that of
S100A10 bound to the N-terminal peptide of annexin A2 (Rety et al. 1999). From the
structure, it was clear that only one AHNAK5 was bound to a dimeric A10A2 through
helix IV in S100A10 and the C-terminal portion from the annexin A2 peptide. These
results provide a novel mode of interaction for AHNAK5 in an S100-target complex.

Keywords: S100; Annexin A2; AHNAK; membrane repair; hybrid protein; protein
interactions; NMR spectroscopy; peptide array; non-denaturing electrospray mass
spectrometry; fluorescence spectroscopy; X-ray crystallography; stoichiometry.
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Chapter 1
Introduction
1.1

Role of Calcium in the Cell
There are at least 1,400 grams of calcium inside the human body (Carafoli

2003). While the majority of calcium resides in the skeleton and teeth, less than 1% of the
ion circulates in the body cells (Carafoli 2002; 2003). The importance of calcium ions in
the cell was first noted by Ringer (Ringer 1883) 128 years ago, when the heart muscle
continued contracting in the presence of calcium in saline medium. Since then, the
implication of calcium ion in many biological processes such as cell growth and
proliferation, fertilization, neurotransmitter release, and memory have been identified
(Berridge et al. 2000).
In a resting cell, the cytosolic concentration of free calcium ions is
approximately 100-300 nM (Tsien 1981), which is approximately 10,000 fold lower than
the concentration of the ion in the extracellular space (1 mM). This calcium concentration
is also about 1,000 fold lower than that found within intracellular storage compartments
such as the sarcoplasmic reticulum (SR), endoplasmic reticulum (ER), the golgi apparatus
and mitochondria (Pozzan et al. 1994; Pinton et al. 1998) (Figure 1.1A). Maintaining this

Parts of this chapter have been taken from the published articles: Rezvanpour, A., and
Shaw, G. S. 2009. Unique S100-target protein interactions. Gen. Physiol. Biophys. 28:
F39-46.
Rintala-Dempsey, A. C., Rezvanpour, A., and Shaw, G. S. 2008. S100-annexin
complexes—structural insights. FEBS J. 275: 4956-4966.

Figure 1.1. Generation of calcium signal through the inositol-lipid pathway.
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Calcium homeostasis in a resting cell is illustrated in (A). To maintain the low level calcium concentration of approximately 100
nM within the cell, calcium ions must be actively transported out of the cell or into intracellular organelles (ER, SR,
mitochondria, golgi apparatus). Various calcium pumps such as plasma membrane calcium ATPase (PMCA) and sarcoendoplasmic reticulum calcium ATPase pumps transfer the calcium ions to the exterior of the cell or to the intracellular
organelles, respectively. In addition to the pumps, Na+/Ca2+ exchangers, transport calcium ions while sodium ions are entering
the cell. An excitable cell (B) can become stimulated by a first messenger such as hormones. This results in the activation of the
G protein coupled receptor and subseqently phospholipase C (PLC) which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2)
into 1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG). IP3 binding to the IP3-sensitive calcium channels (IP3R) on
intracellular storage compartments leads to the opening of the channel and release of calcium into the cytosol. A local increase
in the calcium concentration in the cytosol triggers a physiological response through interaction with a large number of calciumbinding proteins. (This figure was adapted and modified from Missiaen et. al. 2000 and Molecular Cell Biology 3rd Edition by
Lodish et al. 1995).

3

tight regulation of calcium concentration is essential for sustaining life, as calcium ions
act as “second messengers” in various signaling pathways.
The type of a cell designates the type of receptors located on the plasma
membrane. In an excitable cell, first messengers such as neurotransmitters, nerve
impulses or ligands stimulate these receptors, resulting in the release and increase of the
local calcium ion concentration (~1 µM) in the cytoplasm. Figure 1.1B illustrates a signal
transduction cascade initiated by an agonist binding to the cell-surface G protein-linked
receptor. This results in the activation of phospholipase C (PLC) by the G protein and
subsequent cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5triphosphate (IP3) and 1,2-diacylglycerol (DAG) (Clapham 2007). IP3 splits off from PIP2
and diffuses through the cytoplasm to bind to the IP3-sensitive calcium channels (IP3R)
on the intracellular storage compartments. This leads to the opening of the channel and
release of calcium into the cytosol (Figure 1.1B). At this point calcium acts as a second
messenger and triggers a physiological response through interaction with a large number
of calcium-binding proteins (CaBP) such as the EF-hand calcium-binding family of
proteins.
In order to prepare for the next signal, the cell must actively remove the calcium
ions. Calcium is taken up through calcium pumps to the extracellular space or
intracellular compartments through plasma membrane calcium-ATPase (PMCA) and
sarco-endoplasmic reticulum ATPase (SERCA) pumps (Pozzan et al. 1994; Pinton et al.
1998), respectively (Figure 1.1A). Na+/Ca2+ exchangers also remove calcium ions to the
exterior of the cell.
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1.2

The EF-Hand Calcium-Binding Motif
With at least 600 identified members in the human genome, the EF-hand

calcium-binding family of proteins comprises the largest subfamily of CaBP (Kawasaki et
al. 1998). The name EF-hand was first introduced by Kretsinger and Nockolds over 30
years ago with the atomic resolution structure of the crab calcium-buffering protein
parvalbumin (Kretsinger and Nockolds 1973). As shown in Figure 1.2, an EF-hand motif
consists of two α-helices that are connected by a calcium-binding loop. The term EF-hand
is used as the shape of this domain resembles a right hand with an extended index finger
and thumb, depicting the N-terminal helix (helix E) and the C-terminal helix (helix F),
respectively (Tufty and Kretsinger 1975). The remaining curled fingers represent the 1012 amino acid calcium-binding loop. A CaBP may contain between 2-12 EF-hand loops
to maximize the calcium capacity (Carafoli 2002).
The classical, canonical EF-hand loop is characterized by a sequence of 12
amino acids with the pattern X * Y * Z * -Y * -X * * -Z, where the letters are the residues
that participate in metal coordination and the asterisks are the intervening residues
(Strynadka and James 1989). The amino acids at positions 1, 3, 5, 9 (via water) and 12 of
this sequence provide the oxygen ligand to the calcium ion by sidechain carboxyl groups,
and position 7 coordinates the ion through the main chain carbonyl group. Consequently,
the calcium ion is coordinated in a pentagonal bipyramidal arrangement with preferences
for aspartate, glycine and glutamate in positions 1, 6, and 12, respectively (Marsden et al.
1989).
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Figure 1.2. The structure of an EF-hand motif.
(A) The EF-hand calcium-binding motif is comprised of an entering helix (pink) and an
exiting helix (aqua) that are connected by the calcium binding loop (grey). (B) The motif
was called an EF-hand as the N-terminal helix E corresponds to the index finger and the
C-terminal helix F represents the extended thumb. The remaining flexed fingers form the
calcium binding loop. The movements of the C-terminal helix (helix F) in the closed
conformation (light grey) before binding to calcium and after calcium-binding in the open
conformation (dark grey) are also presented. (Figure adapted and modified from LewitBentley et al. 2000).
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Another type of EF-hand motif contains 14 amino acids within the calciumbinding loop and has the X * * Y * Z * * -Y * -X * * -Z pattern (Strynadka and James
1989). In this case, extra residues are introduced between the X and Y, as well as the Z
and –Y positions and the calcium coordination occurs with the main chain carbonyl
groups at positions X, Y, and Z. The EF-hand motif with this type of calcium
coordination is referred to as a pseudo EF-hand loop (Strynadka and James 1989).

1.3

Overview of EF-Hand Calcium Binding Proteins
CaBPs can be divided into two distinct classes: 1) calcium buffers (or calcium

signal modulators) and 2) calcium sensors (da Silva and Reinach 1991). Calcium buffers
are acidic proteins that can be found in the cytosol, organelles or integrated in membranes
(Carafoli 2003). They have a high affinity for calcium and can store large amounts of
calcium. By doing so, these proteins can regulate the intracellular calcium concentration
or transport the calcium throughout the cell. Members of the calcium buffering proteins
include calbindin D9K found in the cytosol and calsequestrin found in the SR. Calbindin
D9K is a small protein of 75 residues and is composed of a pair of EF-hand loops
connected by a linker. While calcium binding occurs with positive cooperativity (Linse et
al. 1987), it does not result in major conformational changes, therefore the calcium-bound
protein maintains a “closed” conformation (Skelton et al. 1994; Gifford et al. 2007).
Consequently, with no identified binding partner, calbindin D9K functions as a transporter
for calcium ions within the cell.
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Calcium sensors, on the other hand, have moderate affinities in the range of 1
to 10 µM for calcium (Schaub and Heizmann 2008), and exist in the calcium-free (apo)
state at resting concentrations of the ion. A local increase in calcium concentration
beyond the resting level results in the calcium-binding by the calcium-sensor proteins.
This leads to a significant calcium-induced conformational change and thus the exposure
of previously buried hydrophobic surface for interaction with biological targets. Some
members of the calcium-sensor family include calmodulin (Han and Campbell 2007),
troponin-C (TnC) and the S100 protein family.
Calmodulin is a small (148 amino acids), highly conserved protein found
ubiquitously in eukaryotes. This protein binds to a large number of targets (more than
350) such as myosin light chain kinase and calcineurin in a calcium-dependent manner
(Yap et al. 2000) and regulates a vast number of cellular activities such as cell growth,
muscle contraction, and secretion. Calmodulin is comprised of two lobes of EF-hand
pairs that are connected through a flexible linker (Kuboniwa et al. 1995; Shao et al.
2006), giving it a “dumbbell-like” overall shape (Babu et al. 1988) (Figure 1.3). The two
N- and C-terminal EF-hand loops in each lobe are arranged in a four-helix bundle.
Consequently, calmodulin is able to bind a total of four calcium ions (Kdcalcium ~ 1-10 µM)
in response to an increase in intracellular calcium concentration (Teo and Wang 1973).
Upon calcium-binding, the α-helices of each EF-hand motif modify their interhelical
angle such that the position of each helix pair changes from an anti-parallel arrangement
(130-140º) to an almost perpendicular conformation (89º) (Shao et al. 2006). These
structural changes allow the “closed” helical bundles of the two lobes to obtain an
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Figure 1.3. Calcium-induced conformational changes of calmodulin.
Ribbon diagrams of (A) apo-calmodulin (1DMO) (Zhang et al. 1995), and (B) calciumbound calmodulin (3CLN) (Babu, et al. 1988) showing calcium induced conformational
changes in the two lobes of EF-hand pairs. Calmodulin has an overall “dumbbell-like”
appearance (Kuboniwa et al. 1995). Upon calcium-binding, the α-helices of each EFhand motif modify their interhelical angle such that the position of each helix pair
changes from an anti-parallel arrangement (130-140º) to an almost perpendicular
conformation (89º) (Zhang et al. 1995). Increased exposure of the hydrophobic surface
allows for interaction with target protein. In both diagrams, the helices in the N-terminal
lobes are coloured, while the helices in the C-terminal lobes are in grey.
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“open” conformation with an exposed hydrophobic surface for interaction with target
proteins.

1.4

Structures of S100 Proteins
The S100 protein family is a group of 25 members, found solely in vertebrates.

These proteins undergo a calcium-induced structural change during signalling events. As
a result, the calcium-bound forms of S100 proteins are able to interact with target
molecules, giving rise to a variety of biological responses including protein
phosphorylation, cell growth, motility and gene transcription (Rintala-Dempsey et al.
2006). The structures of several S100 proteins have been determined using NMR
spectroscopy and x-ray crystallography and show the details of the calcium-binding sites,
dimerization motif and structural changes upon calcium binding. Unlike the dumbbell
shapes of well-studied EF-hand calcium-binding proteins such as calmodulin (Babu et al.
1988) and troponin-C (Herzberg and James 1985), the S100 proteins have a more
compact, globular structure. As shown for S100A11 (Figure 1.4) each S100 protomer is
comprised of two helix-loop-helix motifs, or EF-hands, connected by a flexible linker.
The N-terminal calcium-binding site (site I) is a “pseudo” EF-hand, while the tighter
binding C-terminal site (site II) is a canonical EF-hand. The majority of S100 proteins
form symmetric non-covalent homodimers, a feature that is unique to these proteins
within the EF-hand family of calcium-binding proteins. S100 proteins have also shown
the formation of heterodimers, such as that formed between S100A8 and S100A9
(Korndorfer et al. 2007). The dimer interface is composed of the antiparallel arrangement
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Figure 1.4. Calcium-induced conformational changes of S100 proteins.
Ribbon diagrams of (A) apo-S100A11 (1NSH) (Dempsey et al. 2003) and (B) Ca2+S100A11 (1QLS) (Rety et al. 2000) are shown in similar orientations to demonstrate the
conformational changes that occur upon calcium-binding. The helices are numbered I-IV
for one monomer and I’-IV’ for the other. Helix I is shown in pink, helix II in aqua, helix
III in purple and helix IV in blue. The β-sheets in the calcium-binding loops are shown in
light purple and the calcium ions as yellow spheres. When calcium binds to S100A11 the
largest conformational changes occur in the C-terminal EF-hand. Helix III moves ~ 40º
with respect to helix IV, exposing a hydrophobic cleft between helix IV and the linker of
one monomer and helix I’ of the second monomer. (C) Binding of the N-terminal region
of annexin A1 (green) is mediated by hydrophobic residues of the binding cleft on either
side of S100A11 dimer (1QLS) (Rety et al. 2000) making contacts with helices III and IV
from one monomer and helix I’ of the partner monomer simultaneously. (D) The structure
of S100A10 bound to the N-terminal region of annexin A2 (1BT6) (Rety et al. 1999) is
shown to illustrate the similarity to the Ca2+-S100A11-annexin A1 structure. When the
two S100-annexin structures are superimposed, the backbone RMSD is 0.85.
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of helices I and IV of each protomer. The two calcium-binding loops are held in close
proximity via a short antiparallel β-sheet and are on the opposite side of the molecule
relative to the N- and C-termini.
In the calcium-free (apo) structures of several S100 proteins, including apoS100A11, helices III and IV are nearly parallel to one another, resulting in a number of
residues at their interface that are inaccessible to solvent and giving the protein a more
“closed” structure (Dempsey et al. 2003). Upon calcium-binding, the N-terminus of helix
III moves by almost 40° relative to helix IV and becomes nearly perpendicular to helix
IV, exposing hydrophobic residues on both helices (V57, M61, L85, A88, F93 in
S100A11), as well as on helix I (I12, I16) and the linker region (L45, A47, F48), that
were previously buried in the apo state (Figure 1.4). In S100A11 it has also been noted
that helix IV becomes elongated upon calcium binding. The large conformational change
of helix III and exposure of hydrophobic residues, first shown for S100B (Drohat et al.
1998; Matsumura et al. 1998; Smith and Shaw 1998) and S100A6 (Otterbein and
Dominguez 2002) has become a trademark of the S100 calcium-binding event and is
responsible for the interactions of these proteins with a diverse array of target proteins
(Rintala-Dempsey et al. 2006). One member of the S100 family, S100A10, differs from
others as it is unable to bind calcium ions due to a three-residue deletion in site I (N28,
N29, T30 of S100A11 are absent in S100A10) and mutations of acidic calciumcoordinating residues in site II (D68 and E77 of S100A11 are substituted with C61 and
S70 in S100A10) (see sequences in Figure 1.6A). Remarkably, the structure of calciumfree S100A10 (Rety et al. 1999) is nearly identical (rmsd 0.85 Å) in structure to that of
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calcium-bound S100A11 (Ca2+-S100A11) (Rety et al. 2000) despite the presence (or
absence) of calcium ions in their calcium-binding loops (Figure 1.4).
In S100A10 and Ca2+-S100A11, helices I and IV comprise the dimer interface
as in the other S100 structures, however helix IV is markedly longer in apo-S100A11,
extending nearly to the C-terminus. Helix III has a similar orientation in both S100A10
and in Ca2+-S100A11, thus exposing very similar hydrophobic regions and residue
composition (Figure 1.4).

1.5

Structures of the Annexin Proteins
In humans there are 12 different annexin proteins, annexins A1-A11 and A13

that have orthologs in most vertebrates (Fernandez and Morgan 2003). As of April 2011,
there were 69 three-dimensional structures of annexin proteins, most from x-ray
crystallographic methods, deposited to the Protein Data Bank (www.rcsb.org). These
structures include full-length, truncated and mutant forms of the annexins (particularly
annexin A5), as well as annexin-protein complexes. In particular, vertebrate structures of
human annexins A1, A2, A3, A5, A8 and bovine annexins A4 and A6 have been
determined, some in both the calcium-free and calcium-bound forms.
Consistent with the first annexin structure determined, annexin A5 (Huber et al.
1990a; Huber et al. 1990b; Concha et al. 1993; Sopkova et al. 1993), all annexins except
annexin A6, form a core domain consisting of four conserved structural repeat sequences
(I-IV), each about 70-75 residues in length. Annexin A6 is a unique member of the
annexin family possessing two four-repeat core domains connected by a linker region
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(Avila-Sakar et al. 1998), a result of a gene duplication event. As shown in Figure 1.5
for annexin A1 (Rosengarth et al. 2001), each repeat unit is formed from five α-helices
(A-E) arranged such that helices A, B, D and E are roughly anti-parallel to each other
while helix C is nearly perpendicular to these helices. The repeats pack into two distinct
arrangements within the core domain. The repeat pairs I/IV and II/III pack together
mostly due to hydrophobic interactions between helices B and E in each repeat, arranged
in a near antiparallel fashion (Weng et al. 1993; Rosengarth et al. 2001). For example, in
annexin A2 (Shao et al. 2006) residues in helices B and E from repeat I (V54, V57 and
V98, L102) and repeat IV (I289, V293 and A330, Y333, L334) form a tight non-polar
network between these two repeat units. In general the hydrophobic nature of these
residues in the annexin sequences is highly conserved.
Calcium binding to the annexins promotes their binding to phospholipidcontaining membranes. Most structures of annexins show that coordination of calcium
ions by the annexins occurs via three residues in the A/B loop that ligate the calcium ion
using their backbone carbonyl atoms and the bidentate side chain of either an aspartic or
glutamic acid 38 residues downstream in the D/E loop (Figure 1.5) (Seaton 1996). Water
molecules satisfy the remaining two coordination sites for each calcium ion. In this
manner, each annexin protein coordinates one calcium ion per repeat giving rise to the
trademark annexin sequence pattern GXGT-(38)-D/E (Geisow et al. 1986). In addition,
secondary coordination of calcium ions with lower affinity have also been noted within
the D/E loops of repeats I and III as in annexin A1 (Rosengarth and Luecke 2003) and A2
(Shao et al. 2006) or in the A/B loop near the primary calcium site in this region. In
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Figure 1.5. Extrusion of the N-terminal helix in annexin A1 upon calcium binding.
Ribbon representations of (A) apo-annexin A1 (1HM6) (Rosengarth et al. 2001) and (B)
Ca2+-annexin A1 (1MCX) (Rosengarth et al. 2003). The core domain repeats are colored
pink for repeat I, blue for repeat II, yellow for repeat III and green for repeat IV. The
helices of repeat III are labeled A-E. The N-terminus of apo-annexin A1 was resolved in
the calcium-free crystal structure and is shown in teal. The extreme N-terminal helix of
annexin A1 is associated with repeat III in the absence of calcium and essentially takes
the place of helix D. In the presence of calcium the N-terminal helix is not visible in the
structure and is presumed to be expelled from the core domain. The calcium ions are
shown as orange spheres.
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both these cases a greater number of water molecules are used to satisfy the calcium
coordination. Further, these sites appear to have a greater variability within the annexin
structures, likely due to differences in crystallization conditions. Remarkably, the calcium
ions all lie on the same curved side of the annexin structures (Swairjo et al. 1995) forming
a convex surface proposed to interact with phospholipids (Figure 1.5).
Unlike the structures of EF-hand signalling proteins such as troponin-C
(Herzberg and James 1985) or members of the S100 protein family (Nelson and Chazin
1998; Maler et al. 2002), the annexins do not appear to undergo a significant structural
change within their core domains upon calcium binding. For example, a comparison of
the calcium-free and calcium-bound forms of annexins A1 and A2 show only 1.56 and
0.72 Å differences between the backbone arrangements of these structures. The most
significant difference between these structures is a disruption of the packing of the helices
in repeat III of calcium-free annexin A1 due to the presence of an N-terminal helix. The
N-terminal extension ranges between eleven (annexin A6) and more than 50 residues
(annexin A7, A11) and is only found in some annexins (A1, A2, A6, A7, A9, A11).
However, annexin A1 is the only member of the group where the intact N-terminal
sequence is visible in the x-ray structure (Rosengarth et al. 2001). In the calcium-free
state this structure shows that the N-terminus of annexin A1 forms a kinked α-helix where
residues A2-A11 from this helix are buried against helix E (D259-A271) of repeat III and
backing on to helix C. The unique feature of this N-terminal helix is that it has essentially
replaced helix D from the helical packing arrangement in repeat III found in the calciumbound form of annexin A2 or in other annexin structures. In the presence of calcium, the
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N-terminal helix is absent from the annexin A1 structure suggesting it has been
extruded from the core structure (Rosengarth and Luecke 2003). This calcium-sensitive
extrusion is reminiscent of that exhibited by the EF-hand protein recoverin which releases
an N-terminal myristoyl group upon calcium binding (Ames et al. 1995a; Ames et al.
1995b). Studies of peptides derived from the N-terminus of annexin A1 reveal that an
extruded N-terminus likely has little regular secondary structure but undergoes a coilhelix transition upon protein or membrane binding (Yoon et al. 2000; Hu et al. 2008).

1.6

Structures of S100 Proteins in Complex with the Annexins
The first structure of an S100 protein in complex with an annexin protein was

solved by Rety et al. (Rety et al. 1999) and comprised S100A10 bound to the first 13
residues of the N-terminus of annexin A2. One year later, the structure of Ca2+-S100A11
bound to the 14 N-terminal residues of annexin A1 was determined (Rety et al. 2000).
These two structures (Figure 1.4) provide valuable information regarding how these two
protein families physically interact with one another, and how these interactions give rise
to the biological functions that have been observed in the cell. S100s have long been
known to interact with members of the annexin family and that these interactions play a
role in membrane fusion events (Harder and Gerke 1993; Mayorga et al. 1994; Jost et al.
1997). In particular, the structures reveal a common mode of interaction among these two
protein families as well as key elements for target specificity.
Early studies showed that the binding of annexins A1 and A2 to Ca2+-S100A11
and S100A10 respectively was strongly dependent on the unique N-terminal regions of

17

the annexin proteins (Johnsson et al. 1986; Johnsson et al. 1988; Mailliard et al. 1996;
Jost et al. 1997). This was confirmed from crystal structures of Ca2+-S100A11 and
S100A10 (Rety et al. 1999) in the presence of N-terminal annexin peptides. Despite the
differences between the sequences of the S100 proteins (Figure 1.6), their calcium-bound
state and the sources of the two annexin peptides, both structures show two annexin
peptides per S100 dimer, located in near-identical binding sites on either side of the S100
molecule (Figure 1.4). Each peptide makes contacts with both S100 protomers resulting
in the bridging together of the two protomers by the annexin protein. In each case, the
peptides form α-helical structures when bound to their S100 binding partners, as had been
previously predicted based on their sequences (Acetyl-AMVSEFLKQAWFID and
Acetyl-STVHEILSKLSLEG for annexin A1 and A2, respectively) (Johnsson et al. 1988;
Becker et al. 1990; Mailliard et al. 1996) and the structure of this region in the calciumfree form of annexin A1 (Rosengarth et al. 2001). Furthermore, N-acetylation of the
peptides is a requirement for the S100-annexin interactions (Johnsson et al. 1988; Becker
et al. 1990; Rety et al. 2000) since removal of the acetyl group in annexin A2 results in a
2700-fold decrease in binding affinity to S100A10 (Becker et al. 1990). Although no
direct contacts are made between the acetyl groups and the S100 proteins, it has been
suggested that the acetyl group aids in stabilizing the helix dipole of the annexin Nterminus and therefore the required helical conformation of the peptide. The backbone
RMSD for the entire Ca2+-S100A11-annexin A1 and S100A10-annexin A2 complexes is
0.85 Å. This is a clear indication of a common mode of interaction between these
members of the S100 and annexin families.
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Figure 1.6. Similarity of sequences and protein-protein contacts in S100-annexin
structures.
(A) A sequence alignment of S100A11 (pig) and S100A10 (human) is shown to allow
comparison of the residues involved in interactions with the annexin peptides. The helices
are shaded in similar colours to those used in Figure 1.4 and the calcium-binding loop
residues are underlined. Schematic representations of the contacts between S100A11 and
the annexin A1 peptide (B) and between S100A10 and annexin A2 (C) are shown to
illustrate the similarities in the two complexes. The annexin peptides are shown as helical
wheels to show the relative positions of the amino acids in the helices, with the key
hydrophobic residues shaded in light purple forming a XOOXXOOX motif. The residues
of the respective S100 binding partners that make contacts (< 6 Å) with each of the
hydrophobic residues are labeled. For example, the side chain of L7 of annexin A1 is
within 6 Å of the side chains of L45, A47, F48 within the linker of S100A11, L85 and
C89 of helix IV and E9’ and I12’ of helix I’ of the other monomer. L7 of annexin A2
makes nearly identical contacts with F38, F41, L78, C82, E5’ and M8’ of S100A10 as
can be seen when the residues are compared in the sequence alignment of the two
proteins.
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Hydrophobic surface plays a major role in the interactions between the
annexin N-termini and the S100 proteins. The amphipathic nature of the annexin
sequences presents a series of hydrophobic residues on one face of the α-helix that
interact with S100A10 or Ca2+-S100A11. In annexin A1, the hydrophobic surface is made
up of V3, F6, L7 and A10 and in annexin A2 it is made up of residues V3, I6, L7 and L10
(Figure 1.6). This representation clearly indicates a strong conservation of hydrophobic
residues at these positions (XOOXXOOX; X=hydrophobic residue, O=polar residue) that
make the largest number of contacts with the S100 proteins. In the S100A10-annexin A2
structure, V3 of the annexin A2 peptide interacts with a large number of residues in helix
I’ (E5’, M8’, E9’, M12’). Similarly, E9’, I12’, E13’ and I16’ of S100A11 are in close
proximity to V3 of annexin A1 (Figure 1.6B). The importance of this residue was further
illustrated by its substitution with a polar amino acid, that lead to a complete loss of
binding between annexin A2 and S100A10 (Becker et al. 1990). However, the Ca2+S100A11-annexin A1 complex formation seems less sensitive to substitution since
replacement of V3 with alanine results in little change in binding affinity (RintalaDempsey et al. 2006). The residue at position 6 (I or F) makes numerous contacts with
helix IV (C82, Y85, F86, M90 in S100A10 and L85, A88, C89, S92 in S100A11). The
sidechain of L7 makes the largest number of contacts with the S100 proteins by
interacting with residues in the linker (F38, F41 in S100A10 and L45, A47, F48 in
S100A11), helix IV (L78, C82 in S100A10 and L85, C89 in S100A11) and helix I’ (E5’,
M8’ in S100A10 and E9’, I12’ in S100A11). Reduction of the size of the hydrophobic
sidechain at positions 6 and 7 by substitution with either an alanine or valine in both
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annexins A1 and A2 dramatically reduces binding, indicating the close packing of the
S100-annexin interaction (Becker et al. 1990; Rintala-Dempsey et al. 2006). The residue
at position 10 (A or L) is near helix IV (A81, C82, Y85 in S100A10 and A88, S92 in
S100A11). Several hydrogen bonds between the peptides and the S100 proteins stabilize
the interaction.
The structures of the S100A10-annexin A2 and Ca2+-S100A11–annexin A1
heterotetramers show how a single S100 protein might interact with two annexin proteins
(Rety et al. 1999; Lewit-Bentley et al. 2000; Rety et al. 2000). As proposed by Gerke and
Moss (Gerke and Moss 2002) this would provide an elegant mechanism whereby
calcium-binding by an annexin protein not only promotes its association with a
phospholipid membrane but also facilitates interaction with either S100A10 or Ca2+S100A11 allowing two membrane surfaces to be brought within close proximity for a
fusion or vesiculation event.

1.7

Insights into other S100-Annexin Interactions
Other interactions between the S100 and annexin families have been reported.

Consistent with the calcium-induced conformational change observed in S100A11, most
of these complexes require the calcium form of the S100 protein although there are a few
calcium-independent interactions, including S100A4 and annexin A2 (Semov et al. 2005).
Some annexins, such as annexin A6, have many possible S100 binding partners: S100A1
(Garbuglia et al. 2000), S100A6 (Zeng et al. 1993), S100A11 (Chang et al. 2007) and
S100B (Garbuglia et al. 2000), while other S100 proteins can interact with several
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different annexins. For example, S100A6 has been shown to bind annexins A2 (Filipek
et al. 1995), A6 (Zeng et al. 1993) and A11 (Tokumitsu et al. 1992). The S100A6annexin A11 interaction appears to involve a similar pattern of hydrophobic residues
(XOOXXOOX) from the N-terminal extension of annexin A11 (L52, M55, A56 and
M59) (Sudo and Hidaka 1999) as observed for annexins A1 and A2 and this region is
predicted to adopt an amphipathic helix. Similar to the S100A10-annexin A2 complex,
S100A4 also interacts with the N-terminus of annexin A2 in a calcium-independent
manner (Semov et al. 2005). Alternatively, the interaction between S100A11 and annexin
A6 involves residues within each of the two core domains of annexin A6 (Chang et al.
2007). A similar conclusion has been reached for the interaction of S100A1 and S100B
with annexin A6 (Garbuglia et al. 2000). In this latter case, and for the S100A12-annexin
A5 interaction (Hatakeyama et al. 2004) it has also been observed that the extreme Cterminus of the S100 protein is not involved in the annexin interaction. This is in contrast
to observations for the S100A10-annexin A2 and Ca2+-S100A11-annexin A1 complexes
(Figures 1.4 and 1.6) where the C-termini of the S100 proteins are indispensable, likely
due to the elongated nature of helix IV which extends nearly to last residue in each
protein. Together, these results indicate that multiple modes of binding between S100
proteins and annexins are possible.
Uncovering the potential binding sites in the core domains of annexins A1, A2
and A5 for S100 proteins have not yet been attempted. Other than the calcium-sensitive
extrusion of the N-terminal helix from annexin A1 and A2, the most significant structural
change observed in the annexins is the exposure of Trp187 in annexin A5 at high calcium
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ion concentrations (Huber et al. 1992; Concha et al. 1993; Sopkova et al. 1993). The
exposure of this residue facilitates binding to the phospholipid membrane so is unlikely to
also be used for interactions with an S100 protein. In addition, this residue is not
conserved in annexins A1 and A2 where lysine residues exist. Rather, the most obvious
choice for S100 protein binding with the annexins is the opposite “side” of the core
domain from the membrane-binding region. An attractive site might be helix C from
domain IV as this helix sits near the bottom of the structure (Figure 1.4). In the absence of
calcium, helix C is protected by the N-terminal helix in annexins A1 and A2. Upon
calcium binding to the annexin protein, several residues near helix C become mostly
exposed (E305, N309, D310, A313, K317 in annexin A1). Several of the analogous
residues are also exposed in annexin A5. However, analysis of this helix does not reveal
the XOOXXOOX motif used in the N-terminal helix, suggesting a different mode of
interaction may be occurring. It is also interesting that residues V287-V298 in annexin
A2 match the TRTK-12 consensus motif observed for peptide binding to S100B
(McClintock and Shaw 2000). However, most of these residues appear to be buried in
annexin A2. Further experiments will be needed to confirm whether this or some
alternative site on the annexin proteins is used to interact with other S100 proteins.
While the structures of Ca2+-S100A11 and S100A10 clearly show the surfaces
used to interact with annexins A1 and A2 respectively, models of other S100-annexin
complexes such as Ca2+-S100A11 with annexin A6 are not available. However, some
information about potential binding sites can be gleaned by examination of S100 protein
structures in the apo- and calcium-bound states. For example, S100A11 utilizes several
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residues in helices I (E9, I12, I13, I16), the linker (L45, A47, F48) and the extreme Cterminus of helix IV (L85, A88, C89, S92) to interact with annexin A1 (Figure 1.6).
Many of these residues are inaccessible in the calcium-free state and would be expected
to provide an interactive surface not only for annexin A1 but for other annexin proteins. It
will be important to complete site directed mutagenesis experiments on S100 proteins
such as S100A11 to understand the roles of these residues on the affinities for different
annexin proteins.

1.8

Different Modes of Recognition for S100 Target Protein Complexes
The three-dimensional structures of several S100 proteins have been determined

in complex with a variety of peptides derived from their parent proteins. These include
calcium- bound S100B (Ca2+-S100B) in complex with peptides from the C-terminal
region of p53 (Rustandi et al. 2000), the N-terminal regulatory domain from Ndr kinase
(Bhattacharya et al. 2003) and the actin-capping protein CapZ (TRTK12) (Inman et al.
2002; McClintock and Shaw 2003; Charpentier et al. 2010); calcium-bound S100A1
(Ca2+-S100A1) in complex with peptides from CapZ (Wright et al. 2009) and

the

cytosolic region of the ryanodine receptor (RyR) (Wright et al. 2008); calcium-bound
S100A6 (Ca2+-S100A6) in complex with a C-terminal region from the Siah-1 interacting
Protein (SIP) (Lee et al. 2008) and, Ca2+-S100A11 in complex with the N-terminus of the
phospholipid-binding protein annexin A1 (Rety et al. 2000). In addition, the structure of
S100A10, an S100 protein unable to bind calcium due to substitutions in both calciumbinding loops, is available in complex with the N-terminal region from annexin A2 (Rety
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et al. 1999). In general these structures show there are at least three distinct modes a
target protein adopts when binding to an S100 protein (Figure 1.7), all showing a
symmetric relationship and 1:1 stoichiometry for the target:S100 protomer.
The first mode of binding involves the interaction between the target protein and
the hydrophobic surface exposed between helices III and IV due to calcium binding to the
S100 protein. In this case, all interactions between the target and the S100 protein occur
at the S100 protomer level. This type of interaction is exhibited in the Ca2+-S100B
structures with TRTK12 (Protein Data Bank accession codes - 1MWN, 1MQ1, 3IQO),
Ndr kinase (1PSB, Figure 1.7A) and p53 (1DT7), and the Ca2+-S100A1 structures with
TRTK12 (2KBM, Figure 1.7A) and the ryanodine receptor (2KF2). In the p53 (Rustandi
et al., 2000) and Ndr kinase (Bhattacharya et al. 2003) structures, each bound peptide
forms a three-turn α-helix such that its N-terminus lies near the N-terminus of helix III
and its C-terminus has key interactions with the C-terminus of helix IV of Ca2+-S100B. In
contrast, the TRTK12 structures with Ca2+-S100A1 (Wright et al., 2009) and Ca2+S100B (Inman et al., 2002) form 1.5 turn α-helices and are aligned nearly perpendicular
to the orientations of the p53 and Ndr peptides such that the C-terminus of TRTK12 is
closer to the middle of helix IV (Figure 1.7A). Even though the TRTK12 peptide binds
within the helix III-IV cleft in both structures the presentation of the peptide is different
when bound to Ca2+-S100A1 compared to Ca2+-S100B. In Ca2+-S100A1 the anchoring
tryptophan (W7) of TRTK12 interacts with residues towards the C-terminus of helix IV
(L81, A84, C85, F88) whereas in Ca2+-S100B, this same tryptophan interacts with
residues in the linker (L44, E45, I47) and helix III (V53, V56). These differences have the

Figure 1.7. Different modes for target protein interaction with S100 proteins.
(A) Binding to the helix III-IV hydrophobic displayed by TRTK12 (pink) bound to Ca2+-S100A1 (2KBM)
(Wright et al. 2009) and NDR kinase (cyan) bound to Ca2+-S100B (1PSB) (Bhattacharya et al. 2003). (B)
Binding near helix I’ at the dimer interface displayed by the N-terminal region of annexin A1 (pink) and Ca2+S100A11 (1QLS) (Rety et al. 2000). (C) Two- site surface mode displayed by the C-terminal region of SIP
bound to Ca2+-S100A6 (2JTT) (Lee et al. 2008). Ribbon diagrams of the calcium-saturated S100 proteins are
presented with one of the protomers shaded in black (helices labeled as I-IV) and the other protomer shown in
light grey (helices labeled as I’-IV’). Calcium ions are illustrated in yellow spheres.
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effect of rotating the entire TRTK12 peptide by about 60˚ and “tipping” the peptide by
about 20˚ towards helix III in the Ca2+-S100B structure. Pictorially the binding of a
peptide representing the cytosolic region from the ryanodine receptor to Ca2+-S100A1
(Wright et al. 2008) appears to be quite similar to that described for TRTK12. However,
major differences exist as the RyR peptide forms a three-turn α-helix and is oriented
nearly 180˚ with respect to TRTK12 such that its C-terminus is proximal to the Nterminus of helix III in Ca2+-S100A1. An anchoring tryptophan (W5) in the RyR peptide
interacts with residues near the middle of helix IV (L77, A80, L81) but also with I57 in
helix III. The diversity of the interactions exhibited by these five S100-target peptide
structures can be attributed to the binding surfaces in S100A1 and S100B that are broader
and flatter than other calcium-sensor proteins (i.e. calmodulin) and have different
distributions of hydrophobic and charged residues (Lee et al. 2008). This observation
likely accounts for the broad spectrum of target proteins that interact with the S100
proteins and makes prediction of target binding based on protein sequence somewhat
problematic.
The second mode of interaction utilized by the S100 proteins is displayed by
structures of Ca2+-S100A11 (1QLS, Figure 1.7B) and S100A10 (1BT6) in complexes
with the N-terminal peptides from annexins A1 and A2 respectively (Rety et al. 1999;
Rety et al. 2000). Unlike the diversity displayed by Ca2+-S100A1 and Ca2+-S100B, these
structures show nearly identical locations and orientations for peptide binding such that <
1 Å rmsd exists between structures. In both structures the annexin peptide bridges the two
S100 protomers such that its C-terminus interacts with the linker and helix IV of one
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protomer while the annexin N-terminus has contacts near the N-terminus of helix I’ of
the partner protomer. The similarity of these S100-annexin structures is not surprising
given the conservation of hydrophobic residues in both annexin peptides. The interacting
residues correspond to V3, F6, L7 and L10 in annexin A1 and V3, I6, L7 and L10 in
annexin A2 forming a XOOXXOOX interaction motif (X=hydrophobic residue,
O=variable). This level of conservation does not exist between the TRTK12, RyR, p53
and Ndr sequences described earlier in complex with Ca2+-S100A1 or Ca2+-S100B
proteins. Some similarity also exists in the annexins contacting residues in S100A10 and
Ca2+-S100A11, especially in helix I’ and helix IV.
Although it has been shown that N-terminal peptides from annexins A1 and A2
both interact with Ca2+-S100A11 (Rintala-Dempsey et al. 2006), it is interesting to note
that annexin A1 does not form a tight complex with S100A10 (Streicher et al. 2009).
Further, a strong level of specificity has been shown for S100 recognition of annexins A1
and A2. Other than S100A10 and Ca2+-S100A11, the only other S100 protein that
displays a tight calcium-dependent interaction with annexin A1 is S100A6 (Streicher et
al. 2009).
Whereas both the previous modes of target peptide binding with S100 proteins
utilized different albeit contiguous surfaces, the recent structure (Lee et al. 2008) of the
C-terminal domain from the Siah-1 Interacting Protein (2JTT) shows a hybrid two-site
surface (Figure 1.7C). In this structure the SIP peptide forms two distinct three-turn αhelices oriented nearly perpendicular to each other upon binding to Ca2+-S100A6. The
first helix (Helix A) occupies a position and orientation similar to that observed for the
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RyR peptide utilizing the hydrophobic groove between helices III and IV. Helix A of
SIP lies diagonally across helix III in Ca2+-S100A6 with L196 and I199 anchoring the
peptide through interactions with residues in helix IV and the C-terminus of helix III
respectively. The second helix in SIP (helix B) lies across helix I’ of the adjacent
protomer, in effect bridging the two S100A6 subunits analogous to the S100-annexin
complexes. Whereas the annexin structures only contact the N-terminus of helix I’ in
either S100A10 or Ca2+-S100A11, helix B in SIP has interactions towards the more
central portion of helix I’ (I9’, I13’ and K18’). This results in helix B of SIP and helix I of
Ca2+-S100A6 running along opposite faces of helix I’ forming a near mirror image of
each other, albeit helices I and B are oriented in opposite directions. The two binding
regions for SIP to Ca2+-S100A6 could in part be due to the length of the SIP fragment
(189-219; 30 residues) that is significantly longer than any of the other target peptides for
which structures are available. Lee and co-workers show that the two helices in SIP are
not equivalent in their abilities to coordinate S100A6 with helix A having a much tighter
binding, while the less hydrophobic helix B enhances the affinity by about 4-fold.
The three modes of target binding to the S100 proteins utilize two distinct
binding regions – the helix III-IV hydrophobic groove and the dimer interface near helix
I’ on the partner protomer. It has been suggested that the combination of these two
regions might represent the full interaction surface for single or multiple protein
interactions with the S100 proteins. Otterbein proposed this idea by superimposing the
peptide binding regions for annexins A1 or A2, and p53 on the surface of Ca2+-S100A6
showing these peptides occupied distinct regions of the surface with no observable steric
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clashes between the peptides (Otterbein et al. 2002). Subsequently, it was shown for
TRTK12 binding to Ca2+-S100B that a region similar to the annexin binding site was left
exposed, and that a larger target protein might be accommodated (McClintock and Shaw
2003). The structure of SIP bound to Ca2+-S100A6 (~1100 Å) provides the first structural
evidence for a target protein that occupies both the helix III-IV groove and helix I’
interface, a binding surface that is nearly twice the size of other S100 target protein
surfaces (500-700 Å). Amongst the questions raised by this important structure and
earlier hypotheses are – is there evidence for other S100 protein complexes that might
utilize this larger target protein binding surface or can this surface possibly accommodate
simultaneous binding for two distinct target proteins?

1.9

Evidence for Multiprotein S100 Complexes Involving Annexin Proteins
A variety of S100 protein interactions have been shown to be more complicated

than a single target interacting per S100 protomer molecule. For example multiprotein
complexes between S100A10 and annexin A2 and either AHNAK (Benaud et al. 2004;
De Seranno et al. 2006), TRPV5/6 (van de Graaf et al. 2003; Borthwick et al. 2008) or
plasminogen (MacLeod et al. 2003) have been identified from two- and three-hybrid or
direct binding experiments. The S100A10-annexin A2 complex is thought to be necessary
to recruit an additional target, or allow both targets to bind simultaneously indicating that
the binding sites for AHNAK, TRPV5/6 and plasminogen on S100A10 are likely distinct
from those of annexin A2. The complexes described here focus on those for S100A10,
largely because it functions well in yeast two-hybrid experiments. Other S100 proteins
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(S100B, S100A1, S100A6) do not respond well in this method due to the calciumsensitivity of their protein interactions, although homo- and heterodimeric S100
complexes can be identified using two-hybrid experiments (Deloulme et al. 2000;
Deloulme et al. 2003).
The interaction between the transient receptor potential cation channel proteins
TRPV5 and TRPV6 with S100A10 has been shown using two-hybrid and coimmunoprecipitation experiments (Figure 1.8A) (van de Graaf et al. 2003; Borthwick et
al. 2008). In this role, the S100A10-annexin A2 complex is thought to mediate trafficking
of the TRPV5 and TRPV6 proteins to the plasma membrane where they act as calciumselective channels. The site of interaction on TRPV5 and TRPV6 for S100A10 has been
localized to its intracellular C-terminal tail. Using a series of truncated and substituted
proteins this has been refined to contain residues 598-603 (VATTV), a highly conserved
region in both channel proteins. Although S100A10 forms a ternary complex with
annexin A2 and either TRPV5 or TRPV6, there does not appear to be a direct interaction
between

the annexin and TRPV proteins based

on negative results from

immunoprecipitation experiments. Rather, S100A10 seems to bridge the two proteins
indicative of different binding sites for annexin A2 and TRPV5/TRPV6, although this has
not been demonstrated yet. Since S100A10 and annexin A2 co-localize with
TRPV5/TRPV6, the S100A10-annexin A2 complex has been proposed to traffic these
calcium channels to the plasma membrane.
S100A10 has been shown to interact with the potassium channel TASK-1 using
two-hybrid, GST pull-down and co-immunoprecipitation experiments, and has a role in
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the trafficking of TASK-1 to the plasma membrane (Girard et al. 2002; Renigunta et al.
2006). TASK-1 is an important regulator of membrane potential that can be affected by a
variety of factors including pH, hormone and neurotransmitter binding. Two studies show
binding of S100A10 to the C-terminus of TASK-1 albeit to different regions of the
channel protein. In one study, S100A10 was observed to interact with the extreme Cterminal sequence (SSV) of TASK-1 previously established as a site for 14-3-3 binding
(Girard et al. 2002). In more recent work, the S100A10 site was localized to a more
central region in the C-terminus (residues 292-331) of TASK-1 (Renigunta et al. 2006).
A portion of this sequence is highly conserved in TASK-1 orthologs, but not in TASK-3,
which exhibits little binding to S100A10. Further, a segment of this sequence
(FRNVYAEML) bears a strong similarity to the interaction motif (XOOXXOOX) used
by annexins A1 and A2 upon binding to S100A11 and S100A10, respectively (Mailliard
et al. 1996; Rintala-Dempsey et al. 2008). An interaction between S100A10 and annexin
A2 in the presence of TASK-1 can not be shown suggesting the S100A10 binding regions
for TASK-1 and annexin A2 at least partly overlap. It has further been shown that the
S100A10 interaction promotes retention of TASK-1 in the endoplasmic reticulum due to
the presence of a retention signal at the extreme C-terminus of S100A10 (KQKGKK)
(Renigunta et al. 2006). Alternatively, binding of S100A10 to TASK-1 has been
suggested to mask an endoplasmic retention signal near the C-terminus of TASK-1
(KRR) and promote trafficking of the potassium channel to the plasma membrane (Girard
et al. 2002).
S100A10 interacts with the bluetongue virus protein NS3 (Beaton et al. 2002), a

Figure 1.8. Possible involvement of S100A10 in multiprotein complexes.
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(A) Possible complexes formed by membrane channel proteins such as TRPV5, TRPV6 or Nav1.8 and S100A10annexin A2 for trafficking to the plasma membrane. Once inserted into the membrane, the S100A10-annexin A2
could dissociate or become associated with phospholipids in the membrane. (B) Proposed interactions in the
dysferlin complex are based on multiple biochemical experiments. The C-terminus of AHNAK is shown to
interact with S100A10 and annexin A2, while the dysferlin C2A domain is near annexin A2 (adapted from Huang
et al. 2007). In all cases, dimeric S100A10 could coordinate two annexin A2 proteins although for simplicity only
one is shown.
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membrane spanning protein thought to have a role in the export of virus particles from
infected cells. Two-hybrid and affinity experiments show that residues at the N-terminus
of NS3 (1-13) are most important for its interaction with S100A10. This region has the
potential for α-helix formation and possesses a sequence (LSGLIQRF) corresponding to
the annexin binding motif (XOOXXOOX) suggesting these two proteins likely share the
same binding region on S100A10 (Figure 1.7B). Using synthetic peptides corresponding
to the N-terminus of NS3, it was shown that a peptide comprising residues 1-14 could
compete with annexin A2 for S100A10 binding. Whereas annexin A2 could displace NS3
from an S100A10-NS3 complex, NS3 could only partially displace annexin A2 from an
S100A10-annexin A2 complex indicating annexin A2 has a tighter binding to S100A10
than does NS3. It was suggested that NS3 might play a role in localizing a virus particle
to the interior of the plasma membrane by bridging S100A10 and the virus particle
providing an efficient route for extrusion from the cell.
The voltage-gated sodium channel Nav1.8 has been observed, using two-hybrid
experiments, to interact with S100A10 (Figure 1.8A) (Okuse et al. 2002; Poon et al.
2004). Further, this interaction facilitates trafficking of the channel protein to the plasma
membrane resulting in functional Na+ currents. Other voltage-gated channels such as
Nav1.2, Nav1.5, Nav1.7 and Nav1.9 have much poorer affinity for S100A10 providing
evidence that some degree of specificity for the voltage-gated sodium channel Nav1.8
exists. The site of interaction with S100A10 has been localized to the N-terminus of the
sodium channel. In particular residues 74-103 of the voltage-gated sodium channel
Nav1.8 are sufficient to bind to S100A10 in GST pull-down assays. Reciprocal

34

experiments using segments of S100A10 show that a region spanning much of the Cterminal half of the protein is able to interact with the N-terminal region of the voltagegated sodium channel. This region does not include the extreme N- or C-termini of
S100A10, known to interact with the annexin proteins so would appear to be a unique
binding surface. However, it has not been shown whether annexin A2 can also bind to
S100A10 in the presence of the sodium channel, an event that could facilitate association
with the plasma membrane.
A multiprotein complex has been identified between S100A10, annexin A2 and
AHNAK (Figure 1.8B) (Benaud et al. 2004; De Seranno et al. 2006), a protein found in
the lumen of enlargeosome and trafficked to the plasma membrane in response to calcium
flux. Recruitment of AHNAK to the plasma membrane by S100A10 in complex with
annexin A2 is also proposed to maintain the proper cytoarchitecture of epithelial cells
(Benaud et al. 2004). AHNAK is an important protein for cell membrane differentiation
and membrane repair (Kouno et al. 2004), is expressed in epithelial cells and localizes
near the plasma membrane. The protein contains three main structural domains; an amino
terminus (251 aa), a central region containing thirty-six repeats and a C-terminus (1002
aa) (Shtivelman and Bishop 1993). The interaction between S100A10 and annexin A2
utilizes the N-terminus of annexin A2 similar to that observed in the S100A10-annexin
A2 tetramer crystal structure (Rety et al. 1999). In the absence of annexin A2, a weak
interaction between S100A10 and the C-terminal portion of AHNAK is present.
However, the strength of this interaction was increased more than 150-fold in the
presence of annexin A2. Further, in vitro binding assays showed no detectable
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interactions between annexin A2 and the C-terminus of AHNAK, in the absence of
S100A10, or S100A10 with AHNAK in the absence of annexin A2. These observations
suggest that S100A10-annexin A2 tetramer formation is likely a prerequisite for the
interaction with AHNAK. Using a series of GST pull-down assays, a 20-residue region in
AHNAK corresponding to residues 5654-5673 was found to be sufficient to bind to
S100A10-annexin A2 and can compete for binding to the complex with the entire
AHNAK C-terminus having a Kd of about 30 nM (De Seranno et al. 2006). The AHNAK
interaction appears to be specific for annexin A2 since other annexins (A4, A11) are not
recovered from immunoprecipitation experiments. However, given the similarity of the
binding surfaces and interacting residues for annexins A1 and A2 (Rintala-Dempsey et al.
2008), it is possible that an S100A10-annexin A1 or Ca2+-S100A11-annexin A1/A2 may
also participate in the AHNAK complex. Interestingly, Ca2+-S100B is able to compete
with S100A10-annexin A2 for binding to the AHNAK C-terminus. Further, it has been
observed that Zn2+ binding to S100B enhance its association with AHNAK (Gentil et al.
2001). Unlike the S100A10-annexin A2 interaction that utilizes only the C-terminus of
AHNAK, several regions in AHNAK are able to interact with Ca2+-S100B. These include
sequences in the repeat regions in the central portion of AHNAK (820-1330, 2589-3059,
3730-4188) as well as its C-terminus.

1.10

Role for S100 Proteins in Membrane Repair
The fusion of cellular phospholipid membranes is an important step during

membrane repair, vesicular trafficking and exocytosis. A requisite for plasma membrane
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repair is calcium-regulated exocytosis, controlled by a number of proteins that
coordinate resealing of the membrane. One exocytotic compartment implicated in
membrane fusion is the enlargeosome, characterized by the large scaffolding protein
AHNAK, that relocates to the plasma membrane immediately following membrane
damage (Zhang, et al. 2004). In addition to AHNAK, calcium-sensors such as members
from the synaptotagmin, ferlin (dysferlin) and annexin protein families are involved in
membrane repair. Upon membrane rupture, these sensor proteins respond to the calcium
influx by localizing near the inner membrane surface. Recent proteomic analyses have
identified approximately 115 proteins in the dysferlin complex including calpain 3,
annexin A2 and AHNAK (de Morree et al. 2010; Cacciottolo et al. 2011) that might be
responsible for the repair process. These studies indicate that large protein complexes are
likely needed to orchestrate the repair process and restore the integrity of the membrane.
S100A10, AHNAK and the annexins have been shown to be constituent
proteins in the dysferlin membrane repair complex (Huang et al. 2007). This multiprotein
complex is thought to form at the site of muscle, epithelial and auditory cell damage to
facilitate wound repair. The mechanism of cell membrane repair involves the aggregation
of vesicles containing dysferlin, a type II membrane spanning protein, near the wound.
In vivo and in vitro studies show that annexin A2 is a central protein involved in
membrane transport events such as endo/exocytosis (Sarafian et al. 1991; Emans et al.
1993; Harder and Gerke 1993; Diakonova et al. 1997; Harder et al. 1997; Jost et al. 1997;
Merrifield et al. 2001; Knop et al. 2004; Ayala-Sanmartin et al. 2008; Zibouche et al.
2008; Illien et al. 2010). Calcium-binding to the annexins promotes their localization and
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association with phospholipid-containing membranes through the convex surface of the
core domain (Swairjo et al. 1995). In the case of annexins A1 and A2, calcium binding is
proposed to lead to the release of the previously buried N-terminus to an exposed position
available for interaction with S100A10 protein (Gerke and Moss 2002). Thus, an
S100A10 dimer can coordinate a pair of annexin A2 proteins, potentially bridging
adjacent phospholipid membranes into close proximity during a membrane fusion event
(Gerke and Moss 2002). This leads to the aggregation of vesicles and formation of an
endomembrane patch (Figure 1.9). As with S100A10 and annexin A2, the AHNAK
protein gets located on the plasma membrane (Kouno et al. 2004), where the interaction
between dysferlin and this complex can mediate the docking and fusion of the patch and
sealing of the membrane. For instance, a high calcium concentration (extracellular, via
the wound) causes annexin A1 and A2 association with a dysferlin-containing vesicle and
damaged plasma membranes. The central protein in this process, dysferlin (Doherty and
McNally 2003; Shao et al. 2006; Glover and Brown 2007), has been shown to co-localize
and co-immunoprecipitate with annexins A1 and A2 (Lennon et al. 2003). Recent threehybrid and co-immunoprecipitation experiments have also provided some details of the
dysferlin repair complex. Using a series of truncated AHNAK constructs it has been
shown that the extreme C-terminal domain of AHNAK is responsible for dysferlin
binding. Although dysferlin possesses six ~130-residue C2 domains, the AHNAK
interaction is localized to only the N-terminal C2A domain of dysferlin, a region that
typically coordinates calcium as a prerequisite for phospholipid binding. Calcium binding
to the dysferlin C2A domain is not a requirement for its interaction with AHNAK.

Figure 1.9. Hypothetical diagram illustrating possible interactions of the dysferlin complex important in membrane
repair.
(A) Under resting calcium levels (100 nM), apo-S100A10 interacts with the N-terminal region of annexin A2. (B) In the
case of a lesion in the membrane, calcium influx raises the intracellular calcium concentration locally, triggering the patch
repair response. Intracellular vesicles get aggregated by calcium-bound annexin A2 that is in complex with the S100A10 to
form an endo-membrane patch. (C) This complex is trafficked to the site of disruption. Dysferlin and AHNAK molecules
present on the plasma membrane mediate docking and fusion of the patch and sealing of the membrane. Proposed
interactions in the dysferlin complex are based on multiple biochemical experiments. The C-terminus of AHNAK is shown
to interact with S100A10-annexin A2 complex, while the dysferlin C2A domain is near annexin A2.
38
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Although the exact mechanisms whereby AHNAK is recruited for plasma membrane
repair are not clear, annexin A2 and S100A10 co-localize with AHNAK at the plasma
membrane along with dysferlin providing some evidence this multiprotein complex
functions in the repair process.

1.11

Scope of Thesis
The multiple binding modes used by the S100 proteins to interact with a diverse

array of target proteins suggest a great deal of flexibility in the manner an S100 protein
recognizes a partner protein. This may prove useful to simultaneously coordinate more
than a single target protein by some S100 proteins. Recent in vivo and in vitro
experiments suggest that S100A10-annexin A2 can form multiprotein complexes with
other proteins such as AHNAK and dysferlin that are important in plasma membrane
repair.
Lack of structural information on the arrangement, affinities and structures of
these proteins in the complex does not allow understanding the mechanisms of membrane
repair. Consequently, further biochemical and structural experiments will be needed to
ascertain the general role of S100 proteins in larger multiprotein complexes.
The main goals of this thesis were 1) design, synthesize and characterize a
molecule that would facilitate assembly of larger S100 multiprotein complexes, 2)
investigate the arrangement of the proteins, stoichiometry and affinity of AHNAK for the
S100A10-annexin A2 complex and 3) identify structural details of the ternary complex
formed between S100A10, annexin A2 and AHNAK complex.
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The first objective was achieved by designing a hybrid protein in which
S100A10 was linked in tandem to the N-terminus of annexin A2 (residues 1-15). The
generality of this method was demonstrated by synthesizing a similar hybrid molecule
between S100B and the central region of CapZ (TRTK12; residues 1-12). Using NMR
spectroscopy, it was shown that the spectra for the S100A10-annexin A2 and S100BTRTK12 hybrid proteins are nearly identical to those obtained for the complexes formed
between the individual S100 proteins and synthetic peptides. The hybrid S100A10annexin A2 protein was used in the peptide array experiments to uncover the binding
region of this protein on AHNAK. The identified 20-residue C-terminal region of
AHNAK with the strongest interaction to the S100A10-annexin A2 complex was then
used in the remaining experiments. NMR spectrometry, non-denaturing electro-spray
mass spectrometry (ES-MS) and fluorescence spectroscopy provided the evidence for a
novel 1:1 interaction between an S100A10-annexin A2 dimer and an AHNAK peptide.
The dissociation constant of the interaction between the AHNAK peptide and S100A10annexin A2 was determined by fluorescence spectroscopy. Finally, NMR spectroscopy
and X-ray crystallography confirmed that the interaction of AHNAK to the S100A10annexin A2 complex utilizes residues from both, the S100A10 protein and annexin A2
peptide. Chemical shift mapping produced a binding surface for the S100A10-annexin
A2-AHNAK complex. These results provided a novel model of a larger protein assembly
required during the membrane repair process.
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Chapter 2
Design of High-Affinity S100-Target Hybrid Proteins

2.1

Introduction
Although some structures of different S100 proteins bound to target peptides

have been determined, only three crystal structures are available (S100A10-annexin A2,
Ca2+-S100A11-annexin A1, Ca2+-S100B-TRTK12) (Rety et al. 1999; Rety et al. 2000;
Charpentier et al. 2010). This is likely due to the difficulties associated with crystal
formation of the S100-target complexes. Better progress has been made for S100-target
complexes by NMR spectroscopy where structures such as calcium-bound S100B (Ca2+S100B) with peptide binding regions from p53 (Rustandi et al. 2000), Ndr kinase
(Bhattacharya et al. 2003) and CapZ (Inman et al. 2002; McClintock and Shaw 2003)
have been determined. However, some of these structures suffer from imprecision of the
side chains, especially at the protein-peptide interface making details of the interaction
difficult to characterize. This could be improved by 15N, 13C-labeling of the target peptide
although this is very costly for a synthetic peptide and can suffer from low yields and
proteolysis when expressed as a fusion protein. Only one example of a biosynthetic,
isotopically-labeled peptide exists for the 30-residue Siah-1 interacting region for Ca2+S100A6 (Lee et al. 2008).

Parts of this chapter have been taken from the published article: Rezvanpour, A., Phillips,
J. M., and Shaw, G. S. 2009. Design of high-affinity S100-target hybrid proteins. Protein
Sci. 18: 2528-2536.
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In this chapter, a method is described in which S100B and S100A10 are used
as the carrier proteins for target peptides from CapZ and annexin A2, respectively. The
premise is that the S100 protein will protect the target peptide from degradation during
biosynthesis and purification. S100A10 and S100B proteins were linked to the N-terminal
region of annexin A2 (residues 1-15) and the central region of CapZ (TRTK12; residues
1-12) using linkers containing different protease cleavage sites to facilitate isolation of the
target peptides. NMR spectroscopy has been used to show that the spectra for the
S100A10-annexin A2 (A10A2) and S100B-TRTK12 (BT12) hybrid proteins are nearly
identical to those obtained for the complexes formed between the individual S100
proteins and synthetic peptides.

2.2

Materials and Methods

2.2.1

Source of Materials
The expression vector for human S100A10 (pGEX-6P-1-derived vector, GE

Healthcare) was generously provided by Dr. Michael Walsh (University of Calgary,
Alberta, Canada). For expression vectors with an in-frame N-terminal GB1 fusion of
TRTK12, annexin A2 and AHNAK, pSAF2 vector was obtained from Dr. Susan Safadi
(University of Western Ontario). All forward and reverse oligonucleotides described
within this chapter were synthesized by Sigma-Genosys (Mississauga, ON, Canada). T4
DNA ligase was purchased from Fermentas Life Sciences (Burlington, ON, Canada). Pfu
Turbo DNA polymerase was purchased from Stratagene (La Jolla, CA, USA). All other
chemicals used in cloning were purchased from BioShop Canada (Burlington, ON,
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Canada). PreScission protease was obtained from GE Healthcare (Buckinghamshire,
UK). All DNA sequencing were performed at Robarts Research Institute Sequencing
Facility (London, ON, Canada).
15

NH4Cl and 13C6-glucose were obtained from Cambridge Isotope Laboratories,

Inc. (Andover, MA). Puratronic grade CaCl2 (99.9995% purity) was purchased from
Johnson-Matthey (Ward Hill, MA). Annexin A2 (STVHEILSKLSLEG) and TRTK12
(TRTKIDWNKILSLE) peptides were synthesized as previously described (McClintock
and Shaw 2003; Rintala-Dempsey et al. 2006). All other reagents used in the following
experiments were of the highest purity commercially available.

2.2.2

Construction of GB1-TRTK12, -annexin A2, and –AHNAK in E. coli Expression
Vectors
pSAF2 plasmid, a derivative of the pGEV1 expression vector, containing an in-

frame N-terminal GB1 gene was used to construct the GB1-TRTK12 (residues 1-12), annexin A2 (residues 1-15), and –AHNAK (residues 5654-5673) genes. The genes were
under control of a T7 RNA polymerase promoter and were used for inducible expression
of them in E. coli. In these vectors the N-terminal GB1 gene was linked to the TRTK12,
annexin A2, and AHNAK through a linker containing a thrombin protease cleavage site.
Five glycine residues were added to enhance the accessibility of the protease cut site,
which would be used to remove the GB1 tag following purification. There was also a His6
tag at the C-terminus which was separated from TRTK12, annexin A2, and AHNAK by a
tobacco etch virus (TEV) cleavage site.
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The entire DNA sequences coding for TRTK12, annexin A2, and AHNAK
were created using 5’-phosphorylated, one forward and one reverse single-stranded (ss),
complementary primers (Table 2.1). The forward and reverse primers were designed such
that following annealing, the double-stranded (ds) DNA fragment would have BamHI and
XhoI over-hangs at the N- and C-terminus, respectively. 1 µL of 1 µg/µL stock solutions
of the forward and reverse primers were mixed with 2 µL of Buffer 3 (50 mM Tris-HCl,
100 mM NaCl, 10 mM MgCl2, 1 mM DTT, pH 7.9) and the total volume was adjusted to
20 µL with ddH2O. The mixture was heated to 100 ºC for 2 minutes in a water bath to
eliminate the secondary structure of the single-stranded oligonucleotides and slowly
cooled down to room temperature to facilitate the proper annealing of the complementary
oligonucleotides. The annealed reaction (5 µL) was mixed with 1 µL of Bromophenol
blue and run on a 8 % native polyacrylamide gel in TBE (Tris-borate-EDTA) buffer. The
gel was then stained in TBE buffer with ethidium bromide. The double-stranded DNA
fragment was ligated with the BamHI and XhoI digested pSAF2 vector (Safadi and Shaw
2007) using T4 DNA ligase and then transformed into E. coli strain JM-109. Single
colonies were selected and the correct constructs were confirmed by DNA sequencing.

2.2.3

Expression and Purification of GB1-TRTK12, -annexin A2, and -AHNAK
The GB1-TRTK12, -annexin A2 and -AHNAK vectors were transformed into

E. coli strain BL21 (DE3)-RIL expression cells (Invitrogen), which contain extra copies
of the argU, ileY, and leuW tRNA genes to recognize AGA, AGG, AUA, and CUA
codons. Overnight cultures (25 mL) were used to inoculate 1 L of pre-warmed LB
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Table 2.1. Oligonucleotides used in synthesis of GB1-TRTK12, -annexin A2 and
AHNAK expression vectors.
Parental
Vector

pSAF1

Oligonucleotide
Name

Oligonucleotide Sequence (5’-3’)

Length

TRTK (F2)

GATCCATGACTCGTACTAAGATAGATTGGAACA
AGATACTGTCTC

45

TRTK (R2)

TCGAGAGACAGTATCTTGTTCCAATCTATCTTAG
TACGAGTCATG

45

AnnexinII (F2)

GATCCATGAGCACCGTACACGAAATCTTGAGCA
AACTGTCCCTGGAAGGGC

51

AnnexinII (R2)

TCGAGCCCTTCCAGGGACAGTTTGCTCAAGATTT
CGTGTACGGTGCTCATG

51

AHNAK (F2)

GATCCATGGGCAAAGTCACGTTCCCCAAAATGAA
GATCCCTAAATTCACGTTCTCCGGCAGAGAGTTAC

69

AHNAK (F2)

TCGAGTAACTCTCTGCCGGAGAACGTGAATTTAG
GGATCTTCATTTTGGGGAACGTGACTTTGCCCATG

69
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medium supplemented with 50 µg/mL ampicillin. The cultures were grown at 37 ºC to
a density of (A600) 0.8 AU, when they were induced with 1 mM IPTG. Induction
continued for another 4 h with constant shaking at 37 ºC. Cells were harvested by
centrifugation at 6,000 rpm for 15 min at 4 ºC. Following addition of one complete-mini
protease inhibitor tablet and PMSF (1 mM final concentration), the cells were lysed by
French Pressure at 20,000 psi. Ultracentrifugation of the lysed cells was performed to
remove cell debris on a Beckman ultracentrifuge at 38,000 rpm for 90 min. All
fractionation steps were performed at 4 °C. The supernatant was filtered through 0.45
micron low protein binding Millipore syringe filters (Millipore) to remove the particulate
matter. The protein was subsequently applied to a 5 mL Ni-NTA column pre-equilibrated
in 20 mM Tris-HCl, 10 mM imidazole, 300 mM NaCl, pH 8.0. The column was washed
with the same buffer containing 20 mM imidazole until the OD280 returned to baseline.
Bound protein was then eluted with a 30 mL, 20-250 mM imidazole gradient in the
elution buffer. Fractions containing the protein were pooled and extensively dialyzed
against TEV protease cleavage buffer (20 mM Tris-HCl, 150 mM NaCl, 10 mM
imidazole, 1 mM DTT, pH 7.5) for 6 h with multiple buffer exchange. GB1-peptide was
cleaved from the His6 tag using 250 units of TEV protease in 24 h with gentle agitation.
Cleaved protein was purified on a 20 mL IgG Sepharose fast flow column (Amersham) in
binding buffer to remove the His6 tag. Bound protein was eluted with 0.5 M acetic acid,
pH 3.4. Protein fractions were pooled, dialyzed against thrombin cleavage buffer (20 mM
Tris-HCl, 150 mM NaCl, 2.5 mM CaCl2, pH 8.4) and cleaved with a 1:2000 wt:wt ratio
of thrombin to protein for 14 h at 20 ºC. Cleaved GB1 was then isolated from the
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peptides utilizing an IgG Sepharose column as described above. The integrity of all
proteins was verified on 16.6% SDS-PAGE gel and electrospray ionization mass
spectrometry (Biological Mass Spectrometry Laboratory, University of Western Ontario).

2.2.4

Molecular Modeling of Hybrid S100 Proteins
The lengths of the linker connecting S100A10 to annexin A2 or S100B to

TRTK12 were determined using Swiss-PDB Viewer (Guex and Peitsch 1997). The
coordinates for S100A10 bound to annexin A2 (PDB code: 1BT6) (Rety et al. 1999) and
Ca2+-S100B complexed with TRTK12 (PDB codes: 1MQ1, 1MWN) (Inman et al. 2002;
McClintock and Shaw 2003) were obtained from the Protein Data Bank (Berman et al.
2000). The last four residues at the C-terminus of S100A10 were disordered and not
visible in the structure. Initial linkers were built using glycine spacers with moderate
rotations of φ,ψ angles. A total of nine glycine residues was required to connect the
observed C-terminus of S100A10 (K91) to the N-terminus of the annexin A2 peptide
(STVHEILSKLSLEG). Eleven glycine residues were added in the S100B-TRTK12
(BT12) hybrid from the C-terminus of the S100B (E91) to the N-terminus of the TRTK12
peptide (TRTKIDWNKILS). Each structure was energy minimized using steepest descent
minimization. Upon completion, glycine residues were swapped to those corresponding
to the TEV (S100A10) or PreScission (S100B) cleavage sites. Subsequent energy
minimization and visualization was used to insure the absence of bad contacts between
the linker residues and the corresponding S100 protein.
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2.2.5

Construction of the S100A10-annexin A2 Hybrid Gene
A derivative of the pGEX-6P-1 expression vector containing the human

homologue of S100A10 was used to construct the A10A2 hybrid gene. The QuikChange
method (Stratagene, La Jolla, CA) was used in three consecutive steps to a) substitute the
last four amino acid residues of S100A10; K93E, G94N, K95L, K96Y, b) insert a TEV
protease cleave site, and c) generate the annexin A2 hybrid DNA fragment. Forward and
reverse primers used in these procedures are shown in Table 2.2. The resulting vectors at
each step of the cloning were confirmed by DNA sequencing.

2.2.6

Expression and Purification of S100A10 and S100A10-Annexin A2
Uniformly

15

N,

13

C-labeled GST-S100A10 and GST-S100A10-annexin A2

(A10A2) were over-expressed in the BL21 (DE3) Codon Plus E. coli strain using M9
minimal medium supplemented with 1 g

15

NH4Cl and 2 g

13

C6-glucose as the sole

nitrogen and carbon sources, respectively. The cultures were grown at 37 ºC in the
presence of ampicillin (50 µg/mL) to a density of (A600) 0.8 AU, then induced by adding
1 mM IPTG. Induction continued for another 8 h with constant shaking at 37 ºC. Cells
were harvested by centrifugation at 6,000 rpm for 15 min and lysed by French Pressure at
20,000 psi. Cell debris was removed by centrifugation at 38,000 rpm for 90 min. All
fractionation steps were performed at 4 °C. The supernatant was applied to a 5 mL
glutathione-linked Sepharose column equilibrated in PBS buffer (140 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3). The 15N, 13C-labeled GST-S100A10 or
GST-A10A2 were eluted in elution buffer (50 mM Tris-HCl, 20 mM reduced glutathione,
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Table 2.2. Oligonucleotides used in synthesis of A10A2 expression vector.
Parental
Vector

S100A10

Oligonucleotide
Name

Oligonucleotide Sequence (5’-3’)

Length

S100A10AnX(F1)

GTGCACATGAAGCAGGAGAACCTGTACTGACTCGA
GCGGCCG

42

S100A10AnX(R1)

CGGCCGCTCGAGTCAGTACAGGTTCTCCTGCTTCAT
GTGCAC

42

S100A10AnX(F2)

CAGGAGAACCTGTACTTTCAAGGGGATTCCACAGTT
TGACTCGAGCGGCCG

51

S100A10AnX(R2)

CGGCCGCTCGAGTCAAACTGTGGAATCCCCTTGAAA
GTACAGGTTCTCCTG

51

S100A10AnX(F3)

GGGGATTCCACAGTTCACGAGATTCTGTCGAAATGA
CTCGAGCGGCCG

48

S100A10AnX(R3)

CGGCCGCTCGAGTCATTTCGACAGAATCTCGTGAAC
TGTGGAATCCCC

48

S100A10AnX(F4)

CACGAGATTCTGTCGAAACTATCTCTAGAAGGGGAC
TGACTCGAGCGGCCG

51

S100A10AnX(R4)

CGGCCGCTCGAGTCAGTCCCCTTCTAGAGATAGTTT
CGACAGAATCTCGTG

51
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pH 8.0). Fractions containing the protein were pooled and extensively dialyzed against
PreScission protease cleavage buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1
mM DTT, pH 7.0) overnight. S100A10 or A10A2 were cleaved from the glutathione Stransferase protein using 150 units of PreScission protease in 48 h. The cleaved protein
was applied to a GST column in binding buffer and the flow-through fractions were
collected. MALDI-TOF mass data for A10A2 (MWcalc = 14517.9 Da; MWobs = 14507.2
Da for 15N, 13C-labeled protein) confirmed the protein identities.

2.2.7

Construction of the S100B-TRTK12 Hybrid Gene
The pSS2 expression vector containing human S100B was utilized to construct

the S100B-TRTK12 (BT12) hybrid gene (Smith et al. 1996). In the first step, a unique
XhoI reporter cut site (5’ C↓TCGAG 3’) was generated directly adjacent to the stop codon
of the S100B coding sequence using the QuikChange kit (Stratagene, La Jolla, CA). The
primers used are shown in Table 2.3. The PCR reaction was conducted using Pfu Turbo
DNA polymerase (Stratagene, La Jolla, CA) and the parental DNA was digested with
DpnI endonuclease (Bostrom et al.). The amplified, nicked PCR product was then
transformed into the competent E. coli strain JM109 to repair the nick of the mutant DNA
fragment. Single colonies were selected and the correct constructs were confirmed by
DNA sequencing. The vector was then cleaved with XhoI restriction enzyme and
dephosphorylated with 1 µL of alkaline phosphatase (Amersham Pharmacia Biotech) to
prevent religation of the cut vector. The digestion reaction was run on a 1% agarose gel
and the corresponding band was extracted using QIAquick Gel Extraction Kit (Qiagen).
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Forward

and

reverse

primers

(5’-phosphorylated,

Sigma-Aldrich)

corresponding to residues from the linker region, the entire TRTK12 peptide and
appropriate XhoI site over-hangs (Table 2.3) were annealed together as described in
Section 1.2.2. The double-stranded DNA fragment was ligated with the unique XhoI site
of the dephosphorylated vector containing the S100B gene using T4 DNA ligase and then
transformed into E. coli strain JM-109. Single colonies were selected and the correct
orientation and a single insertion of the annealed primers in the resulting vectors were
confirmed by DNA sequencing.

2.2.8

Expression and Purification of S100B and S100B-TRTK12
Expression and purification of uniformly 15N, 13C-labeled BT12 in Escherichia

coli strain N99 were conducted as described for human S100B (Smith et al. 1996). The
protocol was modified by reducing the (NH4)2SO4 concentration to 50% saturation due to
the decreased solubility of BT12 compared to S100B. Following dialysis (25 mM TrisHCl, 100 mM NaCl, 1 mM DTT, and 5 mM CaCl2, pH 7.5), BT12 was applied to a
phenyl-Sepharose (Amersham Biosciences) column equilibrated in the same buffer. The
column was washed (25 mM Tris-HCl, 100 mM NaCl, 1 mM DTT, 1 mM CaCl2, pH 7.5)
and BT12 was eluted with EGTA buffer (25 mM Tris-HCl, 100 mM NaCl, 1 mM DTT,
and 1 mM EGTA, pH 7.5). MALDI-TOF mass data for

15

N-labeled BT12

(desformylmethionine MWcalc = 13430.2 Da; MWobs = 13427.3 Da, desformyl MWcalc =
13563.2 Da; MWobs = 13559.5 Da, and formylmethionine MWcalc = 13591.2 Da; MWobs =
13587.6 Da) confirmed the presence of the three chemically different forms of BT12 at
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Table 2.3. Oligonucleotides used in synthesis of BT12 expression vector.
Parental
Vector

Oligonucleotide
Name

Length

XhoIfor

GGCTGCTTTCTAATCTCACTCGAGCTCATGTTCAAA
GAACTCG

43

XhoIrev

CGAGTTCTTTGAACATGAGCTCGAGTGAGATTAGAA
AGCAGCC

43

Linker
TRTK-for

TCGACCTCTTCCAAGGCCCAGGCGGCGGCGGCACTC
GTACTAAAATAGATTGGAACAAGATACTCTCTC

69

Linker
TRTK-rev

TCGAGAGAGAGTATCTTGTTCCAATCTATTTTAGTA
CGAGTGCCGCCGCCGCCTGGGCCTTGGAAGAGG

69

S100B

S100BXhoI

Oligonucleotide Sequence (5’-3’)
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its N-terminus similar to those previously characterized for S100B (Smith et al. 1997).

2.2.9

NMR Spectroscopy
All NMR experiments were acquired at 35 ºC on a Varian INOVA 600 MHz

spectrometer equipped with a

13

C-enhanced triple resonance cold probe. NMR samples

of 0.5 mM (monomer) uniformly 15N, 13C-labeled S100A10 and A10A2 were prepared in
10% D2O, 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic
acid, and 100 mM NaCl buffer at pH 7.0, and 100 µM DSS as an internal standard.
Uniformly 15N, 13C-labeled NMR samples of 0.7 mM S100B and BT12 were prepared in
a similar buffer using either 20 mM CaCl2 or 1 mM EDTA. Sequential 1H, 13C, and 15N
resonance assignments of A10A2 and calcium saturated BT12 were completed using
HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH (Grzesiek and Bax 1992a),
HNCO (Kay et al. 1990), HNCA (Grzesiek and Bax 1992b), and C(CO)NH experiments
(Kay 1993). Sensitivity-enhanced 1H-15N HSQC spectra (Kay et al. 1992) for A10A2
were acquired using carrier frequencies of 4.705 (1H) and 114.0 ppm (15N) and spectral
widths of 8000.0 and 1700.0 Hz, respectively. Similar spectra were generated for Ca2+BT12 using carrier frequencies of 4.702 (1H) and 120.0 ppm (15N) and spectral widths of
8000.0 and 2000.0 Hz, respectively. All data were processed using NMRPipe and
NMRDraw (Delaglio et al. 1995) and spectra were analyzed by NMRView (Johnson and
Belvins 1994). The 1H-15N HSQC spectra of the

15

N,

13

C-labeled A10A2, and BT12

hybrid proteins cleaved with TEV and PreScission proteases were acquired 48 h
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following the addition of 16 units of each of the enzymes respectively. The presence of
the fully cleaved product in the NMR sample was verified by SDS-PAGE.

2.2.10

NMR Titration Experiments
The

15

N,

13C

-labeled S100A10 in complex with annexin A2 peptide was

prepared by the titration of 0.5 mM (monomer) S100A10 with a 20 mM stock solution of
annexin A2 peptide under constant buffer conditions. A final peptide concentration of 0.8
mM was used. The pH of the sample remained at 7.0 throughout the titration. The sample
was mixed after each addition and equilibrated for 15 minutes. The total volume increase
of the NMR sample was 24 µL (4%). 1H-15N HSQC spectra were recorded at each point
to monitor the titration. A sample of 0.7 mM (monomer) apo-S100B was prepared in 12
mM CaCl2 and titrated with a 20 mM stock solution of TRTK12 peptide in the same
buffer (above) to a final peptide concentration of 0.9 mM. The pH of the sample remained
at 7.0 throughout the titration.

2.3

Results

2.3.1

Cloning of GB1-TRTK12, -annexin A2, and -AHNAK in Expression Vectors
In order to obtain pure bacterially expressed peptides, the peptide sequence was

fused to a larger, stable and soluble protein which would not only protect it from
proteolysis in the cell but also improve its solubility. Previous attempts to biosynthetically
prepare annexin A1 and A2 peptides using GST-tagged constructs lead to <1 mg
peptide/L culture and the isolated peptide was prone to proteolysis (Rintala-Dempsey,
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unpublished results). The approach opted here involved expression of TRTK12
(TRTKIDWNKILS),

annexin

(GKVTFPKMKIPKFTFSGREL)

A2
peptides

(STVHEILSKLSLEG),
as

GB1

fusion

and
proteins.

AHNAK
The

B1

immunoglobulin binding domain of streptococcal protein G (GB1) is a smaller, Nterminal protein of about 56 residues (Huth et al. 1997; Safadi and Shaw 2007), which
was linked to the peptides through 5 glycine residues and a thrombin cleavage site
(LVPR/GS) as outlined in Figure 2.1. To further protect the C-terminus of the peptides
from degradation by proteases and to facilitate the isolation of untagged peptides, the
peptides were linked to a C-terminal His6 tag through a TEV cleavage site (ENLYFQ/S).
The insert for each cloning reaction was designed as single-stranded primers
(forward and reverse) encoding the entire sequence of each one of the peptides with a
minimum of 41 complementary bases (Figure 2.1). Proper annealing of the two primers
would generate a double-stranded DNA fragment containing over-hangs compatible with
those created by Bam HI and Xho I endonucleases at the N- and C-terminus, respectively.
The double-stranded DNA fragments were readily inserted with the correct orientation
into the Bam HI and Xho I endonucleases cut sites of digested pSAF2 vector (Figure 2.2).

2.3.2

Expression and Purification of GB1-TRTK12, -annexin A2, and -AHNAK
In order to obtain unlabeled, 15N-labeled and 15N, 13C-labeled TRTK12, annexin

A2 and AHNAK peptides, bacterial overexpression of GB1 fusion peptides was
examined in 1 L of LB. High levels of expression of unlabeled GB1-TRTK12 after
induction with 1 mM IPTG are illustrated in Figure 2.3. Similar results were observed

Figure 2.1. Development of cloning and purification procedures for a GB1-TRTK12 fusion protein.
N-terminal GB1 was linked to TRTK12 through 5 glycine residues and a thrombin cleavage site. A C-terminal His-tag
was also connected to the peptide by a TEV cleavage site. The forward and reverse single-stranded oligonucleotides
were designed encoding the entire amino acid sequence of the TRTK12 peptide with 41 complementary bases. Annealed
primers would generate a double-stranded DNA fragment containing Bam HI and Xho I sticky ends at the N- and Cterminus, respectively. The DNA fragment was then inserted into pSAF2 vector. Expression of pSAF2-TRTK12 in E.
coli is followed by purification using the Ni-NTA and IgG-Sepharose fast flow columns.
67
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Figure 2.2. Cloning of GB1-TRTK12, -annexin A2 and -AHNAK.
The DNA samples (5 uL) are run on a 1% agarose gel stained with ethidium bromide.
The sizes for the molecular standard bands are indicated on the left. Lane 1 contains the
molecular weight DNA ladder. Lanes 2, 3 and 4 contain the DNA for GB1-TRTK12, annexin A2 and -AHNAK, respectively.
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for the GB1-annexin A2 and -AHNAK fusion proteins. Following cell lysis, the
supernatant was loaded onto a Ni-NTA column. Bound protein was then eluted by
increasing the level of imidazole in the elution buffer. After dialysis of GB1-TRTK12, the
protein was cleaved from the His6 tag using TEV protease and purified on an IgG
Sepharose fast flow column that binds to the GB1 domain of the protein. Bound protein
was eluted at low pH with 0.5 M acetic acid (pH 3.4). A Coomassie-stained SDS-PAGE
gel of the fractions is presented in Figure 2.4 showing 3 major bands: the first and second
ones are slightly below and above 10 kDa molecular standard marks respectively, and the
third one around 15 kDa. To identify the band corresponding to GB1-TRTK12, a sample
from one of the fractions was sent for electrospray ionization mass spectrometry. Figure
2.5 shows a mass spectrum of three species in the sample with molecular weights of
15667.11, 7598.55, and 9294.42 Da. The peak at 9294.42 Da was in good agreement with
the calculated molecular weight of intact GB1-TRTK12 (MWcal = 9296.2 Da) and
appeared as the middle band on the SDS-PAGE gel. This band ran slightly above 10 kDa
molecular standard mark, which is a characteristic of GB1 bound proteins (Safadi and
Shaw 2007). The peak with molecular weight of 7598.55 Da represents the proteolytic
product of GB1-TRTK12 (MWcal = 7600.2 Da), where the entire sequence of TRTK12
peptide as well as two residues from the linker (S and M) are cleaved from the GB1
fusion protein. Finally, the contaminating protein at 15667.11 Da is the light chain of the
IgG protein that is bound to the Sepharose beads of the column and breaks down due to
the low pH of the elution buffer.
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Figure 2.3. SDS-PAGE analysis of the overexpression of unlabeled GB1-TRTK12
fusion protein.
GB1-TRTK12 was expressed as described in Chapter 2 (Section 2.2.3). An aliquot of the
cells before and after induction with IPTG were suspended in SDS sample buffer, heated
to 90ºC for 5 min and then subjected to electrophoresis on 16.5% SDS-polyacrylamide
gels and protein bands were visualized with Coomassie Brilliant Blue stain. Lane 1
contains the molecular weight standards. The positions and sizes of molecular weight
standards are indicated on the left. Lane 2 shows total cellular protein prior to induction
with IPTG of the 1 L culture batch. Lanes 3 contains total cellular protein 5 hours after
induction of 1 L culture at 37 °C. The arrowhead indicates a high level of expression for
the GB1-TRTK12 (9.3 kDa) fusion protein.
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Figure 2.4. Purification of GB1-TRTK12 on IgG Sepharose fast flow column.
The protein was expressed in E. coli strain Bl21 (DE3)-RIL and lysed cells were purified
as described in Chapter 2 (Section 2.2.3). Following the first purification step on the NiNTA column, fractions containing the protein were dialyzed against TEV protease
cleavage buffer. GB1-TRTK12 was cleaved from the His6 tag using TEV protease and
applied to IgG Sepharose fast flow column. Bound protein was eluted with 0.5 M acetic
acid, pH 3.4. Only lanes of fractions in which GB1-TRTK12 eluted are shown here. Lane
1 contains the molecular weight standards. The positions and sizes of molecular weight
standards are indicated to the left of each gel. Lanes 2-13 contain elution profile of every
fraction. The arrowhead indicates the band for GB1-TRTK12 (9.3 kDa) fusion protein.

Figure 2.5. Mass spectrum of unlabeled GB1-TRTK12.
Following purification of the protein, excess salt was removed. The sample was then subjected to mass
spectrometric analysis. The analysis resulted in three peaks at molecular masses of 7598.55, 9294.42, and
15667.11 Da. The peak at 9294.42 agrees with the calculated mass of GB1-TRTK12.
72
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Changing the order of columns or addition of protease inhibitors did not
improve the yield, as the TRTK12 peptide was degraded very quickly in solution. Since
similar results were observed for the GB1-annexin A2 and –AHNAK fusion proteins, a
different approach was taken to bacterially express the peptides.

2.3.3

Design of Hybrid S100-Target Proteins
In order to generate hybrid S100-target protein complexes, two systems that

have been well characterized by structural methods were chosen. The approach taken was
to analyze the relative positions of the S100 proteins and their target peptides in the
structures and then incorporate a linker between the two components to create a hybrid
protein. The first structure employed S100A10 in complex with the N-terminus of
annexin A2 (1BT6) (Rety et al. 1999), and a second structure utilized Ca2+-S100B
complexed to a portion of the alpha-1 subunit of F-actin capping protein (TRTK12),
CapZ (1MWN, 1MQ1) (Inman et al. 2002; McClintock and Shaw 2003). In both these
structures (Figure 2.6), the C-termini of helix IV in the S100 protein are proximal to the
N-terminus of the binding peptide. Although S100A10 and Ca2+-S100B are structurally
similar, the orientations and distances of the annexin A2 and TRTK12 peptides with
respect to the S100 protein are quite different. Further, in the A10A2 complex the
distance from the C-terminal carboxyl carbon of S100A10 (K91) to the N-terminal
nitrogen of annexin A2 is about 16 Å. For the Ca2+-S100B complexed with TRTK12 the
distance ranges from about 14 - 26 Å in the families of NMR structures. The choice of
these two proteins allowed for testing this approach with one protein (S100B) that
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undergoes a calcium-induced conformational change in order to interact with a target,
and one protein (S100A10) that is calcium-insensitive. Further, the structures of the target
peptides in both structures are quite different. The annexin A2 peptide adopts an α-helical
conformation for most of its sequence while the TRTK12 peptide is unstructured at its Nterminus followed by a single turn of α-helix.
The A10A2 is comprised of a linker spanning the measured protein-peptide
distance (16 Å) in the S100A10-annexin A2 complex connecting the two proteins.
Although this distance is sufficient to accommodate about five amino acid residues linked
in a linear fashion, modeling showed that a further four residues were required in A10A2
hybrid protein to allow favorable φ,ψ angles in the linker. Within the nine-residue linker,
a TEV protease cleavage site (ENLYFQ/G) was introduced. Finally, an aspartic acid at
the N-terminus of the annexin A2 sequence was added to stabilize its α-helical structure
(Figure 2.6A) in lieu of the acetyl group found in the native protein (Johnsson et al.
1988). For the BT12 the maximum linker length observed in the NMR structures (~26 Å)
allowed approximately 11 residues to bridge the protein and target. Within this region a
PreScission protease cut site (LFQ/GP) and four glycine residues were included (Figure
2.6B). The PreScission protease site allowed testing a different protease for the BT12
hybrid compared to the TEV site in the A10A2 hybrid protein. Since the Ca2+-S100B
complexes with TRTK12 are ensembles of NMR structures, the N-terminus of TRTK12
exhibits a wide range of positions with respect to Ca2+-S100B. This may be due to the
flexibility of this region in TRTK12 not observed for annexin A2 in the S100A10
complex. The glycine residues were added in BT12 to maintain backbone flexibility of

Figure 2.6. Models of the S100A10-annexin A2 (A10A2) and Ca2+-S100B-TRTK12 (BT12) hybrid constructs.
Ribbon representations of S100A10 in complex with (A) annexin A2 (1BT6) (Rety et al. 1999) and (B) Ca2+-S100B
bound to TRTK12 (1MWN) (Inman et al. 2002) are shown in similar orientations to demonstrate how the annexin A2
and TRTK12 peptides (magenta) are joined to the S100 proteins through a linker (cyan). In each model one of the
protomers is presented in light gray (helices labeled as I-IV) and the other protomer shaded in black (helices labeled as
I’-IV’). Four bound calcium ions are shown as yellow spheres for Ca2+-S100B. The corresponding schematics of the
constructs used for A10A2 and BT12 hybrid proteins are also illustrated with S100 protein located at the N-terminus
(grey), annexin A2 and TRTK12 peptides positioned at the C-terminus (magenta), and the linker (cyan) connecting the
S100 proteins to the target peptides. The amino acid composition of the linker region and the corresponding protease
cleavage sites are indicated. All numbering is consecutive based on the S100 protein sequences.
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the linker. During the design process, the linkers for both proteins were incorporated
into the existing structures by modeling. Energy minimization was used to ensure that the
hybrid proteins were not constrained or distorted, or that the linker did not make any
significant contacts with the S100 protein that might mask the protease cleavage sites.

2.3.4

Cloning, Expression and Purification of Hybrid S100-Target Proteins
Figure 2.7 shows the DNA product of the last cloning step for A10A2 and

BT12. The DNA band for A10A2 appears higher than the 5000 bp molecular standard
mark which is close to the correct molecular weight of 5334 bp. However, the BT12
DNA band ran lower (around 4500 bp) than the expected molecular weight of 6357 bp.
This is most likely caused by the supercoiling of the BT12 DNA causing the DNA to run
farther in the gel. Both the A10A2 and BT12 hybrid proteins were expressed using a
BL21 (DE3) codon-plus E. coli strain. Following purification, the typical yield was 15-25
mg of 15N, 13C-labeled A10A2 or BT12 protein from 1L M9 minimal media cultures for
heteronuclear NMR spectroscopy experiments. Based on the molecular weights of the
peptides, proceeding with the cleavage of the hybrid proteins would approximately yield
2-4 mg of the isolated peptides. SDS-PAGE (Figure 2.8) and MALDI-TOF mass
spectroscopy analyses showed that the proteins were homogeneous and free of
degradation products, similar to the parent S100B and S100A10 proteins. In both A10A2
and BT12, the accessibility of the protease cleavage sites was tested by proteolysis using
TEV and PreScission proteases, respectively. In both cases cleavage proceeded to
completion allowing separation of the S100 protein and peptide partner (Figure 2.8).
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Figure 2.7. Cloning of A10A2 and BT12.
The DNA samples (5 uL) are run on a 1% agarose gel stained with ethidium bromide.
The sizes for the molecular standard bands are indicated on the left. Lane 1 contains the
molecular weight DNA ladder. Lanes 2 and 3 contain the DNA for A10A2 and BT12,
respectively.
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Figure 2.8. Coomassie-stained SDS-PAGE gel (16.5%) depicting the purification of
A10A2 and BT12 constructs.
Lane 1 contains the protein molecular weight markers, with molecular weights labeled on
the left of the gel. Lanes 2 and 5 contain S100B and S100A10, while BT12 and A10A2
hybrid constructs are presented in lanes 3 and 6, respectively. Lanes 4 and 7 show S100B
and S100A10 following cleavage of BT12 and A10A2 by PreScission and TEV
proteases, respectively. Each of these proteins run at a higher molecular weight than the
parent due to the presence of the linker that remains appended to the C-terminus of the
S100 protein. The TRTK12 and annexin A2 peptides are not observed.
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2.3.5

The S100A10-Annexin A2 Hybrid Protein Adopts an Active Configuration
The A10A2 hybrid protein was examined by NMR spectroscopy to determine if

the complex retained the similar structure observed in the crystal structure for S100A10
in combination with the N-terminal annexin A2 peptide. Using standard heteronuclear
multiple dimensional NMR spectroscopy (HNCA, HNCACB, and CBCA(CO)NH),
chemical shift assignments (1H,

15

N, and

13

C) for A10A2 (Figures 2.9 and 2.10) (Table

2.4) and BT12 (Figures 2.11 and 2.12) (Table 2.5) proteins were completed. Figure 2.10
shows a representative 1H-15N HSQC spectrum of A10A2 that is well dispersed and
characteristic of a folded S100 protein. The spectrum of A10A2 is remarkably similar to
that of

15

N,

13

C-labeled S100A10 in complex with the unlabeled annexin A2 peptide

(Figure 2.13). The 1H-15N correlations for all residues in the annexin A2 segment (S101D115) and the TEV cleavage site (E93-G99) were easily identified in A10A2 (Figure
2.10). These residues are not visible in Figure 2.13 where the annexin A2 peptide is
unlabeled. The resonances for residues S101-D115 are well separated ranging between
7.1 (S108) and 8.9 ppm (T102) indicating the annexin A2 portion of the hybrid is well
folded. In contrast, the linker residues form a tight cluster between 7.9-8.3 ppm indicating
this region of the A10A2 hybrid adopts little regular secondary structure. Backbone
assignment of A10A2, and S100A10 in complex with individual annexin A2 peptide
allowed the chemical shifts of each residue to be compared between the two complexes
(Figure 2.14) as well as that for other Ca2+-bound S100 proteins, indicating that little
structural change has occurred in the S100A10 protein by incorporating the C- terminal
linker and annexin A2 sequences. For BT12 a specific interaction between the S100B and
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Figure 2.9. Selected regions of 600 MHz NMR spectra used for the backbone
assignment of the A10A2 complex.
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of
the three-dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i)
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for
sequential assignment of residues S111-G114 of A10A2.
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Figure 2.10. Backbone amide assignments of A10A2 hybrid protein.
1

H-15N HSQC spectrum of 0.5 mM (monomer) uniformly 15N, 13C-labeled A10A2 hybrid
protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was collected
in 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100
mM NaCl, pH 7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated with their
one letter amino acid code and number. The residues from 15N, 13C-labeled annexin A2
are presented in pink and those from the linker region in cyan. Pairs of resonances for
sidechain amide cross peaks are connected by horizontal lines. Peaks visible at lower
contour levels are indicated by boxes.
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Table 2.4. 15N, 13C and 1H resonance assignments for human A10A2.
Residue HN

N

C’

Cα

Cβ

Other

8.492

122.3

176.09
178.10

63.30
55.49

32.14
42.33

G-2
S-1
M0
P1
S2
Q3

Cγ (27.00), Cδ (49.63)
Cγ (27.31), Cδ1 (24.82)
Cδ2 (23.67)

8.391
8.198
8.190

109.6
115.7
122.3

8.953
9.552

118.8
120.6

176.95
175.25
180.37

45.43
58.07
53.23
62.46
56.87
59.63

64.25
32.83
31.92
65.50
28.19

M4
E5
H6
A7
M8
E9
T10
M11
M12
F13
T14
F15
H16
K17

8.960

119.7

-5

G
P-4
L-3

8.385
8.531
8.523
8.315
8.599
8.069
8.178
9.353

117.9
124.9
118.0
120.2
116.6
122.7
117.9
117.0

7.440
7.592
8.467

119.2
115.7
122.3

F18
A19
G20
D21
K22
G23
Y24
L25

7.111
8.482
7.505
7.948

114.5
122.3
100.9
111.8

7.298
6.912
8.967

T26
K27

179.49
178.02
176.62
177.91
177.83
178.12
177.21
177.83
175.24
176.02
178.06
177.87

56.81
60.18
59.47
55.84
60.31
60.53
67.36
61.30
59.99
60.09
68.35
62.81
61.16
59.40

30.84
29.43
29.80
18.56
35.24
29.92
68.02
32.59
35.10
37.64

Cγ (34.83), Cδ (180.53)
Nε2 (112.78)
Cγ (37.52)
Cγ (30.62)
Cγ (37.43)
Cγ2 (21.43)
Cγ (31.74)
Cγ2 (21.17)

38.79
31.47
32.04
40.39
18.72

103.5
114.1
117.5

178.38
172.65
171.76
178.21

60.78
53.87
44.96
56.04
57.80
46.71
55.49
52.86

9.286
9.136

113.1
120.6

175.58
178.24

60.53
60.77

71.82
32.04

E28
D29
L30

8.107
7.635
8.465

117.5
120.1
118.8

178.78
177.83
177.76

59.65
57.02
57.77

29.01
42.75
41.71

R31
V32
L33

8.174
7.680
8.070

119.3
117.9
122.3

177.80
177.30
179.33

60.60
66.35
59.41

29.79
31.66
42.03

M34
E35
K36

8.554
8.337
8.057

117.5
118.4
115.3

178.02
178.93
178.72

59.17
59.32
57.82

31.83
30.29
33.37

178.06
179.07
174.06

Cγ (27.66), Cδ (50.37)

42.48
31.04
40.13
43.36

Cγ (24.23), Cδ (29.33)
Cε (42.01)

Cγ (23.30)
Cγ (27.15), Cδ1 (23.65)
Cδ2 (20.36)
Cγ (24.96), Cδ (29.23)
Cε (41.94)
Cγ (36.65)
Cγ (26.56), Cδ1 (23.99),
Cδ2 (23.47)
Cγ (27.15), Cδ (43.08)
Cγ2 (22.33), Cγ1 (22.33)
Cγ (28.07), Cδ1 (24.02)
Cδ2 (24.02)
Cγ (33.11)
Cγ (36.97)
Cγ (25.42), Cδ (28.59)
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E37
F38
P39
G40
F41
L42
E43
N44
Q45
K46

8.804
8.110

114.9
118.0

56.45
54.54

29.93
39.44

9.112
7.953
7.746

111.3
121.1
126.2

177.53
175.40
177.77
176.22

46.41
57.61
57.60
59.46
53.71
55.26
57.26

39.20
40.94
29.03
39.19
27.99
31.68

7.523
7.411
8.147

115.3
117.1
119.7

D47
P48
L49

7.939

118.4
119.3

177.57
177.24

50.94
64.20
54.11

42.48
32.21
41.02

8.403

A50
V51
D52
K53

7.562
8.442
7.744
7.964

122.8
115.7
120.6
119.3

179.69
176.57
178.96
178.92

56.12
66.28
57.57
59.73

18.65
31.21
40.45
32.38

I54

7.746

119.7

177.94

64.50

38.26

M55
K56

8.118
7.622

117.1
118.3

177.62
178.06

57.57
59.12

32.16
32.12

D57
L58

7.638
7.694

117.6
118.9

177.32
177.67

55.72
55.65

41.09
42.57

D59
Q60

8.293
8.382

120.9
120.6

177.24
176.75

54.26
57.80

40.41
28.56

C61
R62
D63
G64
K65

8.435
8.079
8.655
9.255
7.471

117.1
120.6
118.8
109.6
118.4

176.54
175.82
176.73
173.84
175.30

58.96
57.15
53.76
46.11
55.39

27.21
28.47
41.08

V66
G67
F68
Q69

9.356
8.485
9.076
8.912

124.5
114.4
121.0
117.5

176.25
174.08
177.10
178.66

62.62
44.29
62.93
60.44

32.58
39.42
27.48

S70
F71
F72
S73
L74

8.060
8.632
8.772
7.925
7.460

117.1
123.6
120.1
114.9
125.4

176.38
175.98
177.62
177.05
177.82

61.90
60.88
62.55
62.47
57.90

63.06
39.21
38.40
62.50
41.06

I75
A76
G77
L78

7.222
9.005
7.871
7.833

117.9
125.8
104.4
120.6

179.51
178.58
177.60
178.65

62.71
55.28
47.36
57.58

35.56
18.68

176.65

Cε (42.66)
Cγ (36.34)

179.41
174.61

34.36

42.61

Cγ (36.70)
Cγ (177.14), Nδ2 (113.30)
Cγ (24.76), Cδ (28.81)
Cε (42.27)
Cγ (27.09), Cδ (51.07)
Cγ (27.37), Cδ1 (25.34)
Cδ2 (22.79)
Cγ2 (21.27), Cγ1 (23.56)
Cγ (25.92), Cδ (29.35)
Cε (42.14)
Cγ1 (28.58), Cδ1 (13.18)
Cγ2 (17.92)
Cγ (24.64), Cδ (28.86)
Cε (42.16)
Cγ (26.09), Cδ1 (22.94)
Cδ2 (22.94)
Cγ (180.23)
Cγ (34.11), Cδ (180.24)
Nε2 (111.97)
Cγ (27.15), Cδ (43.43)
Cγ (24.55), Cδ (29.12)
Cε (42.25)
Cγ2 (21.52), Cγ1 (21.52)
Cγ (34.20), Cδ (179.82)
Nε2 (111.52)

Cγ (25.76), Cδ1 (23.59)
Cδ2 (23.59)
Cγ1 (26.81), Cγ2 (17.52)
Cγ (24.40), Cδ1 (22.17)
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T79
I80
A81
C82
N83
D84
Y85
F86
V87
V88
H89
M90
K91
Q92

8.499
8.837
7.555
8.296
8.595
8.497
7.678
9.051
8.865
7.400
7.954
7.856
7.620
8.166

118.3
123.6
121.5
117.5
120.5
119.2
119.7
121.4
117.5
117.5
113.8
117.1
120.1
117.6

176.85
177.78
181.47
176.43
176.29
174.47
178.05
177.39
177.57
177.43
176.20
176.14
177.21
176.25

68.55
66.10
55.41
63.74
58.05
57.80
62.00
61.18
66.50
65.40
57.77
57.44
58.58
56.99

68.79
38.29
18.14
26.78
39.63
40.48
39.11
40.22
31.91
32.66
30.81
34.90
32.48
28.93

E93
N94
L95

7.838
8.062
7.922

117.9
117.1
120.1

175.97
174.58
176.30

56.75
53.84 (4.518)
55.28 (4.248)

30.05
38.38
42.59

Y96
F97
Q98

7.862
7.946
8.245

118.8
120.9
121.4

175.23
175.24
176.04

57.48 (4.508)
57.71 (4.239)
55.96 (4.293)

38.93
39.17
29.60

G99
D100
S101
T102
V103
H104
E105
I106
L107

8.013
8.361
8.343
8.921
8.823
8.533
7.710
8.328
8.623

110.0
120.1
113.5
123.6
121.5
117.9
116.6
121.0
118.4

173.81
176.34
176.29
179.81
176.72
179.37
178.14
178.42

45.57
54.88 (4.750)
58.15 (4.796)
66.64
67.84 (3.578)
60.35 (3.957)
59.05 (3.953)
66.05 (4.151)
58.27 (4.644)

41.59
63.82
69.36
31.76
28.86
29.33
38.95
41.59

S108
K109

7.101
7.688

111.0
119.7

178.28
177.32

60.65 (4.164)
55.84 (4.304)

63.57
33.28

L110

7.373

120.1

177.08

55.84 (4.086)

43.06

S111
L112

8.377
8.347

116.2
124.9

174.75
177.21

57.38 (4.608)
55.45 (4.331)

64.27
42.15

E113
G114
D115

8.222
8.195
7.947

120.1
110.1
125.8

176.63
172.88

56.63 (4.317)
45.31
55.86 (4.424)

30.69
42.49

Cγ1 (30.94), Cγ2 (17.29)

Cγ2 (22.11), Cγ1 (22.11)
Cγ2 (20.39), Cγ1 (22.57)
Cγ (32.54)
Cγ (24.76), Cδ (28.82)
Cγ (34.04), Cδ (180.18)
Nε2 (111.06)
Cγ (36.29)
Cγ (177.51), Nδ2 (111.87)
Cγ (27.04), Cδ1 (24.96)
Cδ2 (23.64)
Cγ (33.85), Cδ (180.35)
Nε2 (111.49)
Hα2 (3.941), Hα3 (3.900)
Cγ2 (22.14)
Cγ1 (21.61)
Cγ (36.04)
Cγ1 (29.13), Cγ2 (18.33)
Cγ (27.46), Cδ1 (23.97)
Cδ2 (23.97)
Cγ (24.33), Cδ (28.60)
Cε (42.62)
Cγ (25.91), Cδ1 (23.39)
Cδ2 (23.40)
Cγ (27.34), Cδ1 (25.26)
Cδ2 (23.10)
Cγ (36.34)
Hα2 (3.970), Hα3 (3.900)
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Figure 2.11. Selected regions of 600 MHz NMR spectra used for the backbone
assignment of the BT12 complex.
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of
the three-dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i)
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for
sequential assignment of residues G64-E67 of the BT12.
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Figure 2.12. Backbone amide assignments of BT12 hybrid protein.
1

H-15N HSQC spectrum of 0.7 mM (monomer) uniformly 15N, 13C-labeled BT12 hybrid
protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was collected
in 20 mM MOPS, 20 mM CaCl2, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid,
100 mM NaCl, pH 7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated with
their one letter amino acid code and number. The residues from 15N, 13C-labeled TRTK12
are presented in pink and those from the linker region in cyan. Pairs of resonances for
sidechain amide cross peaks are connected by horizontal lines.
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Table 2.5. 15N, 13C and 1H resonance assignments for human BT12.
HN
9.243
8.699
8.228
8.687
8.047
8.061
8.026
8.148
8.064
7.473
8.751
8.914
7.685
7.993
8.349

N
121.9
119.6
121.5
120.0
117.0
123.4
116.6
116.9
122.6
117.3
118.1
120.0
120.0
119.6
116.2
121.6

C
174.72
179.68
177.70
178.70
179.80
178.83
178.22
177.73
179.06
178.56
178.00
179.74
177.05
177.46
178.07
177.72

Cα
57.50
59.80
58.20
59.68
60.17
55.14
60.81
67.00
55.48
58.68
66.05
57.77
66.15
62.82
58.57
58.58

Cβ
65.56
29.22
42.52
29.37
32.74
18.05
33.34
31.60
18.52
42.05
38.86
41.34
31.18
38.98
29.00
28.29

Y17
S18
G19
R20
E21
G22
D23
K24
H25
K26
L27
K28
K29
S30
E31
L32
K33
E34
L35
I36
N37

7.210
8.943
7.605
7.134
9.428

115.4
115.4
110.1
121.1
116.2

176.26
177.44
173.69
177.38

60.93
61.05
45.51
59.90
54.78

40.59

9.483
7.057
9.536
9.690
9.046
8.113
6.542
8.444
8.318
7.345
7.894
8.325
8.407

118.9
114.6
125.7
124.2
121.5
110.5
123.1
119.6
118.1
116.2
123.0
120.4
117.3

176.59
173.35
174.95
175.95
177.71
177.70
177.29
177.72
177.05
177.99
179.06
178.37
177.53

58.08
55.48
55.29
52.74
55.07
62.55
61.11
58.68
57.67
60.40
59.35
59.51
66.21
54.71

31.40
31.11
39.18
43.65
33.08
32.00
61.11
31.44
42.13
32.63
29.36
41.93
38.82
37.26

N38
E39
L40
S41
H42
F43
L44
E45
E46

8.219
8.511
7.717
7.272
10.254
7.543
8.237
8.130
8.270

114.7
113.5
120.0
112.8
121.9
115.5
118.1
120.7
123.4

177.13
178.13
177.31
175.80
176.15
174.68
176.36
175.61
177.32

55.03
55.34
54.41
60.01
59.28
56.85
53.13
56.67
56.67

40.53
30.90
42.04
64.27
28.69
41.09
44.33
30.78
30.86

Residue
S1
E2
L3
E4
K5
A6
M7
V8
A9
L10
I11
D12
V13
F14
H15
Q16

Other

Cγ (33.57), Nε2 (110.5),
Hε21 (6.81), Hε22 (7.19)

30.94
35.06

Nδ2 (106.6), Hδ21 (7.108)
Hδ22 (7.501)
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I47
K48
E49
Q50

9.832
8.861
7.580

E51
V52
V53
D54
K55
V56
M57
E58
T59
L60
D61
N62

9.219
7.094
6.929
8.360
7.580
8.452
8.345
8.216
7.641
7.673
8.120
9.087

D63
G64
D65
G66
E67
C68
D69
F70
Q71
E72
F73
M74
A75
F76
V77
A78
M79
V80
T81
T82
A83
C84
H85
E86
F87
F88
E89
H90
E91
L92
D93
L94
F95
Q96

125.7
126.8
118.5

176.23
176.07
177.07

62.20
56.39
55.35
58.25

38.31
34.60
31.51
28.15

116.6
117.8
118.5
120.0
120.7
121.9
118.1
117.3
114.0
119.6
116.1
127.6

178.65
177.26
177.28
178.64
179.69
177.55
177.28
178.81
175.15
178.04
176.29
176.28

59.66
66.35
66.24
57.94
58.63
67.19
57.82
59.16
66.06
55.63
54.56
54.49

29.23
31.28
31.20
39.80
32.23
31.49
30.74
29.72
69.16
43.21
39.92
40.20

8.234
7.639
8.338
10.094
7.880
9.452
9.790
8.939
8.016

116.3
108.6
120.4
113.1
118.1
124.2
131.4
118.5
119.2

178.00
175.18
177.37
172.68
175.05
174.77
175.52
176.63
179.79

53.35
47.47
53.61
45.78
55.07
56.97
53.04
63.35
59.61

40.14

34.45
27.93
40.28
38.66
28.30

8.795
8.843
8.269
7.535
7.640
8.578
8.466
7.989
8.430
8.717
8.125
7.637
8.410
8.247
7.690
7.979
8.125
8.072
8.147
8.188
7.915
8.173
7.815
8.013
7.946

122.6
122.6
118.9
123.4
121.5
120.0
124.9
120.4
118.5
117.7
117.3
124.2
117.0
118.9
116.6
117.4
116.2
117.0
120.0
120.0
120.7
118.8
120.8
118.4
119.6

179.47
177.27
179.24
180.63
176.68
179.69
179.25
178.77
177.71
177.28
176.39
179.93
175.75
176.21
177.96
176.39
177.01
175.53
175.53
176.49
177.38
176.75
177.39
175.76
175.86

58.71
60.34
55.13
55.13
60.07
66.92
56.35
59.50
66.58
68.24
68.04
55.35
63.48
59.87
58.56
58.95
57.36
57.14
56.84
57.03
56.24 (4.139)
54.86 (4.507)
55.88 (4.073)
58.30 (4.493)
55.79 (4.355)

30.09
39.40
29.30
17.53
38.08
31.08
17.74
33.84
32.02
68.30
67.92
18.09
26.29
29.85
29.87
39.84
38.92
33.37
30.18
29.88
42.19
40.90
42.15
39.14
29.75

Cδ (180.42)
Cγ (32.85), Nε2 (112.9)
Hε21 (6.497), Hε22 (7.974)

Cγ (176.05)
Nδ2 (113.2), Hδ21 (6.934)
Hδ22 (7.767)

40.17

Cγ (34.27), Nε2 (111.7),
Hε21 (6.909), Hε22 (7.613)

Cγ (33.90), Nε2 (111.7)

89
G97
P98
G99
G100
G101
G102
T103
R104
T105
K106
I107
D108
W109

7.830

108.7

8.530

109.3
174.73

44.71
63.71
45.54
45.46

177.80

Hε21 (6.792), Hε22 (7.466)
Hα2 (4.044), Hα1 (4.000)
31.95

8.236
8.084
8.393
8.173
8.049
8.335
7.821
8.489

108.6
113.9
123.5
117.0
121.9
121.9
124.9
122.7

174.22
174.55
176.09
173.30
176.05
174.34
176.98
178.36

45.29
61.91
56.15 (4.486)
62.03 (4.304)
55.46 (4.415)
61.75 (3.956)
52.89 (4.502)
61.19

69.88
31.03
69.95
34.46
38.18
42.87
29.35

N110

8.664

116.9

177.55

56.09 (4.558)

37.73

K111
I112
L113
S114
L115
E116

7.736
7.355
8.086
7.710
8.031
7.773

118.8
117.0
115.8
113.5
123.8
125.4

178.26
176.39
176.59
174.61
176.43

57.79 (4.163)
62.87 (3.808)
55.14 (4.436)
58.50 (4.445)
55.21 (4.370)
58.06 (4.110)

32.05
38.13
42.05
63.06
42.27
31.28

Cγ (176.27), Nε1 (129.5)
Hε1 (10.283)
Nδ2 (112.9), Hδ21 (6.901)
Hδ22 (7.752)
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Figure 2.13. Backbone amide assignments of S100A10-annexin A2 complex.
1

H-15N HSQC spectrum of 0.5 mM (monomer) uniformly 15N, 13C-labeled S100A10
protein bound to 0.5 mM annexin A2 peptide at pH 7.0 acquired on a Varian INOVA 600
MHz spectrometer at 35 ºC. Assigned backbone amide cross peaks are indicated with
their one letter amino acid code and number. Pairs of resonances for sidechain amide
cross peaks are connected by horizontal lines. Peaks visible at lower contour levels are
indicated by boxes.
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Figure 2.14. Comparison of the changes in chemical shift of the A10A2 hybrid
protein and S100A10 in complex with individual annexin A2 peptide.
Chemical shift changes (∆δ) were normalized in both 1HN and 15N using the formula
[{HN2 + (N/5)2}/2]1/2. The dashed line indicates the average change in chemical shift at
0.09 ppm. Proline residues are shown as “P” and asterisks indicate missing assignments
in either or both proteins.
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TRTK12 segments was not observed in the absence of calcium (data not shown).
However, upon calcium addition to BT12, a spectrum was obtained (Figure 2.12) that
was nearly identical to that for Ca2+-S100B in complex with a synthetic TRTK12 peptide
(Figure 2.15). As shown in Figure 2.12, for BT12 all resonances in the linker (L92-G102)
and TRTK (T103-E116) sequences were identified with the exception of three glycine
residues (G99-G101) in the linker that were absent from the spectra due to the fast
exchange with the solvent. Once more, backbone assignment of the BT12 and S100B in
complex with individual TRTK12 peptide allowed measuring the chemical shift changes
of each residue between the two complexes (Figure 2.16) as well as that for other Ca2+bound S100 proteins indicating that little structural change occurred in the S100B protein
as the result of incorporating the C-terminal linker and TRTK12 sequences.
One advantage of the A10A2 and BT12 hybrid proteins is that they allow in situ
cleavage of the linker using TEV or PreScission enzymes, respectively. Figure 2.17
shows the 1H-15N HSQC spectrum of the A10A2 hybrid protein following TEV cleavage.
The positions of the amide resonances for the S100A10 and annexin A2 components in
this spectrum are nearly identical to those found in the presence of the linker (Figure
2.10). Importantly, the NMR spectrum shows a tight complex is maintained between
S100A10 and annexin A2 despite the absence of N-terminal acetylation of the annexin
protein. Parallel experiments for the BT12 hybrid protein following cleavage with
PreScission protease yielded similar results (Figure 2.18).
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Figure 2.15. Backbone amide assignments of S100B-TRTK12 complex.
1

H-15N HSQC spectrum of 0.7 mM (monomer) uniformly 15N, 13C-labeled S100B protein
bound to 0.7 mM TRTK12 peptide in the presence of 6 mM CaCl2 at pH 7.0 acquired on
a Varian INOVA 600 MHz spectrometer at 35 ºC. Assigned backbone amide cross peaks
are indicated with their one letter amino acid code and number. Pairs of resonances for
sidechain amide cross peaks are connected by horizontal lines.
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Figure 2.16. Comparison of the changes in chemical shift of the BT12 hybrid protein
and S100B in complex with individual TRTK12 peptide.
Chemical shift changes (∆δ) were normalized in both 1HN and 15N using the formula
[{HN2 + (N/5)2}/2]1/2. The dashed line indicates the average change in chemical shift at
0.17 ppm. The asterisks indicate missing assignments in either or both proteins.
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Figure 2.17. 1H-15N HSQC spectrum of A10A2 cleaved with TEV protease.
0.5 mM (monomer) uniformly 15N, 13C-labeled A10A12 protein 48 h following cleavage
with TEV protease at pH 7.0 acquired on a Varian INOVA 600 MHz spectrometer at 35
ºC. Assigned backbone amide cross peaks are indicated with their one letter amino acid
code and number. Pairs of resonances for sidechain amide cross peaks are connected by
horizontal lines. Peaks visible at lower contour levels are indicated by boxes.
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Figure 2.18. 1H-15N HSQC spectrum of BT12 hybrid protein cleaved with
PreScission protease.
0.7 mM (monomer) uniformly 15N, 13C-labeled BT12 protein 48 h following cleavage
with PreScission protease at pH 7.0 acquired on a Varian INOVA 600 MHz spectrometer
at 35 ºC. Assigned backbone amide cross peaks are indicated with their one letter amino
acid code and number. Pairs of resonances for sidechain amide cross peaks are connected
by horizontal lines. Peaks visible at lower contour levels are indicated by boxes.
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The assignments of Hα, Cα and C’ resonances of the annexin A2 and
TRTK12 regions in the A10A2 and BT12 hybrid proteins allowed their secondary
structures to be determined using the chemical shift index (Wishart et al. 1992). This
analysis (Figure 2.19) shows that residues T102-S108 of annexin A2 form a well-defined
α-helix. This compares very well with the crystal structure of S100A10 with the Nterminal peptide from annexin A2 (1BT6) that shows residues T2-K9 (T102-K109 in
A10A2) adopt an α-helical structure (Rety et al. 1999). The secondary structure of
TRTK12 in the BT12 hybrid protein shows an unstructured N-terminus and a single turn
of α-helix from D108-K111. The position of the α-helix in BT12 agrees well with the
previously reported crystal and NMR structures of Ca2+-S100B in complex with TRTK12
(1MWN and 3IQO) (Inman et al. 2002; Charpentier et al. 2010).

2.4

Discussion

2.4.1

High Yield Bacterial Expression of S100-Target Hybrid Proteins
Bacterial expression of peptides is a challenging task since unstructured

peptides are prone to degradation by proteases during purification. This results in very
low yields of purified peptides and can lead to inhomogeneity of the peptide due to nonspecific proteolysis. Although successful methods have been developed using GB1tagged (Lindhout et al. 2003) or His-tagged (Lee et al. 2008) peptides for S100B and
S100A6 respectively, in our hands previous attempts to biosynthetically prepare annexin
A1 and A2 peptides using GST- or GB1 constructs lead to <1 mg peptide/L culture and
the isolated peptides were prone to proteolysis (Rintala-Dempsey, unpublished results). In
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Figure 2.19. Secondary structure determinations for annexin A2 and TRTK12
peptides in the A10A2 and BT12 hybrid constructs using the chemical shift index
(Wishart et al. 1992) for Cα, C’ and Hα atoms.
The secondary structure identified for each atom is shown as α-helix (●), β-strand (■) or
coil conformation (○).
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the current work, a successful method has been developed for bacterial expression of
annexin A2 and TRTK12 peptides by linking them to S100A10 and S100B, respectively.
In essence the target protein is used as a carrier for the target peptide. Similar approaches
have been described previously to produce hybrid molecules of calmodulin bound to the
26-residue binding region of myosin light-chain kinase (M13) (Porumb et al. 1994; Hayes
et al. 2004), and peptides from the calmodulin-binding domains of calcineurin (Renigunta
et al. 2006), the olfactory nucleotide-gated ion-channel (Chyan et al. 2005), tobacco
MAPK phosphatase-1 (Ishida et al. 2009), and chromogranin A (Kang et al. 2007). In all
of these studies, the linker was composed of only glycine residues in order to maintain
flexibility in the linker connecting the carrier protein to the target peptides. Here, it was
demonstrated that this is not a necessary requirement and that alternate amino acids can
be used. This is particularly important for the incorporation of proteolytic cleavage sites
such as TEV or PreScission protease used in this work to obtain complete digestion of the
target sites. In principle, this method would allow purification of the target peptides
(annexin A2 or TRTK12). For NMR studies, this would provide a rapid and facile
method to obtain reasonable quantities of 15N, 13C-labeled peptides. Alternatively, it was
chosen not to purify the cleaved peptides and examine the intact hybrid protein or the
complex after in situ cleavage. This further simplifies the procedure and in the case of
protein-peptide complexes offers the advantage of perfect 1:1 stoichiometry.
One requirement for the interaction between some S100 proteins and target
peptides is the N-terminal acetylation of the peptides (Johnsson et al. 1986; Johnsson et
al. 1988; McClintock and Shaw 2003). For example, both annexins A1 and A2 are
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naturally acetylated. Although, crystal structures of S100A10 in complex with annexin
A2 and Ca2+-S100A11 bound to annexin A1 do not illustrate direct contact between the
S100 protein and the peptide acetyl groups (Rety et al. 1999; Rety et al. 2000),
unacetylated peptides show ~1000-fold decreased binding affinity for the respective S100
proteins (Johnsson et al. 1988). It has been suggested that the acetyl group acts to
stabilize the α-helical conformation of the peptide. In the A10A2 hybrid protein
acetylation of the annexin A2 moiety is not possible. However, an acidic residue was
incorporated at the N-terminus of the annexin A2 sequence to neutralize the helical dipole
and stabilize the helix structure. The result clarified that A10A2 hybrid maintains a tight
association between the S100A10 and the annexin peptide indicating the acidic residue is
sufficient to stabilize the interaction. In support of this approach, a GST-annexin A2
fusion protein also shows tight binding to S100A10 presumably because the annexin Nterminus is extended (by GST) in place of acetylation (Mailliard et al. 1996). Similarly,
an interaction between TRTK12 and S100B is enhanced upon acetylation of the TRTK12
peptide (McClintock et al. 2002), even though the α-helix forms further down the peptide
sequence (Inman et al. 2002). The hybrid BT12 protein would support this enhanced
interaction by mimicking the neutralized TRTK12 sequence.

2.4.2

Applications and Limitations in utilizing S100-Target Hybrid Proteins
One of the limitations that could be associated with biosynthesis of hybrid

proteins method is that the hybrid proteins might suffer from reduced solubility in the
unbound form. This was not a problem for A10A2 because binding of annexin A2 to
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S100A10 is not calcium sensitive. However, for BT12 the hybrid showed poorer
solubility in the absence of calcium and exhibited NMR spectra suggestive of protein
oligomerization. This is perhaps not surprising given that the TRTK12 peptide motif or
accompanying linker could result in non-specific interactions in the absence of calcium.
However, upon calcium binding the BT12 showed excellent solubility and provided 1H15

N HSQC spectra that were better compared to the individual protein peptide complexes.
In summary, the approach presented here demonstrated a successful method of

high yield bacterial expression of S100 hybrid proteins. Two different protease cleavage
sites were successfully incorporated into the linker regions and can be used in situ to form
the S100-peptide complex. This method could be applied for the synthesis of S100
binding peptides for biophysical or biological characterization by X-ray crystallography
or NMR. Further, the S100-target hybrid proteins may prove useful for the assembly and
examination of larger S100 complexes. In the following chapters, A10A2 hybrid protein
is used to study the ternary complex involving S100A10, annexin A2 and AHNAK
proteins.
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Chapter 3
The S100A10-Annexin A2 Complex Provides a Novel Asymmetric
Platform for AHNAK Recruitment

3.1

Introduction
A requisite for plasma membrane repair is calcium-regulated exocytosis,

controlled by a number of proteins that coordinate resealing of the membrane. One
exocytotic compartment implicated in membrane fusion is the enlargeosome,
characterized by the large scaffolding protein AHNAK, that relocates to the plasma
membrane immediately following membrane damage (Zhang et al. 2004). In addition to
AHNAK, calcium-sensors such as dysferlin and annexin family members are involved in
membrane repair. Upon membrane rupture, these sensor proteins respond to the calcium
influx by localizing near the inner membrane surface.
Membrane repair and membrane-receptor protein trafficking can be modulated
by the association of an S100A10 dimer with the calcium- and phospholipid-binding
protein annexin A2. This heterotetrameric complex (Rety et al. 1999) has the ability to
form larger multiprotein assemblies such as those with AHNAK and members of the
transmembrane ferlin family (ie. dysferlin). In vitro and in vivo experiments have shown
that the C-terminal domain of AHNAK (van de Graaf et al. 2003; Borthwick et al. 2008)
interacts with S100A10 while bound to annexin A2 (Shtivelman and Bishop 1993).
Parts of this chapter have been taken from the submitted article: Rezvanpour, A., and
Shaw, G. S. 2011. The S100A10-annexin A2 complex provides a novel asymmetric
platform for AHNAK recruitment. J. Biol. Chem.
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Available structural information about the arrangement and mechanisms
used by multi-protein complexes such as those involved in membrane repair is very
limited. In this chapter, peptide array analysis was used to uncover the binding region(s)
of different proteins within the complexes formed between S100A10, annexin A2, the Cterminal region of AHNAK and the C2A domain of dysferlin proteins. For instance, the
designed S100A10-annexin A2 (A10A2) hybrid protein (described in Chapter 2) in which
S100A10 was linked in tandem to the N-terminal 15 residues of annexin A2, was used in
peptide array experiments, to identify the regions of interaction within the C-terminus of
AHNAK. Of the eight consensus regions observed, one of the sequences (referred to as
AHNAK5) having a strong interaction was used as a synthetic peptide to identify the
binding region(s), stoichiometry and affinity with the A10A2 complex. Using NMR
spectroscopy, non-denaturing electrospray mass spectrometry and

fluorescence

spectroscopy a novel asymmetric ternary arrangement between a single AHNAK5
peptide, an S100A10 dimer and two annexin A2 peptides was described. These results
provide the first structural model of a multi-protein assemblage necessary during the
membrane repair. To examine the possibility for the formation of other ternary complexes
involving S100A10 and annexin A2, the interaction between S100A10 or A10A2 with the
transient receptor potential cation channel protein, TRPV5, was also investigated by
peptide array analysis.
Furthermore, the interaction between other components of the membrane repair
machinery was tested. For instance, to identify potential binding sites other than the 12
residue N-terminal region of annexin A2 with the S100A10 protein, peptide arrays of full
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length annexin A2 were probed with S100A10 or A10A2 proteins. Finally, the
interaction between the apo- and calcium-bound C2A domain of dysferlin with the
S100A10 and C-terminal domain of AHNAK was examined by NMR spectroscopy.

3.2

Materials and Methods

3.2.1

Source of Materials
The expression vector for human S100A10 (pGEX-6P-1-derived vector, GE

Healthcare) was a generous gift from Dr. Michael Walsh (University of Calgary, Alberta,
Canada). All forward and reverse oligonucleotides described within this chapter were
synthesized by Sigma-Genosys (Mississauga, ON, Canada). T4 DNA ligase was
purchased from Fermentas Life Sciences (Burlington, ON, Canada). Pfu Turbo DNA
polymerase was purchased from Stratagene (La Jolla, CA, USA). All other chemicals
used in cloning were purchased from BioShop Canada (Burlington, ON, Canada). All
DNA sequencing was performed at Robarts Research Institute Sequencing Facility
(London, ON, Canada).
15

NH4Cl and 13C6-glucose were obtained from Cambridge Isotope Laboratories,

Inc. (Andover, MA). Puratronic grade CaCl2 (99.9995% purity) was purchased from
Johnson-Matthey (Ward Hill, MA). Peptide arrays were produced at Dr. Shawn Li’s
laboratory (University of Western Ontario, ON, Canada). All other reagents used in the
following experiments were of the highest purity commercially available.
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3.2.2

Construction of S100A10C82S and A10A2C82S in E. coli Expression Vectors
DNA fragments encoding either rabbit S100A10 or the S100A10-annexin A2

(A10A2) hybrid proteins (Rezvanpour et al. 2009) were contained in pGEX-6P-1 vectors.
QuikChange site-directed mutagenesis (Wang and Malcolm 1999) was performed to
convert the cysteine codon (Cys82) to a serine in both plasmids using forward (5’ GCCG
GCCTCACCATTGCATCCAATGACTATTTTGTAGTGC 3’) and reverse (5’ GCACT
ACAAAATAGTCATTGGATGCAATGGTGAGGCCGGC 3’) primers. PCR products
were treated with DpnI (Nebgen et al.) restriction enzyme for 1 hr at 37º C to digest the
methylated template DNA and transformed into E. coli strain JM-109. The single point
mutations in the resulting vectors were confirmed by DNA sequencing.

3.2.3

Expression and Purification of the Wild-Type and C82S Substituted Forms of
S100A10 and A10A2
Unlabeled and uniformly 15N, 13C-labeled wild-type and C82S substituted forms

of human GST-S100A10 and/or GST-A10A2 were overexpressed in the BL21 (DE3)RIL E. coli strain as previously described in Section 2.2.6 (Rezvanpour et al. 2009) using
1 L of 2xYT, or M9 minimal medium supplemented with 1 g

15

NH4Cl and 2 g

13

C6 -

glucose as the sole nitrogen and carbon sources, respectively. MALDI-TOF mass data for
unlabeled S100A10C82S (MWcalc = 11598.6 Da; MWobs = 11599.4 Da) and A10A2C82S
(MWcalc = 13733.8 Da; MWobs = 13733.5 Da) confirmed the protein identities.
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3.2.4

Construction of a Short C-Terminal Fragment of AHNAK Expression Vector
An expression vector containing a short C-terminal fragment of AHNAK was

synthesized by DNA 2.0 (Menlo Park, CA). This vector was composed of a His7 tag and a
TEV cleavage site at the N-terminus of the AHNAK coding gene sequence (5362-5434).
The DNA was extracted from the GFC filter by incubating the filter in 100 µL of 10 mM
Tris-HCl at pH 7.5 for 2 min, followed by spinning the sample in a tabletop centrifuge at
full speed. The integrity of the AHNAK DNA fragment was checked by Pst1 restriction
enzyme digestion on a 1% agarose gel. The DNA was transformed into the JM-109 E.
coli strain.

3.2.5

Expression and Purification of the Wild-Type C-Terminal Fragment of AHNAK
Expression vector containing the C-terminal fragment of AHNAK (5362-5434)

was transformed into E. coli strain BL21 (DE3) Codon Plus expression cells (Invitrogen),
which contain extra copies of the argU, ileY, and leuW tRNA genes to recognize AGA,
AGG, AUA, and CUA codons. An overnight culture (25 mL) was used to inoculate 1 L
of pre-warmed LB media supplemented with 30 µg/mL kanamycin. The culture was
grown at 37 ºC to a density of (A600) 0.8 AU, when it was induced with 1 mM IPTG.
Induction continued for another 4 h with constant shaking at 37 ºC. Cells were harvested
by centrifugation at 6,000 rpm for 15 min at 4 ºC. Following addition of one completemini protease inhibitor tablet, PMSF (1 mM final concentration) and leupeptin (1 µL of
100 µM stock per 1 mL of lysate), the cells were lysed by French Pressure at 20,000 psi.
Ultracentrifugation of the lysed cells was performed using a Beckman ultracentrifuge at
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38,000 rpm for 90 min. All fractionation steps were performed at 4 °C. The
supernatant was filtered through 0.45 micron low protein binding Millipore syringe filters
to remove the particulate matter. The protein was subsequently applied to a 5 mL NiNTA column pre-equilibrated in 20 mM Tris-HCl, 10 mM imidazole, 150 mM NaCl, and
5% glycerol at pH 7.5. The column was washed with the same buffer containing 20 mM
imidazole until the OD280 returned to baseline. Bound protein was then eluted with a 30
mL, 20-500 mM imidazole gradient in the elution buffer. Fractions containing the protein
were pooled and extensively dialyzed against TEV protease cleavage buffer (20 mM TrisHCl, 150 mM NaCl, 10 mM imidazole, 1 mM DTT, and 5% glycerol at pH 7.5) for 6 h
with multiple buffer exchanges. The His7 tag was cleaved from the N-terminus of
AHNAK using 250 units of TEV protease in 48 h with gentle agitation. Cleaved protein
was purified on a second 5 mL Ni-NTA column as described above. Cleaved AHNAK
was eluted in the flow-through fractions. The integrity of the protein was verified on
16.6% SDS-PAGE gel and electrospray ionization mass spectrometry (Biological Mass
Spectrometry Laboratory, University of Western Ontario). MALDI-TOF mass data for
unlabeled AHNAK (MWcalc = 7827.0 Da; MWobs = 7827.4 Da) confirmed the protein
identity.

3.2.6

Expression and Purification of Dysferlin C2A Domain
Unlabeled and uniformly

15

N,

13

C-labeled wild-type human C2A domain of

dysferlin (simply referred to as dysferlin) (residues 1-138) were overexpressed in the
BL21 (DE3) E. coli strain using 1 L of pre-warmed LB or M9 minimal medium
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supplemented with 30 µg/mL kanamycin.

15

NH4Cl (1 g) and 13C6-glucose (2 g) were

used as the sole nitrogen and carbon sources in the M9 minimal media. Briefly, the
cultures were grown at 37 ºC to a density of (A600) 0.7 AU. Expression was induced by
the addition of 1 mM IPTG and allowed to continue for another 4 or 8 h with constant
shaking at 37 ºC. Cells were harvested by centrifugation at 6,000 rpm for 15 min, lysed
by French Pressure at 20,000 psi and centrifuged at 38,000 rpm for 90 min. All
fractionation steps were performed at 4 °C. The supernatant was filtered through 0.45
micron low protein binding Millipore syringe filters. The protein was subsequently
applied to a 5 mL Ni-NTA column pre-equilibrated in 20 mM MES, 10 mM imidazole,
150 mM NaCl, and 5% glycerol at pH 6.7. The column was washed with the same buffer
containing 20 mM imidazole until the OD280 returned to baseline. Bound protein was then
eluted with a 30 mL, 20-500 mM imidazole gradient in the elution buffer. Fractions
containing the protein were pooled and extensively dialyzed against TEV protease
cleavage buffer (25 mM MES, 100 mM NaCl, 1 mM DTT, pH 5.5) for 6 h with multiple
buffer exchanges. The His6 tag was cleaved from the N-terminus of dysferlin using 250
units of TEV protease in 48 h with gentle agitation. Cleaved protein was purified on a 5
mL HiTrap SP FF column (GE Healthsciences) equilibrated in the binding buffer (25 mM
MES, 100 mM NaCl, 1 mM EDTA, and 1 mM DTT, at pH 5.5). Bound dysferlin was
eluted with gradual increase in salt concentration over 30 min using 25 mM MES, 250
mM NaCl, 1 mM EDTA, and 1 mM DTT at pH 5.5. Fractions containing the protein were
pooled and stored at -80 ºC. The protein was extensively dialyzed against appropriate

113

buffers to remove EDTA from the sample particularly before calcium titration
experiments.

3.2.7

Fluorescent Labeling of S100A10C82S, A10A2C82S and Dysferlin C2A Domain
Freshly reduced S100A10C82S, A10A2C82S or dysferlin C2A domain was loaded

onto a pre-equilibrated Sephadex G-25 PD-10 column (GE-Healthcare) in 20 mM TrisHCl and 1 mM EDTA at pH 7.0 in order to remove excess DTT in the protein samples.
Acrylodan or Alexa Fluor 680 maleimide (Invitrogen) was dissolved in acetonitrile to a
concentration of 100 mM. The acrylodan or Alexa Fluor 680 solution (100 µL) was added
to 1 mL of 80 µM S100A10C82S, A10A2C82S or dysferlin and the reactions continued for 2
hr at room temperature until quenched with the addition of 5 mM DTT. The unreacted
dye was removed by chromatography through a Sephadex G-25 PD-10 column which
was pre-equilibrated in TBS buffer (50 mM Tris-HCl, and 120 mM NaCl at pH 7.4). The
protein samples were exhaustively dialyzed against 20 mM Tris-HCl, 120 mM NaCl, and
1 mM DTT at pH 7.4 to eliminate all noncovalently linked dye. ESI-MS indicated a
single dye molecule was covalently linked to each protein.

3.2.8

Peptide Array Experiments
Peptide arrays were produced using the SPOT technology on cellulose

membranes (Dr. Shawn Li, University of Western Ontario). Peptide arrays of AHNAK
contained 330 spots of 18-residue peptides that shifted by 3 residues through the Cterminal sequence of AHNAK (residues 4884-5890). A similar array of annexin A2 was
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also synthesized with 18-residue peptides that shifted by either 2 or 3 residues through
the entire sequence of annexin A2 protein. The peptide arrays of annexin A2 were
acetylated at the N-terminus of the peptides as acetylation of the N-terminus of annexin
A2 has been shown to be a requirement for the interaction (Seemann et al. 1996; Rety et
al. 2000). The peptide arrays of TRPV5 contained 18-residue peptides that shifted by 1 or
2 residues through the C-terminal sequence of TRPV5 (residues 577-729). S100A10C82S
and A10A2C82S were both uniformly labeled at Cys61, while dysferlin was uniformly
labeled at Cys23 with Alexa Fluor 680 maleimide as described in Section 3.2.7.
Membranes were hydrated using anhydrous methanol and then washed three times with a
buffer containing TBS + 0.05% Tween for 10 min at room temperature. Subsequently,
membranes were incubated with TBS + 0.05% Tween and skim milk blocking buffer for
1 hour, followed by a final rinse for 10 min with TBS + 0.05% Tween wash buffer.
Alexa-S100A10C82S, -A10A2C82S or -dysferlin (0.2-2 µM of each) in TBS + 0.05% Tween
and skim milk was used to probe each array for 2 hr. The arrays were then rinsed with
TBS + 0.05% Tween buffer three times for 10 min each. To eliminate background
fluorescence, the arrays were treated three times with a solution of 8 M urea, 1% SDS and
0.5% β-mercaptoethanol at pH 7.0 in a sonication bath at 40º C, and washed with 10%
acetic acid, 50% ethanol and 40% distilled and deionized H2O. The spots on the arrays
were visualized using the Odyssey Infrared Imaging System (LI-COR Biosciences) at 700
nm.
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3.2.9

Peptide Synthesis
The AHNAK (GKVTFPKMKIPKFTFSGREL) (referred to as AHNAK5) and

annexin A2 (STVHEILSKLSLEGD) (Bio Basic Inc, ON, Canada) peptides were
synthesized using solid-phase peptide synthesis employing the Fmoc chemistry strategy
(Grant 2002). The N-termini of the peptides were acetylated while the C-termini were
amidated. The synthesized peptides were purified by C18 reversed-phase HPLC, and
lyophilized. The MALDI-TOF mass data for the acetylated AHNAK (MWcalc = 2353.8
Da; MWobs = 2352.5 Da) and annexin A2 (MWcalc = 1669.8 Da; MWobs = 1668.6 Da)
confirmed the peptides identities.

3.2.10

Mass spectrometry
Mass spectrometry analyses were carried out using a quadrupole time-of-flight

mass spectrometer (Q-TOF, micromass) equipped with a nano electrospray (ES) source
by Dr. Suya Liu in Dr. Gilles A. Lajoie’s laboratory (University of Western Ontario, ON,
Canada). Samples were loaded on a gold-coated capillary (Protona) with the tip manually
opened to produce an orifice of approximately 10 µm. Positive ES was performed at a
capillary voltage of 1.5 to 2 kV and cone voltage of 50V. CID experiments were carried
out with collision energy of 80V using argon as the collision gas. Average molecular
masses were calculated using Mass Lynx 4.0 (Micromass).
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3.2.11

Fluorescence Spectroscopy
A10A2C82S was purified and labeled with acrylodan as described in Section

3.2.7. The concentrations of the protein stock solutions were determined using the
Bradford protein assay and triplicate amino acid analysis (Advanced Protein Technology
Centre, Toronto, Canada). Fluorescence experiments were conducted in duplicate using
acrylodan-labeled A10A2C82S (300 nM) in 20 mM Tris-HCl, 120 mM NaCl, and 1 mM
DTT at pH 7.4 (3 mL). A Fluorolog-3 steady-state fluorometer (Horiba Scientific) was
used for all measurements. Solutions were excited at 375 nm and emissions were
monitored between 400-600 nm using an emission band-pass of 1 nm and an integration
time of 1 sec.
Titrations of A10A2C82S (300 nM) with the AHNAK peptide were carried out at
room temperature in a stirred cell holder. A solution of AHNAK peptide was added in 3
µL increments using a calibrated 10 µL Hamilton syringe followed by three 30 µL
additions to insure protein saturation. After each AHNAK addition, the sample was
stirred for 2 min before scanning. Titrations were continued until a final S100
protein:AHNAK ratio of 10:1 was achieved. The dissociation constant (Kd) (Morigasaki
et al.) was determined by plotting the normalized change in fluorescence (∆F) intensity,
monitored at 500 nm for acrylodan-labeled A10A2C82S (Pt), as a function of AHNAK
concentration (Lt). Data were fit using GraphPad Prism5 to equations 1 and 2 where
∆Fmax is the maximum normalized change in fluorescence and PL is the concentration of
the A10A2C82S-AHNAK complex.
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3.2.12

[PL] = [(Pt + Lt + Kd) – {(Pt + Lt + Kd) 2 – (4PtLt)} 0.5]/2

(1)

∆F = [∆Fmax][PL]/[Pt]

(2)

NMR Titration Experiments
All NMR experiments were acquired at 35 ºC on a Varian INOVA 600 MHz

spectrometer equipped with a pulse field gradient triple resonance probe. A10A2C82S,
S100A10, the C-terminal fragment of AHNAK, the AHNAK5 peptide and dysferlin
concentrations were determined by triplicate amino acid analysis (Advanced Protein
Technology Centre, Toronto, Canada). The concentration of the CaCl2 stock solution was
determined by ICP (University of Western Ontario, ON, Canada). NMR samples of
uniformly 15N, 13C-labeled A10A2C82S (143 ± 6 µM) were prepared in 10% D2O, 20 mM
MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, and 100 mM
NaCl buffer at pH 7.0, using DSS as an internal standard. AHNAK peptide (3320 ± 16.4
µM) was added from a stock solution to give a final AHNAK concentration of 584.6 µM.
Samples were equilibrated for 15 min after each peptide addition. 1H-15N HSQC spectra
were collected using carrier frequencies of 4.699 (1H) and 114.0 ppm (15N) and spectral
widths of 8000.0 and 1700.0 Hz, respectively. Intensities of peaks undergoing slow
exchange were measured after each addition and fit to Equation 1 using the software
Prism 5.
For the NMR samples of uniformly 15N-labeled dysferlin C2A domain (200 ± 7
µM), the protein was prepared in 10% D2O, 10 mM HEPES, 1 mM DTT, and 150 mM
NaCl buffer at pH 7.5, using DSS as an internal standard. CaCl2 (37 mM) was titrated
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from a stock solution in 1.2 µL increments for 7 additions to a calcium concentration
of 1296 µM. The NMR sample of apo-dysferlin and AHNAK (5362-5434) proteins
contained ~138 µM

15

N-labeled apo-dysferlin and ~200 µM unlabeled AHNAK. After

collecting a 1H-15N HSQC spectrum of this sample, calcium (37 mM) was titrated in 1.2
µL increments for 7 additions to a calcium concentration of 850 µM. Samples were
equilibrated for 15 min after each addition. 1H-15N HSQC spectra were collected using
carrier frequencies of 4.772 (1H) and 117.0 ppm (15N) and spectral widths of 6982.6 and
1940.0 Hz, respectively.
An NMR sample of uniformly 15N,

13

C-labeled S100A10 (350 ± 7 µM dimer)

was prepared in 10% D2O, 20 mM MOPS, 1 mM DTT, 50 mM arginine, 50 mM glutamic
acid, and 100 mM NaCl buffer at pH 7.0, using DSS as an internal standard. 1H-15N
HSQC spectra were collected using carrier frequencies of 4.750 (1H) and 114.0 (15N)
ppm. Sequential assignment of the polypeptide backbone resonances for S100A10 was
achieved by the HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH (Grzesiek and
Bax 1992), HNCA (Kay et al. 1990), and HNCO (Kay et al. 1990) experiments. The
number of complex data points and the spectral widths were set to 512 and 8000.0 Hz for
the 1H (F3) dimension, and 64 and 2100.0 Hz for the

15

N (F2) dimension, respectively.

For the HNCACB and CBCA(CO)NH experiments, 32 increments and a spectral width of
7840.0 Hz in the 13C (F1) dimension were used. For the HNCA and HNCO experiments,
32 increments and a spectral width of 4524.0 Hz were used in the 13C (F1) dimension.
For the NMR sample of 15N, 13C-labeled apo-dysferlin with unlabeled S100A10,
1:1 (200 µM of each protein) and 1:2 (200 µM:400 µM) molar ratios of
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dysferlin:S100A10 were used, respectively. After collecting a 1H-15N HSQC spectrum
of this sample, calcium (37 mM) was titrated in 3.5 µL increments for 6 additions to a
calcium concentration of 1296 µM. Samples were equilibrated for 15 min after each
addition. 1H-15N HSQC spectra were collected using carrier frequencies of 4.774 (1H) and
117.0 ppm (15N) and spectral widths of 6982.6 and 1940.0 Hz, respectively. All data were
processed using NMRPipe and NMRDraw (Delaglio et al. 1995) and analyzed by
NMRView (Johnson and Belvins 1994).

3.3

RESULTS

3.3.1

A10A2 Binds to Multiple Consensus Regions on AHNAK
To identify the AHNAK residues involved in the interaction with annexin A2-

bound S100A10 complex, Alexa-A10A2C82S protein was used in a separate peptide array
experiment covering the C-terminus of AHNAK (residues 4884-5890). This approach
identifies the sequence dependent but structurally independent interactions between
A10A2C82S and a series of 18-residue peptides spanning the C-terminal sequence of
AHNAK. Overlapping sequences in the arrays that fluoresced upon Alexa-A10A2C82S
binding were used to identify the AHNAK binding sites (Figure 3.1). Blotting of the
arrays with Alexa-A10A2C82S revealed that A10A2C82S associates with eight distinct
regions within the C-terminus of AHNAK. Using the Blocks Server (blocks.fhcrc.org) to
analyze these regions, a nine residue consensus sequence was identified for AHNAK that
could best be represented as +X+XPKφXφ (X – variable; φ – hydrophobic residue; + –
positively charged residue; P – proline; K – lysine).
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Figure 3.1. Mapping the A10A2C82S binding site on the C-terminal region of
AHNAK by peptide array analysis.
A peptide array of the Asp4884-Glu5890 region of AHNAK was synthesized on a
cellulose membrane. Each spot contained an 18-residue peptide shifted by 3 residues
from its predecessor until the C-terminus was reached. The array was probed with Alexa
Fluor 680-A10A2C82S and imaged at 700 nm. The sequences of AHNAK that showed the
best interaction with A10A2C82S are listed beside and below the array; sequence a
(Thr4917 - Gly4940), sequence b (Asp4959 - Pro4994), sequence c (Pro5220 - Ile5243),
sequence d (Asn5607 - Ile5633), sequence e (Gly5652 - Gly5675), sequence f (Ser5703 Thr5729), sequence g (Ala5757 - Ser5780), sequence h (Leu5808 - Glu5837). These
sequences were used to define a consensus sequence showing positively charged (+),
hydrophobic (φ) and variable (X) residues using the Blocks Server (blocks.fhcrc.org).
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Examination of the sequences that interact with A10A2C82S allowed for the
identification of some general trends. For example, sequences b, e and f show the highest
sequence similarity while the most intense binding at any one spot was observed within
sequences b and e (4968-4985, 5652-5669). Since the residues of the conserved motif for
these sequences are identical, the differences in the binding intensities for A10A2C82S
could indicate that the variable residues in the motif or residues on the periphery may be
important for the interaction. For instance the presence of a methionine and an isoleucine
with rather smaller sidechains at the respective second and fourth positions of the
conserved motif of sequence e, instead of a phenylalanine with a ring in the sidechain at
the second position or a lysine with a long, charged sidechain at the fourth position of
sequence b, could enhance the interaction.
Sequences a, d and g showed weaker interactions with the A10A2C82S protein
likely due to one or more substitutions within the consensus region. For example,
sequences a and d have a histidine at the first position instead of lysine, while sequences
d and g have a small non-polar residue (G/S) at the last position in place of a larger
hydrophobe. Sequence c is unusual due to the presence of two possible consensus
sequences, the first as shown in Figure 3.1 and an alternate sequence starting at K5228,
five residues prior to the indicated consensus sequence.
In general, these results agree with a previous study in which the S100A10annexin A2 binding region within the C-terminus of AHNAK was mapped utilizing a
series of GST-AHNAK deletion mutants by pull-down assays (De Seranno et al. 2006). A
20-residue region in the C-terminus of AHNAK corresponding to residues 5654-5673
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(lying within sequence e, residues 5652-5675) was shown to be sufficient for binding
to the S100A10-annexin A2 complex. Further deletions from the N- or C-terminal
extremity of this 20-residue peptide abolished the interaction with the S100A10-annexin
A2 complex, confirming that these residues are crucial for the interaction (De Seranno et
al. 2006).

3.3.2

Unique Interactions of AHNAK with the S100A10-Annexin A2 Complex
A 20-residue AHNAK peptide (5654-5673; referred to as AHNAK5) that

displayed a strong interaction with A10A2C82S based on the peptide array experiments,
and was consistent with GST-AHNAK pull-down assays (De Seranno et al. 2006) was
synthesized and used in NMR titration experiments. Initially, the AHNAK5 peptide was
titrated into

15

N-labeled S100A10C82S in complex with an unlabeled annexin A2 peptide

(residues 1-15) (Figure 3.2, black). In the absence of AHNAK5, a single resonance was
observed in the 1H-15N HSQC spectrum for each residue in S100A10C82S, consistent with
the symmetric structure of the S100A10C82S-annexin A2 complex where only the

15

N-

labeled S100A10C82S is visible (black spectrum). Titration of unlabeled AHNAK5 peptide
to this solution led to the gradual disappearance of many of the S100A10C82S resonances
in the S100A10C82S-annexin A2 complex and the reappearance of new peaks, indicative
of a slow exchange process (Figure 3.2, pink). Remarkably, the 1H-15N HSQC spectrum
of the 15N-labeled S100A10C82S in the presence of annexin A2 and AHNAK5 resulted in
an increased number of peaks that did not change even in the presence of a four-fold
excess of AHNAK5 peptide. In addition, many of the new resonances appeared in pairs
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Figure 3.2. An overlay of 1H-15N HSQC spectrum of annexin A2-bound S100A10C82S
in complex with the AHNAK5 peptide.
1

H-15N HSQC spectrum of 0.5 mM 15N-labeled S100A10C82S (protomer concentration)
bound to 0.5 mM unlabeled annexin A2 peptide (Ac-STVHEILSLKQLEGD) (black) and
in complex with 0.25 mM AHNAK5 (Ac-GKVTFPKMKIPKFTFSGREL) (pink). Peaks
that exhibited obvious multiplicity in the AHNAK5 complex are labeled according to
their one-letter amino acid code and residue number. Spectra were collected on a Varian
Inova 600 MHz spectrometer at 35 ºC in 90% H2O/10% D2O at pH 7.0.
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with each peak having approximately 50% of the intensity of the original peak (Figure
3.2). For example, Phe13, Val66, Ala76 and Gly77 in

15

N-labeled S100A10C82S all

appeared as two peaks in the 1H-15N HSQC spectrum of S100A10C82S-annexin A2 in
complex with AHNAK5.
To examine the effects of AHNAK5 binding on the annexin A2 portion of
S100A10-annexin A2 complex, NMR titration experiments were repeated using the 15Nlabeled A10A2C82S hybrid protein. The 1H-15N HSQC spectrum of A10A2C82S (Figure
3.3, black) was very similar to that of the S100A10C82S-annexin A2 complex (Figure 3.2)
indicating the structures and interactions of the S100A10 and annexin A2 are similar in
the two complexes (Rezvanpour et al. 2009). In addition, since the annexin A2 portion of
A10A2C82S was also 15N-labeled, resonances from this segment of the hybrid protein (ie.
Leu112, G114) were clearly visible in the spectrum. Similar to the S100A10C82S-annexin
A2 peptide complex, addition of AHNAK5 to the

15

N-labeled A10A2C82S protein led to

the disappearance of peaks from S100A10C82S and annexin A2 and the appearance of new
resonances on the slow exchange time scale. Upon saturation, the 1H-15N HSQC spectrum
of 15N-labeled A10A2C82S bound to unlabeled AHNAK5 (Figure 3.3, cyan) bore a strong
resemblance to that of 15N-labeled S100A10C82S in complex with both unlabeled annexin
A2 and AHNAK5 peptides (Figure 3.2). This included an increased number of peaks in
the A10A2C82S spectrum where several resonances from the S100A10C82S protein
appeared as pairs (Phe13, Val66, Ala76, Gly77). Interestingly, some resonances from the
annexin A2 portion of A10A2 also exhibited peak doubling upon addition of AHNAK5
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Figure 3.3. An overlay of 1H-15N HSQC spectrum of A10A2C82S hybrid protein
bound to the AHNAK5 peptide.
1

H-15N HSQC spectrum of 0.5 mM uniformly 15N-labeled A10A2C82S hybrid protein
(protomer) (black) and in complex with 0.25 mM AHNAK5 peptide (Ac-GKVTFPKMKI
PKFTFSGREL) (cyan). Peaks that exhibited multiplicity in the AHNAK5 complex are
labeled according to their one-letter amino acid code and residue number. Spectra were
collected on a Varian Inova 600 MHz spectrometer at 35 ºC in 90% H2O/10% D2O at pH
7.0.
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(L112, G114), indicating that binding of AHNAK5 affected both the S100A10C82S
and annexin A2 portions of the hybrid protein in a similar fashion.
The increased number of resonances and multiplicity of some peaks in both the
S100A10C82S-annexin A2 and A10A2C82S complexes with AHNAK5 is in contrast to 1H15

N HSQC spectra of many other S100-target peptide complexes including Ca2+-S100B

with CapZ, p53 or NDR kinase, S100A6 with Siah1-interacting protein, and S100A1 in
complex with CapZ or RyR (Rustandi et al. 2000; Inman et al. 2002; McClintock and
Shaw 2003; Lee et al. 2008; Wright et al. 2008; Wright et al. 2009). NMR spectra from
these complexes all display a similar number of resonances in the presence or absence of
target, indicating a symmetric relationship in the dimer is maintained. This is borne out in
three-dimensional structures of the complexes. In order to account for the unique spectral
observations made for the S100A10C82S-annexin A2 complex with AHNAK5 several
models were considered including displacement of annexin A2 by AHNAK5, multiple
orientations of AHNAK5 binding and asymmetric binding of a single AHNAK5 peptide
to the S100A10C82S-annexin A2 complex.

3.3.3

Asymmetric Binding of AHNAK to the A10A2 Dimer
Titrations of 15N-labeled S100A10C82S with AHNAK5 in the absence of annexin

A2 peptide did not show an interaction between S100A10C82S and AHNAK5 and resulted
in precipitation of the sample. Analysis of the NMR experiments using

15

N-labeled

A10A2C82S titrated with unlabeled AHNAK5 peptide were carried out to investigate the
stoichiometry and affinity of the interaction (Figure 3.4). The change in the peak
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Figure 3.4. Titration of A10A2C82S with the AHNAK5 peptide.
Representative 1H-15N HSQC spectra from the AHNAK5 titration are illustrated. Small
additions of AHNAK5 peptide were made into a sample of uniformly 15N, 13C-labeled
A10A2C82S (143 µM dimer concentration). Spectra shown are at (A) 0 equivalents, (B)
0.29 eq., (C) 0.58 eq., (D) 0.78 eq., (E) 0.97 eq., and (F) 1.07 eq. of AHNAK5 peptide
relative to the protein concentration. Many of the new resonances appeared in pairs with
each peak having approximately 50% of the intensity of the original peak.
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intensities of Gly40, Val51, Gly77 in S100A10C82S, and Leu112 in annexin A2 were
plotted as a function of AHNAK5 and A10A2C82S concentrations (Figure 3.5). The data
show near linear decreases for the peak intensities in

15

N-labeled A10A2C82S (Figure

3.5A) and concomitant increases in the peaks intensities in the AHNAK5 complex
(Figure 3.5B). The inflection point for the data sets occurs near a stoichiometry of one
AHNAK5 peptide to one A10A2C82S dimer. Fitting for this interaction indicated a Kd less
than 1 µM although a precise determination was not possible by this method due to the
high A10A2C82S protein concentrations used in the NMR experiments. The data were also
fit for the interaction of two AHNAK5 peptides per A10A2C82S dimer, similar to other
S100-target peptide complexes that display symmetric binding (Figure 3.5C). This
resulted

in

obvious

disagreement

with

the

data,

indicating

the

2:1

AHNAK:A10A2C82S(dimer) model was incorrect.
To provide further evidence for a 1:1 AHNAK:A10A2C82S(dimer) stoichiometry
and to show that both proteins are required for the recruitment of AHNAK5, a mixture of
A10A2C82S and AHNAK5 was subjected to non-denaturing electrospray mass
spectrometry (ES-MS) (Figure 3.6) (Loo 2000). This data showed three major peaks in
the spectrum corresponding to the A10A2C82S protomer (MWobs = 13731.8 Da, MWcalc =
13733.8 Da), A10A2C82S dimer (MWobs = 27462.4 Da, MWcalc = 27467.6 Da) and the
A10A2C82S dimer in complex with a single AHNAK5 peptide (MWobs = 29815.5, MWcalc
= 29820.4 Da). The ES-MS spectrum also showed the absence of a peak at 32173.2 Da
that would be expected for the mass of the A10A2C82S dimer in complex with two
AHNAK5 peptides. This result corroborated the NMR titration experiments that showed
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Figure 3.5. Binding plots of A10A2C82S with AHNAK5 peptide measured from 1H15
N HSQC experiments.
Aliquots of the unlabeled AHNAK5 peptide were added to a solution of 143 µM 15N, 13Clabeled A10A2C82S (dimer concentration) and the resulting changes in peak intensities
were monitored. The binding between AHNAK5 and A10A2C82S is shown as the plot of
(A) decrease, and (B) increase in peak intensities for Gly40 (●), Val51 (♦) and Gly77 (▲)
in S100A10C82S and Leu112 (▼) in annexin A2 as a function of the AHNAK5:A10A2C82S
ratio. (C) The normalized change in peak intensities are shown as a function of AHNAK5
concentration. Data sets for Gly40 (●), Val51 (♦), Gly77 (▲), and Leu112 (▼) were
globally fit for 1:1 (–––) and 2:1 (-----) AHNAK5:A10A2C82S stoichiometries. Data fitting
is described in the Materials and Methods Section 3.2.12.

Figure 3.6. Mass spectrum showing the complex formed between A10A2C82S hybrid protein and AHNAK5 peptide.
A10A2C82S protein mixed with the AHNAK5 peptide illustrating masses attributed to the A10A2C82S protomer (M),
A10A2C82S dimer (D), and A10A2C82S dimer complexed with a single AHNAK5 peptide. The spectrum was obtained under
non-denaturing conditions as described in the Materials and Methods Section 3.2.10.
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only one AHNAK5 peptide is bound to the A10A2C82S dimer. In separate experiments,
S100A10C82S was mixed with both the annexin A2 and AHNAK5 peptides (Figure 3.7). A
representative ES-MS spectrum showed peaks representing the S100A10C82S protomer
(MWobs = 11598.2 Da, MWcalc 11598.6 Da), S100A10C82S dimer (MWobs = 23196.3 Da,
MWcalc = 23197.2 Da) and S100A10C82S dimer bound to two annexin A2 peptides (MWobs
= 26530.4 Da, MWcalc = 26531.4). There was little evidence for a peak corresponding to
an S100A10C82S protomer bound to a single annexin A2 peptide (MWcalc = 13266.8 Da)
in agreement with the crystal structure that shows the annexin A2 binding site comprises
regions from both subunits of the S100A10 dimer (Rety et al. 1999). The second most
intense peak in the ES-MS spectrum corresponded to the S100A10C82S dimer in complex
with two annexin A2 peptides and a single AHNAK5 peptide (MWobs =28883.9 Da,
MWcalc = 28884.2 Da). Repeated experiments showed no evidence of complexes with
masses corresponding to the S100A10C82S dimer complexed with either one or two
AHNAK5 peptides (MWcalc = 25549.9 Da, 27901.9 Da). Similarly, a mixture of
S100A10C82S and AHNAK5 was subjected to non-denaturing ES-MS (Figure 3.8). This
data showed three major peaks in the spectrum representing the S100A10C82S protomer
(MWobs = 11598.7 Da, MWcalc = 11598.6 Da), S100A10C82S dimer (MWobs = 23196.5 Da,
MWcalc = 23197.2 Da), and S100A10C82S dimer in complex with a single AHNAK5
peptide (MWobs = 25547.3, MWcalc = 25549.9 Da). In addition, a small peak
corresponding to mass of the S100A10C82S dimer in complex with two AHNAK5 peptides
(MWobs = 27899.9, MWcalc = 27902.7 Da) was present on the spectrum. These
experiments indicate that the S100A10-annexin A2 complex has a stronger interaction

Figure 3.7. Mass spectrum depicting complexes of S100A10C82S, annexin A2 and AHNAK5 peptides.
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S100A10C82S mixed with annexin A2 and AHNAK5 peptides showing masses corresponding to the S100A10C82S
protomer (M) S100A10C82S dimer (D), S100A10C82S dimer complexed with two annexin A2 peptides and, S100A10C82S
dimer complexed with two annexin A2 peptides and a single AHNAK5 peptide. The spectrum was obtained under nondenaturing conditions as described in Section 3.2.10.

Figure 3.8. Mass spectrum depicting complexes of S100A10C82S, and AHNAK5 peptide.
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S100A10C82S mixed with AHNAK5 peptide showing masses corresponding to the S100A10C82S protomer (M),
S100A10C82S dimer (D), S100A10C82S dimer complexed with a single AHNAK5 peptide and, S100A10C82S
dimer complexed with two AHNAK5 peptides. The spectrum was obtained under non-denaturing conditions as
described in Section 3.2.10.
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with AHNAK5, while in the absence of annexin A2, a weak interaction could exist
between the S100A10C82S protein and AHNAK5.
Fluorescence spectroscopy was used to calculate the binding affinity of
AHNAK5 for the A10A2C82S complex and S100A10C82S. Since AHNAK5, A10A2C82S or
S100A10C82S do not possess a good intrinsic fluorescence probe, S100A10C82S and the
A10A2C82S hybrid proteins were covalently labeled with acrylodan at Cys61 in the second
EF-hand loop. Initial fluorescence experiments using acrylodan-labeled S100A10C82S in
the absence of the annexin A2 peptide showed less than 12% change in fluorescence and
little wavelength shift suggestive of a poor interaction (Figure 3.9A). The normalized
change in fluorescence intensity for this titration was plotted as a function of the
AHNAK5:S100A10C82S(dimer) ratio (Figure 3.9B). The points were globally fit with a
1:1 ligand binding curve yielding a dissociation constant of 1.75 ± 0.2 µM. In contrast,
fluorescence experiments of acrylodan-labeled A10A2C82S had a fluorescence maximum
near 495 nm (Figure 3.10A) that decreased in intensity and gradually shifted to 500 nm
upon addition of AHNAK5, indicative of a much tighter interaction. The normalized
change in fluorescence intensity for this titration was plotted as a function of the
AHNAK5:A10A2C82S(dimer) ratio (Figure 3.10B). Global fitting of duplicate data sets
with a 1:1 ligand binding curve yielded a dissociation constant of 3.15 ± 0.6 nM. This
data confirms that the interaction of AHNAK5 with the A10A2C82S hybrid is markedly
stronger than that with S100A10C82S protein alone.

Figure 3.9. The interaction of AHNAK5 with the S100A10C82S protein monitored by fluorescence spectroscopy.
(A) Fluorescence spectra of acrylodan-S100A10C82S (300 nM) showing the change in acrylodan fluorescence with
increasing AHNAK5 peptide concentration. (B) Binding curve for Acrylodan-S100A10C82S titrated with the AHNAK5
peptide showing the normalized change in fluorescence measured at 500 nm as a function of AHNAK5 concentration.
Data was collected from duplicate titrations and curves were fit globally with a 1:1 ligand binding function (solid line).
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Figure 3.10. The interaction of AHNAK5 with the A10A2C82S hybrid protein monitored by fluorescence
spectroscopy.
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(A) Fluorescence spectra of acrylodan-A10A2C82S (300 nM) depicting the change in acrylodan fluorescence with
increasing AHNAK5 peptide concentration. (B) Binding curve for Acrylodan-A10A2C82S titrated with the AHNAK5
peptide showing the normalized change in fluorescence measured at 500 nm as a function of AHNAK5 concentration.
Data was collected from duplicate titrations and curves were fit globally with a 1:1 ligand binding function (solid line).
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3.3.4

Mapping S100A10 and A10A2 Binding Sites on C-terminal Region of TRPV5
Recent two-hybrid and co-immunoprecipitation experiments provided evidence

for interaction of the transient receptor potential cation channel protein TRPV5 and
TRPV6 with the S100A10 protein (van de Graaf et al. 2003; Borthwick et al. 2008). In
this case, the S100A10-annexin A2 complex is thought t o mediate trafficking of the
TRPV5 and TRPV6 proteins to the plasma membrane where they act as calciumselective channels. Although S100A10 forms a ternary complex with annexin A2 and
either TRPV5 or TRPV6, a direct interaction between the annexin and TRPV proteins
have not been observed. To examine the possible formation of a ternary complex
involving S100A10 and annexin A2 proteins, the interaction between TRPV5 with
S100A10 alone and the A10A2 complex was tested by peptide array analysis. Peptide
arrays containing 18-residue peptides spanning the C-terminal sequence of human
TRPV5 (residues 577-730) were synthesized as described in Section 3.2.8. S100A10C82S
or A10A2C82S were labeled with Alexa Fluor 680 maleimide at their unique cysteine
(C61) in the sequence for peptide array blotting. Cys61 is located in the second calciumbinding loop of S100A10, and is not known to be involved in target-binding. As a result,
the Alexa dye should not interfere with the interaction of Alexa-S100A10C82S or A10A2C82S with any of the peptides.
Alexa-S100A10C82S and -A10A2C82S were used for blotting the peptide arrays to
determine whether the N-terminal peptide of annexin A2 in the S100A10-annexin A2
complex is required for the interaction of S100A10 with TRPV5/TRPV6. Peptide array
analysis identifies the sequence dependent but structurally independent interactions
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between S100A10C82S or A10A2C82S with the series of 18-residue peptides spanning
the C-terminal sequence of human TRPV5. The binding regions on TRPV5 were
identified by comparing the overlapping TRPV5 peptide sequences on the array that were
fluorescent (Figure 3.11A and B). For instance, the sequences for the peptides at position
2G, 2H, and 2I on the TRPV5 18-2 array are WPRSGICGCEFGLGDRWF,
RSGICGCEFGLGDRWFLR, and GICGCEFGLGDRWFLRVE, respectively. Thus, each
spot on the array differs from the previous one by losing two residues from the Nterminus, while gaining two residues at the C-terminus of the peptide by moving along
the protein sequence. Peptide array spots that decreased in fluorescence after a
consecutive string of fluorescence spots, specify the importance of the deleted residues
for the S100A10C82S interaction. In all of the arrays the amino acid residues important for
the interactions are shown in red (Figures 3.11-3.14).
On the TRPV5 18-1 array, S100A10C82S associated with five regions of the Cterminal sequence of TRPV5 (Figure 3.11A), while the protein bound to 4 sites on the
TRPV5 18-2 array (Figure 3.11B). The binding sequences for both arrays were very
similar. One of the observed differences was that the two sequences spanning S669-W701
(10G-11H) and L688-E720 (12B-13G) on the TRPV5 18-1 array, appeared as one long
stretch of residues covering S669-E720 (5A-6D) on the TRPV5 18-2 array. The first
interaction site in TRPV5 was located at R594-G620 (2H-3G) in both arrays, which is
localized to its intracellular C-terminal tail. This region contains residues 598-603
(VATTV) that is a highly conserved region in both TRPV5/TRPV6 channel proteins.
These arrays uncovered specific sequences within TRPV5 that are recognized by

139

Figure 3.11. Mapping the S100A10 binding site on TRPV5 protein through peptide
array analysis.
A peptide array of the C-terminal sequence of human TRPV5 (577-730) was synthesized.
Each spot contained an 18-residue peptide shifted by 1 (A) or 2 (B) residues from its
predecessor until the C-terminus was reached. The arrays were probed with Alexa Fluor
680-S100A10C82S and imaged at 700 nm. The sequences of TRPV5 corresponding to the
peptides that showed the interaction with S100A10C82S are listed below the array, with the
residues important in the interaction in red.
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S100A10C82S. Furthermore, since the TRPV5 18-1 array shifted by only a single
residue at each spot, it allowed to examine the importance of every residue in the protein
sequence. These residues are indicated in red in Figure 3.11.
To determine whether the interaction of S100A10 with the N-terminal region of
annexin A2 alters the binding of S100A10 on the TRPV5 protein, similar peptide arrays
were probed with Alexa-A10A2C82S (Figure 3.12A and B). A10A2C82S associated with
five regions on the C-terminal sequence of TRPV5 on the 18-1 array (Figure 3.12A),
while the protein bound to 4 sites on the TRPV5 18-2 array (Figure 3.12B). The two
sequences spanning D590-G620 (2D-3G) and R615-V633 (4I-4J) on the TRPV5 18-1
array, appeared as one extended sequence covering E591-D638 (1H-2K) on the TRPV5
18-2 array. Interestingly, the interaction sites found on the arrays blotted with AlexaA10A2C82S, were similar to those probed with Alexa-S100A10C82S (Figure 3.11A and B).
This suggests that association of S100A10C82S with TRPV5 is not modified when
S100A10C82S is in complex with the N-terminal peptide of annexin A2. This shows the
binding site of TRPV5 on the S100A10C82S is different from that of the N-terminal
peptide of annexin A2 protein. Consequently, the interaction of TRPV5 with the
S100A10C82S-annexin A2 complex is unlike the AHNAK protein, whereby residues from
both the S100A10C82S and annexin A2 are required for the strong interaction of the
AHNAK with the complex.
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Figure 3.12. Identification of the A10A2C82S binding region on TRPV5 protein.
A peptide array scanning the C-terminal sequence of human TRPV5 (577-730) was
synthesized with each spot containing an 18-residue peptide that moves through the
sequence by 1 (A) or 2 (B) residues for each spot. The arrays were blotted with Alexa
Fluor 680-A10A2C82S and imaged at 700 nm. The sequences of TRPV5 corresponding to
the peptides that were found to interact with A10A2C82S are listed below the array, with
the residues important for the interaction in red.
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3.3.5

S100A10 Binds to Specific Regions on Annexin A2
The crystal structure of apo-S100A10 in complex with annexin A2 is only

comprised of the first twelve N-terminal residues of the annexin A2 protein (Rety et al.
1999). Consequently, this structure does not show other potential binding sites of
S100A10 on the annexin A2 protein. To identify additional regions of annexin A2 that are
involved in S100A10 binding, two peptide arrays containing 18-residue peptides
spanning the entire sequence of human annexin A2 were synthesized as described in
Section 3.2.8. The arrays were blotted with Alexa-S100A10C82S or -A10A2C82S, and
stripped to eliminate the background fluorescence and non-specific interactions.
On the annexin A2 18-2 array, S100A10C82S associated with eleven regions of
annexin A2 protein (Figure 3.13A). The first interaction site (1A-1A) was found in the
first 18 residues of the N-terminal tail of annexin A2 (M1-S18), which had shown a
strong interaction with the S100A10 protein in the crystal structure (Rety et al. 1999).
This interaction did not seem as strong compared to some other spots on the array,
indicating the presence of other regions on the annexin A2 sequence that have stronger
binding with S100A10C82S. The second and third binding regions, L13-D34 and V51-H94,
(1G-1I and 2J-3G) encompass the linker that connects the N-terminus of annexin A2 to
repeat I (refer to Section 1.5, Figure 1.5) as well as helices A-D of repeat I, respectively.
These two regions are located on one side of the annexin A2 protein, however, only the
linker and helices A and B of repeat I are accessible to interact with residues of S100A10.
A closer look at the structure of annexin A2 indicates that binding regions comprised of
E125-E142 (4O-4O), I129-K148 (5A-5B), S161-A180 (6A-6B), I191-T208 (6P-6P), and
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Figure 3.13. Mapping the S100A10C82S binding site on annexin A2 protein through
peptide array analysis.
A peptide array of the entire sequence of human annexin A2 was synthesized on a
cellulose membrane. Each spot contained an 18-residue peptide shifted by 2 (A) or 3 (B)
residues from its predecessor until the C-terminus was reached. The arrays were probed
with Alexa Fluor 680-S100A10C82S and imaged at 700 nm. The sequences of annexin A2
corresponding to the peptides that showed the best interaction with S100A10C82S are
listed below the array, with the residues important in the interaction in red.
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G250-K281 (8N-9F) are all located at the core of annexin A2 molecule and are not
available for interaction with S100A10C82S. The fact that all of these regions appeared as a
short or single fluorescence spot on the array is an indication for non-specific interactions
of the protein to these peptides. It is noteworthy that some of the interactions observed
could also be due to sequence similarity of the helices within each repeat unit of annexin
A2. One of the strongest binding regions, P211-V248 (7J-8D), includes helix C of repeat
III (Figure 1.5) where the N-terminal tail of annexin A2 is packed against. Therefore, it is
not surprising to observe the association of S100A10C82S with this region. Finally, the
binding sites encompassing L288-E307 (10A-10B) and M300-K336 (10G-11A) contain
the linker connecting helices B to C, as well as helices C, D, and E of repeat IV of
annexin A2. These sites are located at the same side as the N-terminal tail of annexin A2,
and are accessible for binding to S100A10.
Comparable results were observed for the annexin A2 18-3 array. However,
S100A10C82S associated with ten regions of annexin A2 protein (Figure 3.13B). Two of
the interaction sites, E125-E139 (4O-4O), and I191-T208 (6P-6P), present in the annexin
A2 18-2 array, were not observed on this array confirming that the single fluorescence
spots were indeed non-specific. An additional weak interaction was also noted at L91S117 (4A-4D) that is not available for interaction with S100A10.
In order to determine whether the interaction of S100A10C82S with the Nterminal tail of annexin A2 alters the binding of S100A10C82S to other regions of annexin
A2, similar peptide arrays were probed with Alexa Fluor 680-labeled A10A2C82S protein
(Alexa-A10A2) (Figure 3.14A and B). In the A10A2C82S hybrid protein, the S100A10C82S
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Figure 3.14. Identification of the A10A2C82S binding region on annexin A2 protein.
A peptide array scanning the entire sequence of human annexin A2 was synthesized. Each
spot contained an 18-residue peptide shifted by 2 (A) or 3 (B) residues from its
predecessor until the C-terminus was reached. The arrays were blotted with Alexa Fluor
680-A10A2C82S and imaged at 700 nm. The sequences of annexin A2 corresponding to
the peptides that were found to interact with A10A2C82S are listed below the array, with
the residues important for the interaction in red.
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is in complex with the N-terminal tail of annexin A2. As expected, Alexa-A10A2C82S
did not interact with the spots containing the N-terminal tail of annexin A2 on the array.
In addition, some of the non-specific bindings such as E125-E139 (4O-4O), I129-K148
(5A-5B), and I186-T208 (6P-6P) observed on the arrays blotted with Alexa-S100A10C82S,
were absent.
Some of the interaction sites on the arrays blotted with Alexa-A10A2C82S were
analogous to those probed with Alexa-S100A10C82S (Figure 3.13A and B), signifying that
A10A2C82S associates with similar sequences on the annexin A2 protein. Thus, these
interactions are not modified when S100A10C82S is bound to the N-terminal tail of
annexin A2. Due to the high number of fluorescent spots on these arrays, it was difficult
to identify the stronger binding sites.

3.3.6

Expression and Purification of the Wild-Type Dysferlin C2A Domain
Wild-type forms of human dysferlin C2A domain (simply referred to as

dysferlin) (residues 1-138) were overexpressed in the BL21 (DE3) E. coli strain.
Following the first run on the Ni-NTA column, the His6 tag was cleaved from the Nterminus of dysferlin. The cleaved protein was not stable in buffer containing imidazole,
which is used to elute the protein from Ni-NTA columns. Therefore, cleaved dysferlin
was purified on a HiTrap SP FF column. Figure 3.15 shows the SDS-PAGE of the last
purification step, indicating a single band at an apparent molecular weight of
approximately 14.8 kDa. This roughly corresponds to the calculated molecular weight for
human dysferlin (1-138) of 14805.9 Da. Since dysferlin is a calcium-binding protein,
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Figure 3.15. Coomassie-stained SDS-PAGE gel (16.5%) depicting the purification of
wild-type C2A domain of dysferlin.
Lane 1 contains the protein molecular weight markers, with molecular weights labeled on
the left of the gel. Lanes 2-12 contain elution profile of every fraction following removal
of His6 tag on the HiTrap SP FF column. The arrowhead on the right indicates dysferlin
protein at molecular weight of approximately 14.8 kDa.
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some of the early NMR spectra indicated that after the last purification step the protein
was partially bound to calcium. To ensure that dysferlin was in the apo form, 1 mM
EDTA was present in the buffers used in the second column run. Before calcium titration
experiments, the protein was extensively dialyzed against EDTA-free buffers to remove
excess EDTA as it could bind to calcium ions.

3.3.7

Sequential Backbone assignment of S100A10
The structure of S100A10 in the apo state and complexed with the N-terminal

peptide of annexin A2 has been solved by X-ray crystallography (Rety et al. 1999). The
lack of an NMR assignment of apo-S100A10 makes it difficult to determine the details of
the interaction of this protein with target peptides. Thus, the NMR assignment of
S100A10 was completed. Wild-type S100A10 was purified. However, concentrating this
protein to a usable concentration for NMR samples resulted in rapid precipitation of
S100A10. To overcome this problem, dilute S100A10 was dialyzed against a buffer
containing equimolar concentrations (50 mM) of arginine and glutamic acid prior to
concentration, which was previously shown to stabilize proteins during concentration
(Golovanov et al. 2004). Sufficient quantities of wild-type 15N, 13C-labeled S100A10 for
NMR samples at a concentration of 1 mM were prepared. However, the 1H-15N HSQC
spectrum of this sample showed that the concentrated sample was too viscous which
resulted in increasing the line-width of the peaks. Diluting the sample to 500 µM allowed
better spectra to be collected for the resonance assignment of the protein. Chemical shift
assignments (1H,

15

N, and

13

C) for S100A10 were accomplished using standard
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heteronuclear multiple dimensional NMR spectroscopy (HNCA, HNCACB,
CBCA(CO)NH, and HNCO) (Figure 3.16 and 3.17). Figure 3.17 shows a representative
1

H-15N HSQC spectrum of S100A10 that is well dispersed, indicating that the protein is

well folded. The 1H and

15

N backbone amide resonances of S100A10 for 78 out of 93

non-proline residues were assigned (Table 3.1). There were 5 residues on the 1H-15N
HSQC spectrum that did not appear on any of the three-dimensional NMR spectra and
thus could not be assigned. Most of the remaining residues were not visible on the spectra
due to fast exchange with the solvent and could not be assigned.

3.3.8

Interaction Study of Apo- and Calcium Bound Dysferlin C2A Domain with
S100A10
To further examine the arrangement of multi-protein complexes involved in

membrane repair, the binding region(s) of different proteins within the complexes such as
those formed between S100A10 and dysferlin must be uncovered. Sequence alignments
of dysferlin with other members of the ferlin family such as synaptotagmin have proposed
six potential calcium binding sites in the C2A domain of dysferlin (Britton et al. 2000).
Recently, it was shown that the C2A domain of synaptotagmin (Syt1) associates with
fibroblast growth factor protein (FGF) as well as one of the members of the S100 family,
S100A13, in the presence of calcium (Mohan et al. 2009; Mohan et al. 2010).
The assigned spectra (1H,

15

N, and

13

C) for the apo-C2A domain of dysferlin

(Chantal Forristal, data not published, University of Western Ontario, ON, Canada) and
S100A10 would allow the interaction of sites between dysferlin and S100A10 proteins to
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Figure 3.16. Selected regions of 600 MHz NMR spectra used for the backbone
assignment of the wild-type S100A10 protein.
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of
the three dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i)
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for
sequential assignment of residues E28-E31 of the S100A10.
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Figure 3.17. Backbone amide assignment of S100A10 protein.
1

H-15N HSQC spectrum of 0.5 mM (monomer) uniformly 15N, 13C-labeled S100A10
protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was collected
in 20 mM MOPS, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100 mM NaCl, pH
7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated with their one letter
amino acid code and number. The “?” indicates the peaks that appeared on the 1H-15N
HSQC spectrum, however, were absent on the three-dimensional NMR experiments used
for assignment purposes. Pairs of resonances for side chain amide cross peaks are
connected by horizontal lines.
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Table 3.1. 15N, 13C and 1H resonance assignments for human S100A10.
Residue
P1
S2
Q3
M4
E5
H6
A7
M8
E9
T10
M11
M12
F13
T14
F15
H16
K17
F18
A19
G20
D21
K22
G23
Y24
L25
T26
K27
E28
D29
L30
R31
V32
L33
M34
E35
K36
E37
F38
P39
G40
F41
L42
E43
N44
Q45
K46
D47
P48
L49
A50
V51
D52
K53
I54

HN

N

9.265
9.023
8.522
8.497
8.330
8.410

121.4
120.1
121.0
118.4
123.8
117.1

8.423

116.7

8.050
7.840
8.053

124.1
117.2
124.1

7.173
8.506
7.454

114.4
122.7
100.9

8.305
7.354

117.1
104.0

9.218
9.098
8.196
7.723
8.352
7.980
7.610
8.026
8.505
8.084
8.179
8.767

112.8
120.1
118.4
120.1
118.3
119.7
118.3
122.0
117.6
117.3
114.9
114.5

9.256
6.882
8.892
8.284
7.681
7.602
8.090

111.8
113.6
117.6
119.3
116.1
118.0
119.7

8.238
7.625
8.230
7.896
7.961
7.605

119.00
122.7
116.6
120.2
118.4
119.6

C’

Cα

Cβ

175.17
180.01
178.81
179.42
178.09
178.61

57.79
59.55
57.92
60.17
59.56
55.74
57.83
60.03

64.85
28.39
32.02
29.53
29.90
18.24
32.02
29.40

66.80

68.51

178.44
176.98

58.23
62.70
58.31

41.46
62.55
41.57

177.70
176.05

59.24
60.36
53.92
44.78
56.56
57.65
46.49

32.17
40.74
18.77

53.20
60.72
60.70
59.79
57.22
57.5
60.26
66.31
59.42
59.06
59.26
57.93
56.22

43.47
71.85
31.95
29.09
42.70
41.80
29.78
31.91
42.02
31.64
30.11
33.68
30.58

179.62
172.46
171.81
179.47
177.35
175.11
177.57

65.63
46.46
55.60
52.90
58.48
53.99
55.97
57.20

31.07

29.64
39.40
28.99
32.81

177.77
177.60
178.84
174.88
178.81
178.87
178.10

64.28
54.91
55.69
66.42
57.61
59.75
64.22

32.44
41.30
18.92
31.44
40.75
32.64
38.21

177.98
178.25

178.16
175.89
178.46
178.71
177.97
178.16
177.32
179.34
177.96
178.76
178.86

40.63
31.15

40.14
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M55
K56
D57
L58
D59
Q60
C61
R62
D63
G64
K65
V66
G67
F68
Q69
S70
F71
F72
S73
L74
I75
A76
G77
L78
T79
I80
A81
C82
N83
D84
Y85
F86
V87
V88
H89
M90
K91
Q92
K93
G94
K95
K96

8.074
7.771
7.721
7.659
8.220
8.254
8.050

116.8
118.9
118.7
120.2
121.5
117.1
118.0

8.527
8.352
7.491
9.271
8.467
8.734

118.8
107.1
118.8
124.4
114.4
119.7

8.043
7.871
8.175

124.9
104.7
122.4

178.30
178.17
177.47
177.87
177.29
176.36
176.48
176.51
173.56
175.49
176.08
173.72

179.04
179.19
176.04
175.65

8.605

122.8

7.793

115.0

8.029
7.761
7.974
8.016
7.965
8.128
8.166
8.345
8.035
7.974

118.5
120.0
119.7
118.8
120.5
119.8
121.8
109.6
121.1
128.0

178.96

176.63
177.20
177.14
176.23
176.94
177.00
176.17
177.07
173.79

57.89
58.88
56.06
55.82
56.04
56.89
58.95
57.91
54.32
46.04
55.66
62.43
44.31
62.13

62.83
55.54
47.07
59.72
61.72
60.86
54.11
59.22

60.00
64.66
64.50
57.76
56.51
57.15
56.20
56.79
45.32
56.28
57.84

32.20
32.26
40.88
42.06
40.85
28.81
27.54
29.55
40.69
34.21
32.73
39.33

18.11
39.09
63.33
39.06
19.08
28.24

39.65
32.04
32.30
30.00
32.62
32.76
29.30
32.94
33.32
33.75
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be identified using chemical shift perturbations. To determine whether the interaction
between S100A10 and dysferlin was dependent upon calcium binding to dysferlin, a 1H15

N HSQC spectrum of apo-C2A domain of dysferlin was collected (Figure 3.18A). A

similar NMR sample containing excess amount of S100A10 was also prepared and a
second 1H-15N HSQC was then obtained (Figure 3.18B). Comparison between the two
spectra of C2A domain of dysferlin in the presence and absence of S100A10 showed that
the peaks are in nearly identical positions. This could suggest that the interaction between
C2A domain of dysferlin and S100A10 is calcium dependent.
Small additions of calcium from a stock with known concentration
(determined by ICP) were made to the NMR sample of apo-C2A domain of dysferlin and
1

H-15N HSQC spectra were collected at each point (Figure 3.19). Calcium additions

resulted in the gradual disappearance of a subset of dysferlin C2A domain resonances and
the reappearance of new peaks at each step of the titration. This shows the sequential
association of the calcium ion to each calcium-binding loop of the protein in a slow
exchange process with dissociation constants of less than 20 µM for all calcium-binding
sites. The C2A domain of dysferlin was saturated when the calcium concentration was
equivalent to 6 times the protein concentration (Figure 3.19F). Comparable titrations were
made into the NMR sample containing the mixture of apo-C2A domain of dysferlin and
S100A10 (Figure 3.20B). The 1H-15N HSQC of this sample was identical to the spectrum
of calcium-bound dysferlin protein (Figure 3.20A), demonstrating a lack of interaction
between C2A domain of dysferlin and S100A10 under the conditions used.

Figure 3.18. Interaction study of dysferlin C2A domain and S100A10 in the absence of calcium.
1
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H-15N HSQC spectrum of 200 mM uniformly 15N, 13C-labeled dysferlin C2A domain alone (A) and mixed with 400
mM wild-type S100A10 protein (B) in 10 mM HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5 acquired at 35 ºC on a
Varian INOVA 600 MHz spectrometer.
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Figure 3.19. Titration of dysferlin C2A domain with calcium ions.
Representative 1H-15N HSQC spectra from the calcium titration are illustrated. Small
additions of calcium were made into a sample of uniformly 15N, 13C-labeled dysferlin
C2A domain (200 µM). Spectra shown are at (A) 1 equivalent, (B) 2 eq., (C) 3 eq., (D) 4
eq., (E) 5 eq., and (F) 6 eq. of calcium relative to the protein concentration. The C2A
domain of dysferlin binds to 6 calcium ions.

Figure 3.20. Interaction study of dysferlin C2A domain and S100A10 in the presence of calcium.
1
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H-15N HSQC spectrum of 200 mM uniformly 15N, 13C-labeled calcium-bound dysferlin C2A domain alone (A) and
mixed with 400 mM wild-type S100A10 protein (B) in 10 mM HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5
acquired at 35 ºC on a Varian INOVA 600 MHz spectrometer.
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3.3.9

Expression and Purification of the C-terminal Fragment of Human AHNAK
Protein
Recombinant C-terminal fragment of human AHNAK (residues 5362-5434) was

expressed and purified from E. coli strain BL21 (DE3) Codon Plus expression cells. Since
the protein degraded very quickly, purification procedures were performed at 4 °C in the
presence of one complete-mini protease inhibitor tablet, PMSF and leupeptin. The protein
was purified on two consecutive Ni-NTA columns. Figure 3.21 shows the SDS-PAGE of
fractions from the second column run. The AHNAK protein appears as a band at
approximately 9 kDa, which roughly corresponds to the calculated monomer molecular
weight for the C-terminal fragment of AHNAK of 7827.0 Da. Fractions containing a
single band corresponding to the mass of AHNAK were pooled and stored at -80 °C. ESI
mass spectrometry was used to verify the purity, integrity and molecular weight of the
protein. Figure 3.22 shows a mass spectrum of unlabeled AHNAK with two peaks. The
first peak appears at 7827.4 Da, which is in agreement with the calculated mass of
monomeric AHNAK. The second peak at 15652.87 Da corresponds to the molecular
weight of a dimeric AHNAK protein. Fresh DTT as a reducing agent was required to
prevent formation of an intermolecular disulfide bond between Cys5382 of the AHNAK.
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Figure 3.21. Coomassie-stained SDS-PAGE for the purification of short C-terminal
fragment of AHNAK.
Lane 1 contains the protein molecular weight markers, with molecular weights labeled on
the left. Lanes 2-13 contain elution profile of every fraction following removal of His7 tag
on the Ni-NTA column. The arrowhead on the right indicates monomeric AHNAK at
molecular weight of approximately 9 kDa.

Figure 3.22. Mass spectrum of an unlabeled C-terminal domain construct of AHNAK protein.
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After purification of the protein, excess salt was removed. The protein was subjected to mass spectrometric analysis to
verify the molecular weight of the protein. The analysis resulted in two peaks. The peak at 7827.4 Da is in agreement
with the calculated mass of monomer AHNAK (7827.0 Da). The peak at 15652.9 Da corresponds to the mass of a
dimer AHNAK when a disulfide bond is formed between cysteines at position 5382.
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3.3.10

Interaction Study of Apo- and Calcium Bound Dysferlin C2A Domain with
the C-terminal Fragment of AHNAK
Recent three-hybrid and co-immunoprecipitation experiments have provided

some evidence on the interaction between the C-terminal domain of AHNAK and the Nterminal C2A domain of dysferlin. Further, it was also shown that calcium binding to the
dysferlin C2A domain is not a requirement for its interaction with AHNAK (Huang et
al. 2007). To identify the residues involved in this interaction, dysferlin C2A domain was
labeled with Alexa Fluor 680 maleimide at the only cysteine (Cys23) in the sequence for
peptide array blotting. Alexa-dysferlin protein was used in a peptide array experiment
covering the C-terminus of AHNAK (residues 4884-5890). This approach identifies the
structurally independent interactions between dysferlin and a series of 18-residue peptides
spanning the C-terminal sequence of AHNAK. Overlapping sequences in the arrays that
fluoresced upon Alexa-dysferlin C2A domain binding were used to identify the AHNAK
binding sites (Figure 3.23). Blotting of the arrays with Alexa-dysferlin revealed that the
apo-dysferlin C2A domain associates with four distinct regions within the C-terminus of
AHNAK. Using the Blocks Server (blocks.fhcrc.org) to analyze these regions, a six
residue consensus sequence was identified for AHNAK that could best be represented as
XPKφ±φ (X – variable; φ – hydrophobic residue; ± – charged residue; P – proline; K –
lysine).
The most intense binding at any one spot was observed within sequences b
(Gly5367 - Ser5393), while sequences a (Met5025 - Phe5042), c (Leu5394 - Ser5414)
and d (Phe5619 - His5649) showed weaker interactions with the dysferlin C2A
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Figure 3.23. Mapping apo-dysferlin C2A domain binding site on the C-terminal
region of AHNAK by peptide array analysis.
A peptide array of the Asp4884-Glu5890 region of AHNAK was synthesized. Each spot
contained an 18-residue peptide shifted by 3 residues from its predecessor until the Cterminus was reached. The array was probed with Alexa Fluor 680-dysferlin and imaged
at 700 nm. The sequences of AHNAK that were found to bind dysferlin C2A domain (red
fluorescent spots) are listed and indicated with arrows; sequence a (Met5025 - Phe5042),
sequence b (Gly5367 - Ser5393), sequence c (Leu5394 - Ser5414), sequence d (Phe5619 His5649). These sequences were used to define a consensus sequence showing charged
(±), hydrophobic (φ) and variable (X) residues using the Blocks Server (blocks.fhcrc.org).
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domain. This could be due to the presence of certain residues upstream of the
consensus sequence. For example, when residues L5370-G5372 were eliminated from the
second fluorescent spot of sequences b, the fluorescent signal of the next spot was
dramatically reduced.
Previous GST-pull down assays of AHNAK indicated that the binding site for
dysferlin C2A domain is located between residues M5146-V5643 (Huang et al. 2007).
However, the peptide array experiment identified an extra binding region, specified as
sequence a (Met5025 - Phe5042). This interaction could be explained by sequence
similarity of this region with the remaining binding sites. It would be interesting to repeat
a similar array in the presence of calcium to observe whether calcium-bound dysferlin
C2A domain would bind to different regions on the AHNAK.
To further examine and locate the interaction sites between dysferlin and
AHNAK proteins, both the C-terminal fragment of AHNAK and the C2A domain of
dysferlin proteins were purified as described in Sections 3.2.5 and 3.2.6, respectively. A
1

H-15N HSQC spectrum of apo-C2A domain of dysferlin was collected (Figure 3.24). A

similar NMR sample containing an excess amount of AHNAK was also prepared and a
second 1H-15N HSQC was obtained (Figure 3.24). The overlay of the two 1H-15N HSQC
spectra did not show significant changes in chemical shifts of C2A domain of dysferlin in
the presence and absence of AHNAK.
To test whether this interaction is calcium dependent, small additions of
calcium were made to the NMR sample of apo-C2A domain of dysferlin. Once more, the
C2A domain of dysferlin was saturated when the calcium concentration was equivalent to
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Figure 3.24. Interaction study of C2A domain of dysferlin and C-terminal fragment
of AHNAK in the absence of calcium.
Overlay of 1H-15N HSQC spectra of apo-dysferlin (black) and apo-dysferlin mixed with
C-terminal fragment of AHNAK protein (blue). Two NMR samples of 138 µM uniformly
15
N, 13C-labeled apo-dysferlin alone and mixed with 200 µM AHNAK protein in 10 mM
HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5 were used to collect the respective HSQC
spectra. No significant changes in chemical shifts were observed in the absence of
calcium.
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6 times the protein concentration (Figure 3.25). Similar titrations were made into the
NMR sample containing the mixture of apo-C2A domain of dysferlin and AHNAK
(Figure 3.25). The 1H-15N HSQC of this sample perfectly superimpose the spectrum of
calcium-bound dysferlin protein. This indicates that under the conditions used, C2A
domain of dysferlin does not interact with the AHNAK protein in the presence or absence
of calcium. Similar results were obtained when analogous experiments in different buffer
conditions (ie. 50 and 100 mM NaCl) were repeated (data not shown).

3.4

Discussion
Proteomic studies have indicated that a large number of proteins are involved in

membrane repair processes (de Morree et al. 2010; Cacciottolo et al. 2011). Included in
this group is the EF-hand protein S100A10, the phospholipid-binding protein annexin A2
and the enlargeosome protein AHNAK, all proposed to participate in a multi-protein
complex near the plasma membrane. This chapter provides the first details of the
architecture for a ternary complex between these three proteins.

3.4.1

Evidence for a Scaffolding Role of the AHNAK C-terminus
Peptide array experiments show eight potential binding regions within the C-

terminal domain of AHNAK for the A10A2C82S hybrid protein. Not surprisingly, these
sequences all have some similarity forming a consensus sequence +X+XPKφXφ. The
repeating nature of these sequences is not unique to the C-terminus of AHNAK. The
central region of the protein includes 24 repeat motifs (165-residues each) suggested to
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Figure 3.25. Interaction study of C2A domain of dysferlin and C-terminal fragment
of AHNAK in the presence of calcium.
Overlay of 1H-15N HSQC spectra of calcium-bound dysferlin (black) and calcium-bound
dysferlin mixed with C-terminal fragment of AHNAK protein (pink). Two NMR samples
of 138 µM uniformly 15N, 13C-labeled apo-dysferlin alone and mixed with 200 µM
AHNAK protein were titrated with 850 µM of calcium. The two samples were in 10 mM
HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5. 1H-15N HSQC spectra did not show any
significant changes in chemical shifts when calcium was added.
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adopt a series of β-propeller structures similar to RCC1 (Shtivelman et al. 1992;
Shtivelman and Bishop 1993). The nature of the AHNAK consensus sequence differs
from other S100 binding motifs such as those found in the N-terminus of annexins A1
and A2 (A/VXXφLXXφXφ) and CapZ (R/KL/IXWXXIL). The single-residue spacing of
the hydrophobic residues in the AHNAK sequence suggests it does not have amphipathic
character similar to the α-helical structure found in the annexin-binding sequences. In
addition, a central proline residue would not favor helix formation upon binding. The
possibility for eight binding regions in the C-terminus of AHNAK for the S100A10annexin A2 complex is consistent with a scaffolding role for AHNAK. In principle, this
would allow up to eight S100A10-annexin A2 heterotetramers to assemble on the Cterminus. Since binding of the complex to the phospholipid surface is governed by
calcium binding to the annexin moiety, this would allow a highly cooperative association
of the complex with the membrane. Despite this potential, other experiments have shown
that only the Gly5654 - Gly5673 region within the C-terminus of AHNAK displays a
strong interaction with the S100A10-annexin A2 (De Seranno et al. 2006). This could
indicate that other sequences identified in the peptide array are masked by the AHNAK
tertiary structure. Similarly, the Gly5654 - Gly5673 region had the strongest binding spot
in the peptide array suggesting it could have a much stronger affinity than the other
sequences.
The ability of the S100A10-annexin A2 heterotetrameric complex to participate
in the assembly of other larger multiprotein complexes was also examined for transient
receptor potential cation channel proteins TRPV5. Peptide array experiments uncovered
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five potential binding sequences within the C-terminus of TRPV5, including residues
598-603 (VATTV) that forms a highly conserved region in both TRPV5/TRPV6
channel proteins. However, regions such as D627-V648 (ie. in Figure 3.11A, 6A-6E)
showed stronger binding than that observed with the conserved VATTV sequence, to
both the S100A10C82S and A10A2C82S proteins. The S100A10C82S and A10A2C82S
associated to the same region on TRPV5 protein, suggesting that the N-terminal peptide
of annexin A2 may not be required for the interaction of S100A10 to TRPV5.
Consequently, the interaction site between TRPV5 with S100A10 or annexin A2-bound
S100A10 is different from the complex formed with the AHNAK, where residues from
both S100A10 and annexin A2 are required for the strong interaction of the peptide.
Further experiments such as the binding affinity assays are necessary to determine
whether a difference exists for the binding affinity of TRPV5 to the S100A10 or annexin
A2-bound S100A10 protein, similar to that observed for the AHNAK. This experiment
would indicate that although TRPV5 may use a binding mechanism different from the
AHNAK protein, strong interaction of TRPV5 requires the complex formed between
S100A10 and annexin A2 proteins.

3.4.2

An Asymmetric S100A10-Annexin A2-AHNAK Complex
A representative sequence (AHNAK5) identified from the peptide array was

used to identify the arrangement of the S100A10-annexin A2-AHNAK5 ternary complex.
Using both the A10A2C82S hybrid protein and complex of S100A10C82S with an Nterminal peptide of the annexin A2, a single AHNAK5 peptide was found to coordinate in
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an asymmetric fashion to the S100A10-annexin A2 heterotetramer. Although it is a
ternary complex, an asymmetric arrangement within an S100-target protein complex has
not been observed to date. For example, multiple S100-peptide complexes such as those
between S100B and CapZ (Inman et al. 2002; McClintock and Shaw 2003; Charpentier et
al. 2010), p53 (Rustandi et al. 2000) or Ndr kinase (Lee et al. 2008), S100A1 with RyR
(Wright et al. 2008) and CapZ (Wright et al. 2009) and S100A6 with Siah1 interacting
protein (Lee et al. 2008) all display symmetric arrangements. In S100A10-annexin A2 the
addition of AHNAK acts to break the symmetry of the heterotetramer. In contrast the EFhand calcium-binding protein calmodulin (CaM) can form asymmetric complexes with
the dimeric targets glutamate decarboxylase and Cdc42-WASP. In these cases, binding of
calcium-activated CaM to the symmetric, dimeric arrangements of glutamate
decarboxylase and Cdc42-WASP results in an overall asymmetric arrangement essential
for enzyme activity (Yuan and Vogel 1998; Kim et al. 2000; Yap et al. 2003).
In the A10A2-AHNAK5 complex, significant changes in chemical shift occur
mainly for residues in helix IV of the S100A10 (Gly77, Ala81) as well as the N-terminus
of the annexin A2 (Leu112, G114) peptides. In the S100A10-annexin A2 structure helices
IV and IV’ from S100A10 form a portion of the dimer interface oriented roughly 180˚
from each other on one face of the protein (Rety et al. 1999). The two annexin A2
peptides in the heterotetramer are both oriented such that their C-termini lie on the same
side of the complex as helices IV and IV’. Thus the interaction of AHNAK5 with the
S100A10-annexin A2 is consistent with binding that utilizes one face of the dimeric
protein comprising helices IV and IV’ and the adjacent annexin A2 C-termini.
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The tight binding between AHNAK5 and S100A10-annexin A2 (~3 nM)
requires initial formation of the heterotetramer since experiments lacking the annexin A2
peptide yield a much poorer (~1000 fold) interaction. This observation is in excellent
agreement with yeast triple-hybrid and in vitro binding assays that show both S100A10
and annexin A2 are required for strong association with the C-terminal domain of
AHNAK (De Seranno et al. 2006). This requirement indicates there are two calciumregulated steps for AHNAK delivery to the membrane surface both mediated by annexin
A2. The first is the extrusion of N-terminus of annexin A2 upon calcium binding to the
protein core domain allowing formation of the heterotetramer and subsequent recruitment
of AHNAK. The second step is the localization of the entire complex to the phospholipid
surface through calcium bridging between annexin A2 and the membrane. It is interesting
that several other proteins have also shown an association with the S100A10-annexin A2
heterotetramer including TRPV5/6 (van de Graaf et al. 2003; Borthwick et al. 2008),
TASK-1 (Girard et al. 2002; Renigunta et al. 2006) and NS3 (Beaton et al. 2002). While
the calcium regulation of these interactions is less known, it is possible that the
asymmetric interaction proposed here for AHNAK is a general feature for trafficking of
these proteins to the cell membrane.

3.4.3

Interaction between Other Proteins in the Membrane Repair Complexes
In addition to the 12 residue N-terminal peptide of annexin A2, other potential

binding sites for S100A10 were identified on the peptide array of full length annexin A2.
In fact, interaction with the 12 residue N-terminal peptide of annexin A2 appeared as one
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of the weakest binding sites for S100A10. Except for annexin A6, the remaining 11
different annexin proteins contain a core domain consisting of four conserved structural
repeat sequences (I-IV) (Huber et al. 1990; Concha et al. 1993; Sopkova et al. 1993).
Each repeat unit is formed from five α-helices (A-E) arranged such that helices A, B, D
and E are roughly anti-parallel to each other while helix C is nearly perpendicular to these
helices (Figure 1.5) (Weng et al. 1993; Rosengarth et al. 2001). Due to sequence
similarity of the helices within each repeat unit of annexin A2 (Barton et al. 1991), it is
not surprising to observe the binding of S100A10 to all four structural repeats on the
peptide array. Peptide array analysis identifies the sequence dependent but structurally
independent interactions between a protein and a series of peptides spanning a particular
region of a protein. Consequently, some of the annexin A2 repeat units that showed
binding with S100A10 in the peptide array will be excluded as they are buried in an intact
annexin A2. In addition, the amount of protein used in probing the peptide arrays of
annexin A2 with S100A10 or A10A2 was about 2 µM, which could result in non-specific
interaction of the protein to these peptides particularly when the Kd of binding is low. A
low dissociation constant of approximately 30 nM for the interaction of the 12 residue Nterminal peptide of annexin A2 with S100A10 was previously determined (Johnsson et al.
1988). Thus, to prevent the non-specific interactions, lower amount of proteins must be
used for probing the peptide arrays.
S100A10, annexin A2 and AHNAK have been identified as binding partners of
dysferlin, a central protein in the membrane repair complex (Huang et al. 2007). This
multiprotein complex is proposed to facilitate wound repair of damaged epithelial,
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auditory and muscle cells upon extracellular calcium influx. A better understanding of
the arrangement or assembly of the proteins in the membrane repair complex allows
proposing a model in which this process takes place. It has been shown that the
association of annexins A1 and A2 with a dysferlin-containing vesicle and damaged
plasma membranes (Doherty and McNally 2003; Glover and Brown 2007; Han and
Campbell 2007) is calcium dependent. Previous GST-pull down assay (Huang et al. 2007)
as well as the peptide array experiment in this work, identified the interaction of the Cterminus of AHNAK with the apo-C2A domain of dysferlin (aa 2-130), while NMR
spectroscopy experiments did not indicate any interaction between the two proteins in the
presence or absence of calcium. The AHNAK protein used in the NMR experiments was
composed of amino acid residues 5362-5434, which is much shorter than the AHNAK
protein used in the GST-pull down (5146-5643) (Huang et al. 2007) or peptide array
(4884-5890) experiments. Consequently, it is possible that the binding site for AHNAK
on dysferlin C2A domain is indeed located in residues 5435-5643.
NMR spectroscopy of S100A10 and the dysferlin C2A domain did not suggest a
direct interaction between these two proteins in the presence or absence of calcium. In
contrast, S100A13 interacts with the synaptotagmin C2A domain (Mohan et al. 2009;
Mohan et al. 2010). In this case, synaptotagmin was shown to mediate the interaction
between S100A10 and fibroblast growth factor (FGF1). Synaptotagmin is a synaptic
vesicle protein that belongs to the fer-1 family of proteins. The Dysferlin C2A domain
has the highest level of homology with the C2A domain of rat synaptotagmin (Britton et
al. 2000). Furthermore, proteomic analyses identify both annexin A2 and AHNAK as
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members of the dysferlin complex (de Morree et al. 2010; Cacciottolo et al. 2011).
Consequently, it is possible that the interaction between S100A10, annexin A2 and
dysferlin is mediated through AHNAK, the largest protein within the complex. The
identification of a ternary asymmetric complex between S100A10-annexin A2 and
AHNAK provides an initial framework for understanding the intricate assembly of these
membrane repair proteins.
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Chapter 4
Novel Structure of S100A10-Annexin A2 in Complex with the AHNAK
Peptide
4.1

Introduction
The crystal structures of S100A10 and calcium-bound S100A11 in complex

with the N-terminal regions of the phospholipid-binding proteins annexin A2 (Rety et al.
1999) and annexin A1 (Rety et al. 2000), respectively, illustrate the heterotetrameric
nature of these complexes. The symmetric arrangement and stoichiometry of these
complexes are characteristic of every S100 protein-target peptide structure examined to
date, including those of Ca2+-S100B in complex with peptides from the C-terminal region
of p53 (Rustandi et al. 2000), the N-terminal regulatory domain of the Ndr kinase
(Bhattacharya et al. 2003) and the actin-capping protein CapZ (TRTK12) (Inman et al.
2002; McClintock and Shaw 2003; Charpentier et al. 2010); Ca2+-S100A1 in complex
with peptides from the cytosolic regions of the ryanodine receptor (RyR) (Wright et al.
2008) and CapZ (Wright et al. 2009), and Ca2+-S100A6 in complex with the C-terminus
of the Siah-1 Interacting Protein (SIP) (Lee et al. 2008). These structures show that some
variation in the target peptide binding-site exists (Rezvanpour and Shaw 2009), although
a symmetric arrangement is always maintained comprising two S100 protomers and two
target peptides. Structural information on the architecture of higher order complexes such
as that involving S100A10, annexin A2 and AHNAK are unknown and would be
important for understanding how this group of proteins assemble to participate in the cell
membrane repair process. To examine how S100A10 and annexin A2 recruit AHNAK, a
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hybrid protein complex was designed (described in Chapter 2) in which S100A10 was
linked in tandem to the fifteen N-terminal residues of annexin A2 (referred to as A10A2),
separated by a nine-residue spacer sequence. Previous work has shown that the linker
does not perturb the structures of S100A10 or the bound annexin A2 and allows an
interaction similar to the one observed with separate molecules (Rezvanpour et al. 2009).
Peptide array experiments identified eight binding regions within the C-terminus of
AHNAK for the interaction with the A10A2 hybrid protein (described in Chapter 3). Of
the eight consensus regions observed, one of the sequences (referred to as AHNAK5)
having a strong interaction was used as a synthetic peptide to identify the binding
region(s), stoichiometry and affinity with the A10A2 complex. NMR spectroscopy, nondenaturing electrospray mass spectrometry and fluorescence spectroscopy identified a
novel asymmetric ternary arrangement between a single AHNAK5 peptide, and an
S100A10-annexin A2 heterotetramer (described in Chapter 3). In this chapter, the A10A2
hybrid protein was used to investigate the binding region of the S100A10-annexin A2
complex with the AHNAK5 peptide. Using both chemical shift mapping by NMR
spectroscopy and X-ray crystallography, the three-dimensional structure of the AHNAK5
peptide on the surface of A10A2 was determined, showing that this interaction required
residues from helices IV and IV’ of dimeric S100A10 as well as the C-terminal portion of
the N-terminal peptides of annexin A2.
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4.2

Materials and Methods

4.2.1

Source of Materials
15

NH4Cl and 13C6-glucose were obtained from Cambridge Isotope Laboratories,

Inc. (Andover, MA).
15

15

N-methionine,

15

15

N-phenylalanine,

N-valine,

15

N-leucine, and

N-isoleucine were obtained from Sigma-Aldrich (St. Louis, MO). All other reagents

used in the following experiments were of the highest purity commercially available.
The auxotrophic bacterial strains CT19 (avtA::Tn5/ trpB83::Tn10/ dcm omT lon
λDE3 ilvE12 tyrB507 aspC13) and B834 (F- ompT hsdSB(rB- mB-) gal dcm met DE3) were
kindly provided by Dr. L. Mcintosh (University of British Columbia, Canada) and Dr. H.
Ling (University of Western Ontario, Canada) and were utilized in the selective

15

N-

labeling of specific amino acids.

4.2.2

Expression and Purification of the Wild-Type and the C82S Substituted A10A2
Unlabeled wild-type and uniformly

15

N,

13

C-labeled C82S substituted

(A10A2C82S) GST-tagged human A10A2 were overexpressed in the BL21 (DE3)-RIL E.
coli strain using 1 L of 2xYT, or 1 L of M9 minimal medium supplemented with 1 g
15

NH4Cl and 2 g

13

C6-glucose as the sole nitrogen and carbon sources, respectively, as

described in Sections 2.2.6 and 3.2.3 (Rezvanpour et al. 2009). The purification
procedures were modified for the unlabeled wild-type A10A2 protein. After the last
purification step, fractions containing this protein were pooled and dialyzed against a
buffer containing 50 mM Tris, 100 mM NaCl at pH 7.0 and 4 ºC. This protein was
concentrated and further purified by gel filtration on a HiLoad 16/60 Superdex-75 (GE
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Healthcare) column using FPLC. Fractions containing wild-type A10A2 were pooled
and dialyzed against 50 mM Tris, and 1 mM DTT at pH 7.5 and 4 ºC. The purity of the
protein was assessed by SDS-PAGE analysis.

4.2.3

Selective 15N-Labeling of A10A2C82S Protein
Selectively

15

N-labeled A10A2C82S proteins were obtained by growing E. coli

strain CT19 (avtA::Tn5/ trpB83::Tn10/ dcm omT lon λDE3 ilvE12 tyrB507 aspC13) in
M9 minimal media supplemented with either
or

15

15

N-phenylalanine,

15

N-valine,

15

N-leucine

N-isoleucine in addition to the remaining 19 unlabeled amino acids. Similarly,

selective 15N-methionine labeling of A10A2C82S protein was achieved by growing E. coli
strain B834 (F- ompT hsdSB(rB- mB-) gal dcm met DE3) in M9 minimal media containing
15

N-methionine and the remaining 19 unlabeled amino acids. The purification of the

selectively

15

N-labeled A10A2C82S proteins followed the same protocol as described in

Sections 2.2.6 and 3.2.3 (Rezvanpour et al. 2009) of the Materials and Methods.

4.2.4

Peptide Synthesis
The AHNAK5 peptide (GKVTFPKMKIPKFTFSGREL) was purchased from

Bio Basic Inc (Toronto, Canada), synthesized using solid-phase peptide synthesis
employing the Fmoc chemistry strategy (Grant 2002). The N-terminus of the peptide was
acetylated while the C-terminus was amidated. The synthesized peptides were purified by
C18 reversed-phase high performance liquid chromatography (HPLC), and lyophilized.
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The MALDI-TOF mass data for the acetylated AHNAK5 (MWcalc = 2353.8 Da;
MWobs = 2352.5 Da) confirmed the identity of the peptide.

4.2.5

NMR Spectroscopy of A10A2C82S and A10A2C82S-AHNAK5 Complex
All NMR experiments were acquired at 35 ºC on a Varian INOVA 600 MHz

spectrometer equipped with a pulsed-field gradient triple resonance probe. The
concentration of A10A2C82S was determined by amino acid analysis in triplicate
(Advanced Protein Technology Centre, Toronto, Canada). Two NMR samples of
uniformly

15

N,

13

C-labeled A10A2C82S (400 ± 8 µM dimer) were prepared in 10% D2O,

20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, and
100 mM NaCl buffer at pH 7.0, using DSS as an internal standard. The AHNAK5 peptide
was added to one of the samples to a final concentration of 550 µM. Similarly, samples of
30-100 µM selectively 15N-labeled A10A2C82S proteins containing 40-110 µM unlabeled
AHNAK peptide were prepared. 1H-15N HSQC spectra were collected using carrier
frequencies of 4.691 (1H) and 114.0 (15N) ppm. Sequential assignment of the polypeptide
backbone resonances for A10A2C82S alone and A10A2C82S in complex with the AHNAK5
peptide were achieved by the HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH
(Grzesiek and Bax 1992), and HNCA (Kay et al. 1990) experiments. The number of
complex data points and the spectral widths were set to 512 and 8000.0 Hz for the 1H
(F3) dimension, and 32 and 1700.0 Hz for the 15N (F2) dimension, respectively. For the
HNCACB and CBCA(CO)NH experiments, 32 increments and a spectral width of 7840.0
Hz in the 13C (F1) dimension were used. For the HNCA experiment, 32 increments and a
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spectral width of 4500.0 Hz were used in the

13

C (F1) dimension. All data were

processed using NMRPipe and NMRDraw (Delaglio et al. 1995) and analyzed by
NMRView (Johnson and Belvins 1994).

4.2.6

Crystallization of the Wild-Type A10A2 in Complex with the C-Terminal Peptide
of AHNAK
Prior to crystallization, an excess amount of the AHNAK5 peptide was added to

a solution of purified A10A2 to ensure that all A10A2 molecules formed a complex with
the AHNAK5 peptide. The excess/unbound AHNAK5 peptide was removed from the
sample using a HiPrep 26/10 Desalting column (GE Healthcare) equilibrated in 50 mM
Tris, and 1 mM DTT at pH 7.5. The solution of the A10A2-AHNAK5 complex was
concentrated to 8 mg/mL. Screening for crystallization conditions was done using several
commercial screens such as the Cryo Kit (Sigma-Aldrich), the Crystal Magic Screens I
and II (BioGenova), the PEG/Ion Plus Screen (BioGenova), and the Nucleix Suite
(QIAGEN). Diffraction-quality crystals were grown in five days at 20°C by the hangingdrop vapor diffusion method, with drops containing 1 µL of the solution of the A10A2AHNAK5 complex (8 mg/mL in 50 mM Tris-HCl, 1 mM DTT at pH 7.5), 1 µL of the
precipitant (QIAGEN Nucleix Suite condition #85: 100 mM sodium chloride, 200 mM
magnesium chloride, 0.05 M sodium cacodylate (CH3)2AsO2Na), 20 % (w/v)
polyethylene glycol (PEG) 1000, pH 6.5) and 0.2 µL of the crystallization additive
(Hampton Research Additive Screen condition #68: 0.15 mM CYMAL-7). The reservoir
contained 500 µL of 1.5 M ammonium sulfate.
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4.2.7

X-ray Diffraction Data Collection and 3-D Structure Determination
X-ray diffraction data were collected at Beamline X25 (equipped with an ADSC

Q315 CCD detector) of the National Synchrotron Light Source in Brookhaven National
Laboratory. The data set was indexed, scaled and merged using HKL-2000 (Otwinowski
and Minor 1997).
Initial phases were obtained by the molecular replacement method, using the
structure of the complex of S100A10 with an N-terminal peptide from annexin A2
(molecules B and D from PDB 1BT6) as the search model (Rety et al. 1999). Molecular
replacement was done, and the structural model was built and refined using PHENIX
(Adams et al. 2010). During refinement, the structural model was adjusted manually
when needed using Coot (Emsley et al. 2010). The stereochemical quality of the
structural model was assessed using PROCHECK (Laskowski et al. 1993). Graphical
representations of the structural model were prepared using PyMOL (Version 1.2r2,
Schrödinger, LLC.). The interaction between A10A2 and the AHNAK5 peptide were
analyzed using LIGPLOT (Wallace et al. 1995).

4.2.8

Buried Surface Area Calculation Using VADAR
The overall change in the buried surface area upon peptide binding was

determined using the program VADAR (Volume Area Dihedral Angle Reporter) (Willard
et al. 2003). The coordinates of the X-ray structural model of A10A2 in complex with the
AHNAK5 peptide were utilized for the analysis. Further, the coordinates of the AHNAK5
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peptide were removed from the A10A2-AHNAK5 complex to monitor the changes in
the buried surface area of the A10A2 alone.

4.3

RESULTS

4.3.1

The C82S Substitution in the A10A2 Protein Does Not Alter Its Structure
To locate the A10A2 residues involved in the interaction with AHNAK5

peptide, backbone assignments of the protein in the absence and presence of the peptide
were completed. Although the chemical shift assignment for the wild-type A10A2 was
previously completed (Rezvanpour et al. 2009), to keep the experiments consistent with
those performed in Chapter 3, the C82S substituted form of A10A2 was used for all NMR
experiments. Due to similar properties of cysteine and serine residues, this mutation was
not expected to make a dramatic conformational change in the structure of the A10A2
protein. Using standard heteronuclear multiple dimensional NMR spectroscopy (HNCA,
HNCACB, and CBCA(CO)NH), chemical shift assignments (1H,

15

N, and

13

C) for 90%

non-proline residues of A10A2C82S (Figure 4.1 and 4.2) (Table 4.1) protein was
completed. Figure 4.3 compares the 1H-15N HSQC spectra of the wild-type and C82S
substituted A10A2 proteins. Except for a few residues including I75-V88 that are
adjacent to the C82S substitution site, the two spectra are superimposable, indicating that
comparable geometry and chemistry are maintained in the secondary structure of both
forms of A10A2 proteins.
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Figure 4.1. Selected regions of 600 MHz NMR spectra used for the backbone
assignment of the A10A2C82S protein.
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of
the three dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i)
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for
sequential assignment of residues M55-L58 of the A10A2C82S.
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Figure 4.2. Backbone amide assignments of A10A2C82S hybrid protein.
1

H-15N HSQC spectrum of 0.4 mM (monomer) uniformly 15N, 13C-labeled A10A2C82S
hybrid protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was
collected in 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic
acid, 100 mM NaCl, pH 7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated
with their one letter amino acid code and number. The residues from 15N, 13C-labeled
annexin A2 are presented in pink and those from the linker region in cyan. Pairs of
resonances for sidechain amide cross peaks are connected by horizontal lines.
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Table 4.1. 15N, 13C and 1H resonance assignments for human A10A2C82S.
Residue
G-5
P-4
L-3
G-2
S-1
M0
P1
S2
Q3
M4
E5
H6
A7
M8
E9
T10
M11
M12
F13
T14
F15
H16
K17
F18
A19
G20
D21
K22
G23
Y24
L25
T26
K27
E28
D29
L30
R31
V32
L33
M34
E35
K36
E37
F38
P39
G40
F41
L42
E43

HN

N

8.495

122.3

8.390
8.201
8.193

109.6
115.7
122.3

8.902
9.566

118.9
120.9

8.979

119.7

8.375
8.522
8.493
8.281
8.592
8.066
8.164
9.367

Cα
63.24
55.47

Cβ
32.39
42.37

45.43
58.06
53.23
62.44
56.85
59.54

64.26
32.83
31.62
65.67
28.19

117.9
124.9
118.3
120.1
116.5
122.7
117.9
117.4

56.75
59.68
59.41
55.90
60.47
60.32
67.06
61.25
59.86
59.85

30.84
29.94
29.63
18.45
35.27
29.78
68.43
32.80
35.14
37.58

7.441
7.635
8.440
7.101
8.475
7.495

119.2
115.7
122.3
114.5
122.3
100.9

62.78
61.23
59.38
60.71
53.70
44.79

38.86
31.34
32.11
40.43
18.75

103.6
114.1
117.5
113.1
120.6
117.5
120.0
118.8
119.3
117.9
122.3
117.5
118.3
115.3
114.9
117.9

40.53
43.53
71.90
32.06
29.08
42.88
41.78
29.67
31.78
42.11
31.87
29.93
33.38
30.34
39.53

9.115

110.6

57.77
46.71
55.61
52.85
60.58
60.59
59.51
57.14
57.59
60.55
66.31
59.32
59.41
59.33
57.77
56.44
54.54
65.27
46.48

30.94

7.284
6.900
8.976
9.270
9.125
8.091
7.629
8.472
8.172
7.660
8.066
8.566
8.318
8.040
8.792
8.131

59.29

28.96

Other

Cγ (34.78), Nε2 (113.1),
Hε21 (6.873), Hε22 (7.778)
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N44

7.509

115.3

53.82

39.29

Q45
K46
D47
P48
L49
A50
V51
D52
K53
I54
M55
K56
D57
L58
D59
Q60

7.407
8.133
7.926

117.1
119.7
118.4

8.412
7.567
8.462
7.733
7.975
7.751
8.155
7.622
7.606
7.710
8.266

119.3
122.8
115.7
120.6
119.3
120.0
117.3
118.1
117.6
118.8
120.6

55.39
57.22
50.94
64.15
54.09
56.19
66.30
57.70
59.69
64.63
57.68
59.17
55.88
55.79
54.20
57.72

28.06
31.95
42.48
32.18
40.99
18.72
31.13
40.34
32.29
38.49
32.49
32.17
41.11
42.62
40.31
28.52
27.38
28.26
41.22

63.19
39.42
38.47

C61
R62
D63
G64
K65
V66
G67
F68
Q69

8.471

117.0

8.660
9.282
7.462
9.332
8.479
9.078
8.916

118.8
109.6
118.4
124.5
114.4
121.0
117.5

59.08
57.07
53.82
45.93
55.39
62.69
44.27
62.95
60.50

S70
F71
F72
S73
L74
I75
A76
G77
L78
T79
I80
A81
S82
N83
D84
Y85
F86
V87
V88
H89
M90
K91
Q92

8.060
8.605
8.802
7.901
7.427
7.126
8.994
7.879

117.1
123.6
120.1
114.9
125.4
117.8
125.8
104.6

61.84
60.84
62.67
61.95
57.93
62.88
55.25
47.43

7.674

120.6

66.30
55.34

38.28
18.40

8.017
8.059
8.950
8.828
7.476
7.954
7.878
7.625
8.169

121.0
120.5
121.5
117.9
117.4
113.6
117.6
120.1
117.9

54.70
55.49
57.57
61.00
65.04
65.44
57.95
57.61
58.63
56.92

40.96
42.58
39.45

Nδ2 (113.9), Hδ21 (6.800),
Hδ22 (7.593)

Cγ (34.09), Nε2 (111.8),
Hε21 (6.839), Hε22 (7.563)

34.37
32.76
39.48
27.48

Cγ (34.13), Nε2 (112.0),
Hε21 (6.823), Hε22 (7.569)

41.37
40.84
18.46

32.94
30.81
34.88
32.71
28.96

Cγ (34.16), Nε2 (111.5),
Hε21 (6.724), Hε22 (7.413)
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E93
N94

7.856
8.054

117.9
117.0

56.79
53.83

30.06
38.38

L95
Y96
F97
Q98

7.918
7.845
7.920
8.237

120.1
118.8
120.6
121.4

55.29
57.48
57.68
55.89

42.63
38.96
39.31
29.65

G99
D100
S101
T102
V103
H104
E105
I106
L107
S108
K109
L110
S111
L112
E113
G114
D115

8.079
8.364
8.302
8.918
8.876
8.488
7.738

110.1
120.5
113.5
123.9
121.4
117.8
116.7

45.70
54.78
58.34

41.39
63.94

8.565
7.086
7.684
7.322
8.352
8.347
8.219
8.188
7.943

118.0
111.3
119.7
119.8
115.9
124.9
120.1
110.0
125.8

67.77
60.19
58.90
66.26
58.21
60.54
55.72
55.69
57.43
55.56
56.68
45.26
55.94

31.67
29.42
41.75
63.67
33.23
43.22
64.22
42.17
30.75
42.48

Nδ2 (111.9), Hδ21 (6.868),
Hδ22 (7.538)

Cγ (33.93), Nε2 (111.6),
Hε21 (6.776), Hε22 (7.444)
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Figure 4.3. Comparison of the 1H-15N HSQC spectra of the wild-type and C82S
substituted forms of A10A2 protein.
Overlay of 1H-15N HSQC spectra of wild-type (black) and C82S substituted (aqua)
A10A2. NMR samples of uniformly 15N, 13C-labeled A10A2 (400 µM dimer) were
prepared in 10% D2O, 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50
mM glutamic acid, and 100 mM NaCl buffer at pH 7.0. Spectra were collected on a
Varian INOVA 600 MHz spectrometer at 35 ºC.
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4.3.2

Backbone Assignment of A10A2C82S in Complex with AHNAK5 Peptide
The 20-residue AHNAK peptide (5654-5673; AHNAK5) that displayed the

strongest interaction with A10A2C82S on the peptide array, was used in NMR experiments
to assess structural changes that occur in A10A2C82S upon formation of the complex with
AHNAK5. As shown in Chapter 3 (Section 3.3.6 and Figure 4.4), titration of unlabeled
AHNAK5 peptide to the solution of

15

N,

13

C-labeled A10A2C82S resulted in the gradual

disappearance of many of the A10A2C82S resonances and the appearance of many new
peaks. The large number of chemical shift changes in the amide cross peaks of the two
spectra indicates that AHNAK5 peptide is indeed binding to the A10A2C82S protein.
Interestingly, the 1H-15N HSQC spectrum of the

15

N,

13

C-labeled A10A2C82S in the

presence of AHNAK5 resulted in an increased number of peaks in which many of the
new resonances appeared in pairs with each peak having approximately 50% of the
intensity of the original peak (Figure 4.4). As an initial step towards completing the
assignment of the A10A2C82S-AHNAK5 complex, HNCACB, CBCA(CO)NH and HNCA
experiments were collected. Analyses of these spectra were quite challenging as the
doubling of peaks resulted in overlapping of many peaks. Consequently, selective

15

N-

labeling of the backbone amides of leucine, isoleucine, methionine, phenylalanine, and
valine of A10A2C82S in complex with AHNAK5 was performed. This accounted for 36%
of the amino acid sequence of the A10A2C82S protein. The simplified 1H-15N HSQC
spectra of selective 15N-labeled A10A2C82S-AHNAK5 complex (Figure 4.5 and 4.6) along
with the triple-resonance NMR experiments (Figure 4.7 and 4.8) contributed greatly in
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Figure 4.4. 1H-15N HSQC spectrum of A10A2C82S hybrid protein bound to the
AHNAK5 peptide.
1

H-15N HSQC spectrum of 400 µM uniformly 15N-13C labeled A10A2C82S hybrid protein
(protomer) in complex with 550 µM AHNAK5 peptide (Ac-GKVTFPKMKIPKFTFSGR
EL). Some of the peaks that exhibited multiplicity in the AHNAK5 complex are shown in
boxes. Spectra were collected on a Varian INOVA 600 MHz spectrometer at 35 ºC in
90% H2O/10% D2O at pH 7.0.
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Figure 4.5. 1H-15N HSQC spectra of selectively
with the AHNAK5 peptide.

15

N-labeled A10A2C82S in complex

The spectra show selectively labeled (A) 15N-leucine, (B) 15N-isoleucine, and (C) 15Nmethionine A10A2C82S in complex with AHNAK5 peptide. The residues are numbered 1115 in both protomers. Multiple resonances from the A10A2C82S protein that appeared as
pairs upon addition of AHNAK5 are presented as “a” and “b” with the corresponding
residue number in the first or the second protomer.
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Figure 4.6. 1H-15N HSQC spectra of selectively
with the AHNAK5 peptide.

15

N-labeled A10A2C82S in complex

The spectra show selectively labeled (A) 15N-phenylalanine, and (B) 15N-valine
A10A2C82S in complex with AHNAK5 peptide. The residues are numbered 1-115 in both
protomers. Multiple resonances from the A10A2C82S protein that appeared as pairs upon
addition of AHNAK5 are presented as “a” and “b” with the corresponding residue
number in the first or the second protomer.
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Figure 4.7. Selected regions of 600 MHz NMR spectra used for the backbone
assignment of the A10A2C82S in complex with the AHNAK5 peptide.
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of
the three dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i)
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for
sequential assignment of residues E93-L95 of the A10A2C82S bound to the AHNAK5
peptide.
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Figure 4.8. AHNAK5 peptide interacts with the A10A2C82S.
Selected regions of the 600 MHz 1H-15N HSQC spectra showing the interaction of the
AHNAK5 peptide with 15N, 13C-labeled (A-C) A10A2C82S hybrid protein. In all figures,
the A10A2C82S alone is shown in the absence (black contours) and in the presence of 1
equivalence (aqua contours) of AHNAK5 peptide. The spectra were collected in 20 mM
MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100 mM
NaCl, pH 7.0 at 35 ºC. Both spectra were assigned by triple-resonance NMR experiments.
Spectra are presented at the same contour levels.

199

identification and completion of the assignment of 107 of 112 non-proline residues in
the protein (Table 4.2).

4.3.3

The Binding surface of AHNAK5 Peptide on A10A2C82S
Backbone assignments of the A10A2C82S alone and in complex with the

AHNAK5 peptide allowed for the analysis of chemical shift changes of each residue
between the two states of the protein (Figure 4.9A and B). Addition of the peptide to the
A10A2C82S protein resulted in different changes in the 1H-15N HSQC spectrum. While
some peaks remained in their original positions, others shifted and appeared as single or
double peak(s) in the spectrum. This suggested that the protein is affected by the peptide
binding, either through direct interaction of a residue with the peptide or indirectly by a
secondary effect. The most striking chemical shift perturbations occurred for residue
E113 of the annexin A2 peptide region in the A10A2C82S hybrid protein of both protomers
a and b. Both these residues experienced an amide nitrogen chemical shift change of 1.38
ppm, which was approximately three times the average chemical shift (0.48 ppm).
Several other residues also had large chemical shift perturbations including I54a, K56a/b
and D59a/b in helix III, C61a/b, D63a/b and G64a/b in the second calcium binding loop,
and F72a/b, I75b, G77a/b and D84a in helix IV of the S100A10C82S region in both
A10A2C82S protomers. Furthermore, residues S108-S111 and G114 of protomer a, and
L110-S111 of protomer b in the annexin A2 peptide region of A10A2C82S showed
significant changes in chemical shift. These observations could indicate that these
residues are either directly at the protein-peptide interface or indirectly affected by
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Table 4.2. 15N, 13C and 1H resonance assignments for A10A2C82S-AHNAK5
complex.
Protomer

Residue
P1
S2
Q3
M4
E5
H6
A7
M8
E9
T10
M11
M12
F13
T14
F15
H16
K17
F18
A19
G20
D21
K22
G23
Y24
L25
T26
K27
E28
D29
L30
R31
V32
L33
M34
E35
K36
E37
F38
P39
G40
F41
L42
E43
N44
Q45
K46
D47
P48
L49

HN

N

9.080
9.575
9.030

119.3
120.6
119.3

8.418
8.452
8.556
8.342
8.569
8.118
8.199
9.301

118.1
124.4
117.9
120.5
116.2
122.7
117.9
117.5

Cα
62.40
56.93
59.62
56.62
59.77
59.53
55.82
60.20
60.44
67.13
61.24
60.14
60.32

Cβ
32.08
65.34
28.17
30.74
29.62
29.65
18.19
35.03
29.79
68.18
33.69
34.99
37.81

7.580
7.508
8.362
7.098
8.483
7.474

119.2
115.7
122.2
114.4
122.3
100.8

62.77
61.15
59.33
60.59
53.79
44.78

38.90
31.42
32.00
40.50
18.74

103.9
113.9
117.5
113.4
120.6
117.1
119.7
118.8
119.4
117.9
121.8
117.5
118.8
115.3
114.9
118.0

57.77
46.68
55.59
52.88
60.68
60.58
59.44
57.06
57.52
60.67
66.51
59.19
59.53
59.22
57.69
56.36
56.83

30.81

7.308
6.918
8.897
9.298
9.162
8.059
7.633
8.616
8.246
7.789
8.111
8.582
8.528
7.928
8.750
8.182

40.05
42.95
71.87
32.28
29.03
42.70
41.46
29.97
31.81
41.76
32.23
30.06
33.37
29.91
39.31

8.254
7.849

121.9
119.7

7.357
7.435

114.9
115.7

7.824

118.0

8.544

119.6

48.55
57.72
57.68
59.50
53.95
54.50
56.92
51.00
64.27
53.81

40.34
40.11
28.89
39.30
26.94
31.16
42.80
32.48
41.02
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“a”

A50
V51
D52
K53
I54
M55
K56
D57
L58
D59
Q60
C61
R62
D63
G64
K65
V66
G67
F68
Q69
S70
F71
F72
S73
L74
I75
A76
G77
L78
T79
I80
A81
C82
N83
D84
Y85
F86
V87
V88
H89
M90
K91
Q92
E93
N94
L95
Y96
F97
Q98
G99
D100
S101
T102

7.584
8.584
7.724

122.4
114.9
120.1

8.068
8.161
7.411
7.430

121.0
116.0
115.7
118.0

8.376
8.156
7.696

117.1
118.8
116.6

8.488
8.385
7.445
9.438
8.342
9.238

122.3
109.7
118.0
125.0
114.4
121.4

7.992
8.762
9.087

117.1
124.1
121.4

7.297
7.198
9.045
8.497
7.708

123.6
117.8
125.1
105.6
118.8

9.100
7.417
7.767
8.472
8.321

123.6
119.6
115.8
121.8
119.2

8.925
8.842
7.478
7.911
7.856
7.636
8.178
7.869
8.060
7.912
7.844
7.934
8.230
8.116
8.348
8.297

121.3
118.0
117.5
114.0
117.4
120.1
117.9
117.9
117.0
120.1
118.8
120.6
121.0
110.1
120.5
113.6

56.45
67.29
57.57
58.57
66.05
58.98
58.83
55.27
56.87
57.52
59.92
58.72
63.24
55.53
45.43
55.45
62.28
44.42
63.56
60.58
61.67
60.49
62.58
62.31
58.31
62.77
55.00
48.44
58.00
67.24
66.22
55.16
62.99
57.94
57.96
61.19
66.45
65.47
58.00
57.54
58.43
56.89
56.87
53.82
55.26
57.46
57.68
55.94
45.67
54.74
58.27
66.04

18.43
31.14
40.33
29.07
38.63
32.66
32.17
42.50
40.57
40.30
32.66
29.24
32.35
42.36
34.60
32.30
27.19
63.56
39.08
38.75
62.73
40.59
18.53
42.31
67.68
38.22
19.91
39.40
40.53
40.41
31.97
32.77
31.56
34.89
32.62
28.90
29.95
38.43
42.61
38.95
39.18
29.51
41.47
63.84
69.48

202
V103
H104
E105
I106
L107
S108
K109
L110
S111
L112
E113
G114
D115
P1
S2
Q3
M4
E5
H6
A7
M8
E9
T10
M11
M12
F13
T14
F15
H16
K17
F18
A19
G20
D21
K22
G23
Y24
L25
T26
K27
E28
D29
L30
R31
V32
L33
M34
E35
K36
E37
F38
P39
G40

8.927

121.4

61.12

8.209
8.457
6.889
7.913
7.006
8.592
8.628
8.433
8.304
7.943

120.5
118.0
109.6
118.4
118.4
114.4
124.6
125.8
111.9
126.0

9.074
9.577
8.980

119.3
120.6
119.3

8.424
8.448
8.500
8.291
8.564
8.117
8.199
9.235

118.2
124.4
117.9
120.5
116.2
122.7
117.9
117.0

59.68
65.91
58.47
60.24
54.82
54.29
57.16
56.00
57.03
45.18
55.94
62.40
56.85
59.65
56.42
59.77
59.58
55.80
60.18
60.51
67.08
61.25
60.16
60.28

7.387
7.513
8.360
7.099
8.483
7.465

119.2
115.6
122.2
114.4
122.3
100.6

62.88
61.15
59.33
60.59
53.86
44.79

38.70
31.42
31.94
40.50
18.74

103.9
113.9
117.5
113.4
120.6
117.1
119.7
118.8
119.4
117.5
121.9
117.5
118.3
115.3
115.0
118.0

57.77
46.68
55.60
52.88
60.72
60.50
59.46
56.98
57.52
60.58
66.37
59.21
59.51
59.47
57.72
56.36
56.92

30.81

7.308
6.918
8.895
9.298
9.163
8.059
7.547
8.618
8.246
7.661
8.111
8.585
8.449
8.043
8.754
8.186

48.55

32.91
37.61
42.29
63.56
33.07
43.54
66.01
42.64
30.78
42.48
32.08
65.29
28.20
30.99
29.62
29.73
18.21
34.96
29.79
68.18
33.69
35.08
37.81

40.19
42.95
71.85
32.32
29.01
42.61
41.46
30.02
31.58
41.83
32.23
29.96
33.42
29.95
39.31

203

“b”

F41
L42
E43
N44
Q45
K46
D47
P48
L49
A50
V51
D52
K53
I54
M55
K56
D57
L58
D59
Q60
C61
R62
D63
G64
K65
V66
G67
F68
Q69
S70
F71
F72
S73
L74
I75
A76
G77
L78
T79
I80
A81
C82
N83
D84
Y85
F86
V87
V88
H89
M90
K91
Q92
E93

8.254
7.849

121.9
119.7

40.34
40.36
28.89
39.30
26.94
31.16
42.80
32.24
41.05
18.43
30.87
40.33
29.31
38.46
32.99
32.24
42.09
40.57
40.25
32.49
29.29
32.27
42.36

123.6
120.1
114.0
121.8
119.6

57.72
57.68
59.50
53.95
54.50
56.92
51.00
64.21
53.81
56.50
67.02
57.57
57.53
65.69
59.32
58.69
54.56
56.87
57.54
59.78
58.77
63.17
55.53
45.48
55.33
62.28
44.33
63.19
60.58
61.67
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Figure 4.9. Comparison of the changes in chemical shift of the A10A2C82S hybrid
protein and AHNAK5-bound A10A2C82S for both protomers a (A) and b (B) in the
dimer A10A2C82S.
Chemical shift changes (∆δ) were normalized in both 1HN and 15N using the formula
[{HN2 + (N/5)2}/2]1/2. The dashed line indicates the average change in chemical shift at
0.48 ppm. Proline residues are shown as “P” and asterisks indicate missing assignments
in either or both proteins. Different helices of A10A2C82S (based on the crystal structure
of the S100A10-annexin A2 complex) are coloured with helix I in pink, helix II in aqua,
helix III in purple, helix IV in blue, and annexin A2 in light green.
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residues that were involved in the interaction. The crystal structure of S100A10 in
complex with the 12-residue N-terminal peptide of annexin A2 (PDB Code:1BT6) (Rety
et al. 1999) was used to map all of the chemical shift changes greater than the average
value (0.48 ppm) onto the surface of the A10A2C82S protein (Figure 4.10A). This allowed
the interaction surface of the AHNAK5 peptide on the A10A2C82S hybrid protein to be
obtained. The length of annexin A2 peptide in the A10A2C82S hybrid construct is 3
residues longer than that in the crystal structure. Thus, residues E113a/b and G114a are
not colored in Figure 4.10A. Regardless, the significant change in the chemical shifts for
these two residues indicates that E113a/b and G114a are affected by the interaction with
the AHNAK5 peptide. Several residues including L58a/b in helix III, Q60a/b and R62a/b
in the second calcium binding loop, and S73a/b, L78a/b-I80a/b, and S82a/b-N83a/b in
helix IV of the A10A2C82S protomers were lacking chemical shift changes due to missing
assignments. Since most of these peaks were assigned in the AHNAK5-bound A10A2C82S
(not in the A10A2C82S), the doubling of peaks corresponding to these residues in the
complex was considered as a means to identify those affected by the interaction with the
AHNAK5 peptide. Among them, only residues Q60a/b, S73a/b and I80a/b appeared as
double peaks on the spectrum and thus are inclined to be involved in AHNAK5 binding.
In Figure 4.10A, these residues are shaded in a different color to distinguish them from
the residues with determined and large chemical shift perturbations. A contiguous surface
containing residues E113a-G114a, S108a-S111a, D84a, S82a, I80a, G77a-A76a, S73a,
F72a/b, S73b, I75b, A76b-G77b, I80b, L110b-S111b and E113b is formed on the
A10A2C82S for the interaction with the AHNAK5. With the current data it is difficult to
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Figure 4.10. The A10A2C82S binding surface for the AHNAK5 peptide.
Surface and ribbon representation of A10A2C82S depicting residues affected by the
interaction with the AHNAK5 peptide. (A) The surface is coloured according to the
chemical shift changes [{HN2 + (N/5)2}/2]1/2 observed in NMR experiments resulting
from the interaction with AHNAK5 for both protomers a and b in the dimeric A10A2C82S
protein. Residues with chemical shift changes greater than the average chemical shift
change of 0.48 ppm are shown in cyan. Residues Q60, S73 and I80 are shaded in purple
indicating those that were affected by the binding (doubled peaks in NMR spectrum),
even though a chemical shift change could not be determined for them due to the lack of
an amide proton or missing assignments in A10A2C82S in the absence of the AHNAK5
peptide. Residues are labeled according to their one-letter amino acid code and residue
number. (B) The same complex is oriented approximately 180 with respect to (A) to show
that the AHNAK5 peptide binds to one side of the A10A2 dimer.
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conclude whether residues such as I54a, K56a/b, D59a, Q60a/b, C61a/b, D63a/b and
G64a/b are in direct contact with the AHNAK5 peptide or are only affected by the
secondary conformational changes resulted from peptide binding. Overall, these data
show that the AHNAK5 peptide is bound to only one side of the dimeric A10A2C82S
protein, comprised of helices IV and IV’ as well as the adjacent C-termini of the annexin
A2 peptide region (Figure 4.10A and B).

4.3.4

Crystal Structure of the A10A2-AHNAK5 Complex

4.3.4.1

The Structure of A10A2-AHNAK5 Is Similar to the Non-covalent Complex of
S100A10 and Annexin A2
Diffraction quality crystals of the A10A2-AHNAK5 were obtained and the

structure of this complex was solved by molecular replacement, using the structure of the
S100A10-annexin A2 N-terminal peptide complex (molecules B and D from PDB 1BT6)
(Rety et al. 1999) as the search model. The parameters and the statistics of X-ray
diffraction data collection and structural model refinement are summarized in Table 4.3.
The A10A2-AHNAK5 complex crystallized in the monoclinic space group C2, with two
A10A2 molecules (chains a and b) and one AHNAK5 peptide (chain c) in each
asymmetric unit. Collected X-ray diffraction data allowed for the computation of electron
density maps at a resolution of 2.97Å. Residues Q3a to M90a and Q3b to H89b of the
S100A10 regions, T102a to E113a and V103b to E113b of the annexin A2 regions in
both protomers of the A10A2 protein, and twelve of the twenty residues of the AHNAK5
were identified. The electron density for some of the residues including C61, I80, A81
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Table 4.3. Parameters and statistics of X-ray diffraction data collection and
structural model refinement.
A10A2-AHNAK5 Complex
X-ray Diffraction Data Collection
Wavelength (Å)
Resolution limitsa (Å)
Space group
Unit-cell constants
a, b, c (Å)
α, β, γ (°)
Number of unique reflections
Redundancy
Completeness (%)
Rsymb (%)
I / σ(I)

1.100
28.96 – 2.97 (3.02 – 2.97)
C2
79.80, 54.99, 62.92
90, 113.56, 90
5,107 (265)
3.7 (3.7)
97.3 (99.3)
5.1 (45.5)
22.2 (2.9)

Structural Model Refinement
Resolution range (Å)
28.96 – 2.97
Rwork / Rfreec (%)
31.43 / 39.72
Number of non-hydrogen atoms per asymmetric unit (average B factors, Å2)
Protein
1,483 (175.81)
Solvent
0 (---)
Root-mean-square deviation from ideal geometry
Bond lengths (Å)
0.006
Bond angles (°)
1.070
Ramachandran statistics
Most favored (%)
70.8
Additional allowed (%)
25.3
Generously allowed (%)
3.9
Disallowed (%)
0.0
a
Numbers in the parentheses refer to the highest resolution bins.
b
Rsym = ∑hkl∑i|Ihkl,i - <Ihkl>| / ∑hkl∑iIhkl,i, where Ihkl,i and <Ihkl> are the i-th observed intensity and the
average intensity of the reflection hkl, respectively.
c
Rwork = ∑||Fo| - |Fc|| / ∑|Fo|, where |Fo| and |Fc| are the observed and the calculated structure factor
amplitudes of a particular reflection, respectively. The summation is over 95 % of the reflections in the
specified resolution range. The remaining 5 % of the reflections were randomly selected before the
structure refinement and not included in the structure refinement. Rfree was calculated over these
reflections using the same equation as for Rwork (Brünger 1992).
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and M90 in the S100A10 region of protomer b, K91, G114-D115 in the annexin A2
region as well as the nine residues in the linker connecting the S100A10 to the annexin
A2 peptide of both protomers were not visible. The structural model presented here was
refined to an Rwork and an Rfree values of 31.43 % and 39.72 %, respectively. A high
percentage (96.1%) of residues in this structural model lie in the most favored and the
additionally allowed regions of the Ramachandran Plot.
The A10A2-AHNAK5 complex contains an A10A2 dimer (Figure 4.11B),
whose structure is analogous to that of S100A10 in complex with the N-terminal peptide
of annexin A2 (Figure 4.11A). Similarly, helices I, I’, IV and IV’ of A10A2 comprise the
dimer interface. In the A10A2 dimer, helices IV and IV’ are roughly antiparallel to each
other and form a portion of the dimer interface on one side of the protein as in the other
S100 structures. Further, the two annexin A2 peptide regions of the A10A2 dimer bind in
nearly the same manner to either side of the S100A10 regions of the dimer such that the
C-termini of the annexin A2 peptides are positioned on the same side of the complex as
helices IV and IV’. The hydrophobic surface of the annexin A2 peptide region is made up
of residues V3a/b, I6a/b, L7a/b and L10a/b. For instance, in protomer a of the A10A2
dimer, V3a of the annexin A2 peptide region interacts with a large number of residues in
helix I’ (E5’, M8’, E9’, M12’). The residue at position 6a (I) makes contacts with helix
IV (C82, Y85, F86, M90). The sidechain of L7a makes numerous contacts with the
S100A10 region via residues in the linker sequence (F38, F41), helix IV (L78, C82) and
helix I’ (E5’, M8’). Finally, the residue at position 10a (L) is in close proximity of helix
IV (A81, C82, Y85). All of these findings are in perfect agreement with the X-ray
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Figure 4.11. Comparison of the S100A10-annexin A2 structures alone and in complex with the AHNAK5
peptide.
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Ribbon diagrams of (A) S100A10 bound to the N-terminal peptide of annexin A2 (Rety et al. 1999) and (B) A10A2
in complex with the AHNAK5 peptide are shown in similar orientations to demonstrate the lack of conformational
changes that occur upon binding to the AHNAK5 peptide. In both structures, protomer a (including its associated
annexin A2 peptide) is shown in light purple and its helices are numbered I-IV, while protomer b (including its
corresponding bound annexin A2 peptide) is presented in light blue and its helices are numbered I’-IV’. The single
AHNAK5 peptide is shown as a yellow strand bound to an A10A2 dimer in (B). Superposition of these two structures
gives a backbone rmsd value of 0.66 Å.
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crystallographic results (Rety et al. 1999) for the S100A10-annexin A2 complex in
the absence of AHNAK5. Despite the non-covalent complex of S100A10 and the
individual N-terminal peptide of annexin A2 in the X-ray crystallographic structure (Rety
et al. 1999), and the covalent linkage between these two proteins in the A10A2-AHNAK5
complex, these two structures are indeed similar to each other with an rmsd of 0.66 Å.
This provides further evidence that the linker connecting S100A10 to the N-terminal
peptide of annexin A2 in the A10A2 hybrid protein has not perturb the structure.
Comparison between the structures of S100A10 in complex with the individual
N-terminal peptide of annexin A2, A10A2 and AHNAK5-bound A10A2 with the
S100A10 protein resulted in small rmsd values of 0.91, 1.11, and 1.37 Å, respectively.
Once more, these values confirm that the backbone structure of S100A10 does not change
significantly in any of the complexes when S100A10 binds to either annexin A2 or both
annexin A2 and AHNAK5 peptides.

4.3.4.2

Binding Region of AHNAK5 on A10A2
Following fitting for the S100A10 and annexin A2 portions of the A10A2

structure, outstanding electron densities were clearly observed for the backbone of the
AHNAK5 peptide in the electron density maps (Figure 4.12A). This electron density was
only sufficient to fit a single AHNAK5 peptide on helix IV side of the A10A2 complex.
This stoichiometry of 1:1 for an A10A2(dimer):AHNAK5 complex is in agreement with
the fluorescence, NMR and non-denaturing mass spectroscopy experiments presented in
Chapter 3. As explained above and shown in Figure 4.11, interaction of the AHNAK5
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Figure 4.12. Orthogonal views of the A10A2-AHNAK5 complex.
Outstanding electron density of the AHNAK5 peptide are shown in (A) and omitted for
clarity purposes in (B). In both diagrams, the ribbon representation of the A10A2-AHNAK5
complex is oriented approximately 90º with respect to each other to show the binding region
of a single AHNAK5 peptide. Protomer a of the A10A2 dimer is colored in light purple and
its helices are numbered I-IV, whereas protomer b is shown in light blue and its helices are
numbered I’-IV’. The single AHNAK5 peptide is represented as sticks, with carbon atoms in
yellow, nitrogen atoms in blue and oxygen atoms in red.
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peptide with the A10A2 dimer does not cause a significant conformational change in
the backbone structure of the A10A2 hybrid protein. Adopting a coil conformation, the
bound AHNAK5 peptide was located on one face of the dimeric A10A2, comprising
helices IV and IV’ as well as the adjacent C-termini of the annexin A2 peptide regions
(Figure 4.11B and 4.12). In the model shown, residues P6 to G17 of the AHNAK5
peptide (ie. PKMKIPKFTFSG) were modeled in the electron densities. However, the
sidechain conformations of K9, and F13 could not be determined (Figure 4.13). The PDB
file for the crystal structure was used in the LIGPLOT program (Wallace et al. 1995) to
generate schematic 2D representations of the A10A2-AHNAK5 complex, showing
intermolecular interactions as well as their strengths including hydrogen bonds,
hydrophobic interactions and atom accessibilities (Figure 4.14). Based on this analysis,
P6, M8, F15, and S16 of the AHNAK5 peptide are involved in interactions with the
A10A2 dimer (Figure 4.13 and 4.14). The residue at position 6 (P) of the AHNAK5
peptide interacts with S111 at the C-terminus of the annexin A2 peptide region of
protomer a in the A10A2 dimer. M8 of the AHNAK5 makes contacts with helix III (I54,
L58) of the S100A10 region of also protomer a. F15 of the AHNAK5 peptide interacts
with L78 of the S100A10 and L112 from the C-terminus of the annexin A2 peptide
regions of protomer b in the dimeric A10A2 protein. Lastly, a hydrogen bond exists
between the sidechain of S16 of the bound AHNAK5 with S111 at the C-terminus of the
annexin A2 peptide region of protomer b in the A10A2 dimer.
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Figure 4.13. AHNAK5-binding site on the A10A2 dimer.
Close-up stereo views of the (A) N-terminal half and (B) C-terminal half of the bound
AHNAK5 peptide on the A10A2 dimer are shown. In both diagrams, the two A10A2
subunits are colored in light purple (protomer a) and light blue (protomer b), and the
helices are numbered I-IV and I’-IV’ for protomer a and b, respectively. The single
AHNAK molecule is represented in orange. Residues of A10A2 interacting with the
AHNAK5 peptide are also presented as sticks, with carbon atoms in the original color,
nitrogen atoms in blue and oxygen atoms in red.
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Figure 4.14. Schematic representation of intermolecular interactions in the A10A2AHNAK5 complex.
The LIGPLOT program was used to generate a 2D schematic for the intermolecular
interactions between the residues from the AHNAK5 peptide and A10A2 protein. The
). Covalent bonds in the
hydrogen bonds and their distances are indicated by (
AHNAK5 peptide are shown by (
), while covalent bonds in the A10A2 dimer
are presented by (
). Residues of the A10A2 dimer (protomers a and b) and
specific atoms involved in Van der Waals contacts are indicated by (
) and ( ),
respectively.
3.0
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4.4

Discussion

4.4.1

Comparison of the Binding Surface of AHNAK5 on A10A2 Determined by X-ray
Crystallography and NMR Spectroscopy
In this chapter, the AHNAK5 peptide which had previously shown the strongest

interaction with A10A2C82S was utilized to identify the arrangement of the S100A10annexin A2-AHNAK5 ternary complex. NMR spectroscopy and X-ray crystallography
were used to determine which residues of A10A2 protein and AHNAK5 peptide are
involved in the interaction. 1H-15N HSQC spectra were collected to monitor the changes
made in the A10A2C82S spectra after addition of the AHNAK5 peptide. NMR experiments
revealed a significant number of chemical shift changes in the amide cross peaks of the
two spectra confirming that an interaction with the AHNAK5 peptide has taken place.
Significant changes in chemical shift were observed mainly for residues in helix IV and
IV’ of protomers a and b of the S100A10 region (D84a, S82a, I80a, G77a-A76a, S73a,
F72a/b, S73b, L74b, A76b-G77b, I80b), as well as the residues from the annexin A2
peptide region (E113a-G114a, S108a-S111a, L110b-S111b and E113b) of A10A2C82S
protein (Figure 4.10). Overall, these results showed that interaction of a single AHNAK5
peptide with the A10A2C82S protein is consistent with asymmetrical binding to one face of
the dimeric protein comprising helices IV and IV’ and the adjacent annexin A2 C-termini.
A number of significant chemical shift changes also occurred in helix III and III’ as well
as the second calcium-binding loops of both protomers of A10A2C82S protein (Figure
4.10) either through direct contact with the AHNAK5 peptide or by indirect changes
resulting from peptide binding.
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Determining resonance assignments for an unlabeled peptide such as
AHNAK5 in a protein-peptide complex is difficult by NMR spectroscopy as only proton
signals of the unlabeled peptide will be observed in the spectra. Consequently, residues
from the AHNAK5 peptide that are directly involved in the interaction could not be
determined. X-ray crystallography of the A10A2-AHNAK5 complex was useful in
obtaining detailed information on the bound peptide. The backbone structure of A10A2AHNAK5 complex is similar to that of S100A10 in complex with the N-terminal peptide
of annexin A2 (Figure 4.11A and B). The hydrophobic surface of the annexin A2 peptide
region of the A10A2 hybrid protein in the A10A2-AHNAK5 complex was also similar to
that of the X-ray crystallographic results of the S100A10 bound to individual N-terminal
peptide of annexin A2. Even though computation of electron density maps was only
possible to a resolution of 2.97Å, it was still clear that only one AHNAK5 peptide is
bound to one face of the dimeric A10A2, comprising helices IV and IV’ as well as the
adjacent C-termini of the annexin A2 peptide regions (Figure 4.11B and 4.12A and B).
This is in perfect agreement with the results obtained by NMR spectroscopy. Some of the
important residues for this interaction included I54, L58 and S111 of protomer a, and
L78, S111 and L112 of protomer b in the A10A2 protein. The X-ray crystallography data
explains some of the NMR spectroscopy observations. For instance, the significant
chemical shift of I54a is due to interaction of this residue with the methionine sidechain at
position 8 of the AHNAK5 peptide. This interaction would explain the large chemical
shifts of other residues in helix III and the second calcium-binding loop of protomer a in
the dimeric A10A2 protein. Chemical shift changes could not be determined for residue
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L58a and L78b of the A10A2 protein by NMR experiments due to the missing
assignments or lacking chemical shift changes, respectively. However, chemical shift
changes greater than the average chemical shift values for S111 in both protomers a and b
was observed. Although, a significant chemical shift for S111a was observed, the change
in chemical shift (more than twice the average chemical shift value) was more
pronounced for S111 in protomer b. This could be explained by the hydrogen bond
formed between the sidechain of S16 of the bound AHNAK5 with S111 at the C-terminus
of the annexin A2 peptide region of protomer b in the A10A2 dimer. Residue L112 in
protomer b of the dimeric A10A2 protein was identified as one of the residues involved in
the interaction with the AHNAK5 peptide by X-ray crystallography, while a chemical
shift change below the average change in chemical shift was obtained for this residue by
NMR spectroscopy. Further, the fractional accessible surface area for the sidechains of
residues of A10A2 in the absence and presence of AHNAK5 peptide were calculated
from the three-dimensional X-ray crystallography model using the program VADAR
(Willard et al. 2003). This showed that 558 Å2 of the sidechain surface area in A10A2
protein was buried upon binding AHNAK5 in A10A2-AHNAK5 complex. Residues in
the A10A2 protein that decreased their sidechain exposure by greater than 40% upon
AHNAK5 binding included F41, I54, L58, S73, L74, A76, G77, L78, A81, L110 and
L112 of protomer a and I54, L58, S73, L74, G77, L78, D84, L110 and L112 of protomer
b of the A10A2 protein. This method allowed identifying additional residues such as F41
and A81 in protomer a, as well as I54 and L58 in protomer b of A10A2 that were buried
by the interaction of AHNAK5. Higher quality crystals allowing higher resolution
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electron density maps, or complete NMR assignments of A10A2 protein alone and in
complex with the AHNAK5 peptide could help finding the answer to some of the
discrepancies observed here.
X-ray crystallography results complemented the peptide array experiments in
identifying the important residues of AHNAK5 that were involved in A10A2 binding
(Chapter 3). Peptide array identified a nine residue consensus sequence for AHNAK,
represented as +X+XPKφXφ (X – variable; φ – hydrophobic residue; + – positively
charged residue; P – proline; K – lysine) (Figure 3.1). Proline at position 6 of the
AHNAK5 peptide that showed interaction with S111 at the C-terminus of the annexin A2
region of protomer a in the A10A2 dimer, is not included in the consensus sequence.
However, the binding was abolished as soon as the 3 residues FPK (positions 5-7 of
AHNAK5) were eliminated from the peptide sequence on the array. Residue M8 of the
AHNAK5 peptide makes contacts with helix III (I54, L58) of the S100A10 region of
protomer a. This residue is presented as a variable (X) in the consensus, while peptide
array sequence analysis showed that smaller sidechain of methionine at this position
enhances the interaction. The consensus sequence does not include residues F15 and S16
of the AHNAK5 peptide that associated with L78, S111 and L112 of protomer b in the
A10A2 protein by X-ray crystallography. However; the strongest interaction was
observed when these residues became a part of the peptide sequence on the array.
Interestingly, amino acids F41, I54, L58, S73, L74, A76, G77, L78 and A81 in
the S100A10 region of A10A2 protein that were the key residues in binding AHNAK5 in
the X-ray crystallographic structure, are conserved hydrophobic residues in the S100
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family of proteins (Wilder et al. 2006). While, the possibility of a similar complex
formed between an S100 dimer, a pair of annexins and a single AHNAK exists, only
some of the S100 proteins have shown an interaction with annexin family of proteins.
These include Ca2+-S100A1 with annexin A5 (Garbuglia et al. 1998) and annexin A6
(Propper et al. 1999; Arcuri et al. 2002); Ca2+-S100A6 with annexin A11 (Watanabe et al.
1993; Tomas and Moss 2003; Williams et al. 2005), annexin A2 (Zeng et al. 1993;
Filipek et al. 1995), annexin A5 (Tokumitsu et al. 1992), and annexin A6 (Zeng et al.
1993); Ca2+-S100A11 with annexin A1 (Rety et al. 2000; Bianchi et al. 2003); Ca2+S100B with annexin A6 (Garbuglia et al. 1998; Arcuri et al. 2002); apo-S100A4 with
annexin A2 (Semov et al. 2005); and apo-S100A10 with annexin A2 (Osborn et al. 1988;
Johnsson and Weber 1990; Bianchi et al. 1992; Rety et al. 1999). Closer look at the first
fourteen amino acid residues at the N-terminus of annexin A1, A2, A5, A6, and A11
reveals that in fact only annexin A1 and A2 have significant sequence similarity. Thus,
formation of a ternary complex involving an AHNAK protein associated with annexin
A2-bound apo-S100A10, apo-S100A4 or Ca2+-S100A6; or annexin A1-bound Ca2+S100A11 could occur in a similar manner, where any one of these complexes could
perform a similar function in the appropriate cell type.

222

4.5

References:

Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd,
J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. 2010. PHENIX: a
comprehensive Python-based system for macromolecular structure solution. Acta
Crystallogr D Biol Crystallogr 66: 213-221.
Arcuri, C., Giambanco, I., Bianchi, R., and Donato, R. 2002. Annexin V, annexin VI,
S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience
109: 371-388.
Bianchi, R., Giambanco, I., Arcuri, C., and Donato, R. 2003. Subcellular localization of
S100A11 (S100C) in LLC-PK1 renal cells: calcium- and protein kinase Cdependent association of S100A11 with S100B and vimentin intermediate
filaments. Microsc Res Tech. 60: 639-651.
Bianchi, R., Pula, G., Ceccarelli, P., Giambanco, I., and Donato, R. 1992. S-100 protein
binds to annexin II and p11, the heavy and light chains of calpactin I. Biochim.
Biophys. Acta 1160: 67-75.
Bhattacharya, S., Large, E., Heizmann, C. W., Hemmings, B., Chazin, W. J. 2003.
Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100
target specificity and activation of the kinase. Biochemistry 42: 14416-14426.
Brünger, A. T. 1992. Free R value: a novel statistical quantity for assessing the accuracy
of crystal structures. Nature 355: 472 -475.
Charpentier, T.H., Thompson, L.E., Liriano, M.A., Varney, K.M., Wilder, P.T.,
Pozharski, E., Toth, E.A., and Weber, D.J. 2010. The effects of CapZ peptide
(TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray
crystallography. J Mol Biol 396: 1227-1243.
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995.
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J
Biomol NMR 6: 277-293.
Emsley, P., Lohkamp, B., Scott, W.G., and Cowtan, K. 2010. Features and development
of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501.
Filipek, A., Wojda, U., and Lesniak, W. 1995. Interaction of calcyclin and its cyanogen
bromide fragments with annexin II and glyceraldehyde 3-phosphate
dehydrogenase. Int J Biochem Cell Biol 27: 1123-1131.

223

Garbuglia, M., Verzini, M., and Donato, R. 1998. Annexin VI binds S100A1 and
S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP
assemblies into intermediate filaments. Cell Calcium 24: 177-191.
Grant, G. 2002. Synthetic Peptides: A User's Guide. Oxford University Press, New York.
Grzesiek, S., and Bax, A. 1992. Correlating backbone amide and sidechain resonances in
larger proteins by multiple relayed triple resonance NMR. J. Am. Chem. Soc. 114:
6291-6293.
Inman, K.G., Yang, R., Rustandi, R.R., Miller, K.E., Baldisseri, D.M., and Weber, D.J.
2002. Solution NMR structure of S100B bound to the high-affinity target peptide
TRTK-12. J. Mol. Biol. 324: 1003-1014.
Johnson, B.A., and Belvins, R.A. 1994. NMRView: A computer program for the
visualization and analysis of NMR data. J Biomol NMR 4: 603-614.
Johnsson, N., and Weber, K. 1990. Alkylation of cysteine 82 of p11 abolishes the
complex formation with the tyrosine-protein kinase substrate p36 (Annexin 2,
Calpactin 1, Lipocortin 2). J. Biol. Chem. 265: 14464-14468.
Kay, L.E., Ikura, M., Tschudin, R., and Bax, A. 1990. Three-dimentional triple-resonance
NMR spectroscopy of isotopically enriched proteins. J. Magn. Reson. 89: 496514.
Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. 1993. PROCHECK:
a program to check the stereochemical quality of protein structures. J. Appl. Cryst.
26: 283-291.
Lee, Y.T., Dimitrova, Y.N., Schneider, G., Ridenour, W.B., Bhattacharya, S., Soss, S.E.,
Caprioli, R.M., Filipek, A., and Chazin, W.J. 2008. Structure of the S100A6
complex with a fragment from the C-terminal domain of Siah-1 interacting
protein: a novel mode for S100 protein target recognition. Biochemistry 47:
10921-10932.
McClintock, K.A., and Shaw, G.S. 2003. A novel S100 target conformation is revealed
by the solution structure of the Ca2+-S100B-TRTK-12 complex. J Biol Chem
278: 6251-6257.
Osborn, M., Johnsson, N., Wehland, J., and Weber, K. 1988. The submembranous
location of p11 and its interaction with the p36 substrate of pp60 src kinase in situ.
Exp. Cell Res. 175: 81-96.

224

Otwinowski, Z., and Minor, W. 1997. Processing of X-ray diffraction data collected
in oscillation mode. Methods in Enzymology. Academic Press, New York, NY, pp.
307-326.
Propper, C., Huang, X., Roth, J., Sorg, C., and Nacken, W. 1999. Analysis of the MRP8MRP14 protein-protein interaction by the two-hybrid system suggests a prominent
role of the C-terminal domain of S100 proteins in dimer formation. J Biol Chem.
274: 183-188.
Rety, S., Osterloh, D., Arie, J.P., Tabaries, S., Seeman, J., Russo-Marie, F., Gerke, V.,
and Lewit-Bentley, A. 2000. Structural basis of the Ca(2+)-dependent association
between S100C (S100A11) and its target, the N-terminal part of annexin I.
Structure Fold Des 8: 175-184.
Rety, S., Sopkova, J., Renouard, M., Osterloh, D., Gerke, V., Tabaries, S., Russo-Marie,
F., and Lewit-Bentley, A. 1999. The crystal structure of a complex of p11 with the
annexin II N-terminal peptide. Nat Struct Biol 6: 89-95.
Rezvanpour, A., Phillips, J.M., and Shaw, G.S. 2009. Design of high-affinity S100-target
hybrid proteins. Protein Sci 18: 2528-2536.
Rezvanpour, A., and Shaw, G.S. 2009. Unique S100 target protein interactions. Gen
Physiol Biophys 28 Spec No Focus: F39-46.
Rustandi, R.R., Baldisseri, D.M., and Weber, D.J. 2000. Structure of the negative
regulatory domain of p53 bound to S100B(ββ). Nat. Struct. Biol. 7: 570-574.
Semov, A., Moreno, M.J., Onichtchenko, A., Abulrob, A., Ball, M., Ekiel, I., Pietrzynski,
G., Stanimirovic, D., and Alakhov, V. 2005. Metastasis-associated protein
S100A4 induces angiogenesis through interaction with Annexin II and accelerated
plasmin formation. J Biol Chem 280: 20833-20841.
Tokumitsu, H., Mizutani, A., Minami, H., Kobayashi, R., and Hidaka, H. 1992. A
calcyclin-associated protein is a newly identified member of the
Ca2+/phospholipid-binding proteins, annexin family. J Biol Chem 267: 89198924.
Tomas, A., and Moss, S.E. 2003. Calcium- and cell cycle-dependent association of
annexin 11 with the nuclear envelope. J Biol Chem 278: 20210-20216.
Wallace, A.C., Laskowski, R.A., and Thornton, J.M. 1995. LIGPLOT: a program to
generate schematic diagrams of protein-ligand interactions. Protein Eng 8: 127134.

225

Watanabe, M., Ando, Y., Tokumitsu, H., and Hidaka, H. 1993. Binding site of
annexin XI on the calcyclin molecule. Biochem Biophys Res Commun 196: 13761382.
Wilder, P.T., Lin, J., Bair, C.L., Charpentier, T.H., Yang, D., Liriano, M., Varney, K.M.,
Lee, A., Oppenheim, A.B., Adhya, S., et al. 2006. Recognition of the tumor
suppressor protein p53 and other protein targets by the calcium-binding protein
S100B. Biochim Biophys Acta.
Willard, L., Ranjan, A., Zhang, H., Monzavi, H., Boyko, R.F., Sykes, B.D., and Wishart,
D.S. 2003. VADAR: a web server for quantitative evaluation of protein structure
quality. Nucleic Acids Res 31: 3316-3319.
Williams, L.H., McClive, P.J., Van Den Bergen, J.A., and Sinclair, A.H. 2005. Annexin
XI co-localises with calcyclin in proliferating cells of the embryonic mouse testis.
Dev Dyn 234: 432-437.
Wittekind, M., and Mueller, L. 1993. HNCACB, a high-sensitivity 3D NMR experiment
to correlate amide-proton and nitrogen resonances with the alpha- and beta-carbon
resonances. J. Magn. Reson. Series B. 101: 171-180.
Wright, N.T., Cannon, B.R., Wilder, P.T., Morgan, M.T., Varney, K.M., Zimmer, D.B.,
and Weber, D.J. 2009. Solution structure of S100A1 bound to the CapZ peptide
(TRTK12). J Mol Biol 386: 1265-1277.
Wright, N.T., Prosser, B.L., Varney, K.M., Zimmer, D.B., Schneider, M.F., and Weber,
D.J. 2008. S100A1 and calmodulin compete for the same binding site on
ryanodine receptor. J Biol Chem 283: 26676-26683.
Zeng, F.Y., Gerke, V., and Gabius, H.J. 1993. Identification of annexin II, annexin VI and
glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in
bovine heart. Int J Biochem 25: 1019-1027.

226

Chapter 5
SUMMARY
5.1

Introduction
The S100 proteins are a group of proteins comprising at least 25 members in

humans including S100B, S100A1, S100A6, S100A10 and S100A11 (Donato 2001;
Heizmann et al. 2002). These proteins are dimeric, having two “EF-hand” calciumbinding motifs in each subunit. In vivo experiments have shown that both homo- and
heterodimeric S100 complexes are formed (Propper et al. 1999; Deloulme et al. 2000;
Wang et al. 2005). The S100 proteins act as calcium-signaling molecules by converting
changes in cellular calcium levels to a variety of biological responses. In this manner,
many of the S100 proteins modulate enzyme activities, oligomerization of cytoskeletal
protein components (tubulin, glial fibrillary acidic protein), modulate ubiquitination,
control membrane vesicle formation and participate in trafficking of proteins to the inner
surface of the plasma membrane (Santamaria-Kisiel et al. 2006).
Most S100 proteins bind calcium ions and undergo a conformational change
that allows them to interact with specific target proteins and control a cellular activity
(Zimmer et al. 2003; Santamaria-Kisiel et al. 2006; Wilder et al. 2006). Threedimensional structures of several S100 proteins in the calcium-free (apo) and calciumbound states show that the major structural change involves the movement of helix III
with respect to helix IV. This leads to the exposure of previously buried residues and
creates a hydrophobic surface. In one S100 protein, S100A10, substitutions in both its
calcium-binding sites have left this protein with the inability to coordinate calcium.
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Consequently, S100A10 does not undergo a calcium-induced structural change and
instead adopts a structure in its calcium-free state that is very similar to the calciumbound states of other S100 proteins (Rety et al. 1999; Rety et al. 2000). As a result
S100A10 interacts and controls the functions of more than a dozen proteins in a calciuminsensitive manner.
In the last few years, several proteins (AHNAK, TASK-1, dysferlin, NS3) have
been found to interact with S100A10 together with annexin A2 as a possible means for
trafficking of these proteins to the plasma membrane or assemble multiprotein complexes
important in membrane repair processes. Unfortunately, lack of structural information on
the arrangement, affinities and structures of these proteins in the complex does not allow
understanding the mechanisms they are involved in. In this thesis, the focus was on the
complexes of S100A10 with annexin A2, AHNAK, and dysferlin proteins to provide the
first structural model of a multi-protein assemblage required for membrane repair.

5.2

Previous Work
Frequent partners for the S100 proteins are members of the annexin protein

family. At least 10 different S100-annexin complexes have been characterized
(Santamaria-Kisiel et al. 2006). Each annexin protein has a core domain comprised of
four (annexins A1-A5, A7- A11, A13) or eight (annexin A6) structurally conserved
repeats, each possessing five α-helices and a short 30-reside N-terminal ‘tail’. Calcium
binding to the annexins promotes association with phospholipid membranes, which leads
to the release of the N-terminal tail for interaction with the S100 proteins.
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The first two structures of S100 proteins in complex with the annexins were
solved by Rety et al. (Rety et al. 1999; Rety et al. 2000) and comprised apo-S100A10 and
Ca2+-S100A11 in complex with the N-terminal peptides of annexin A2 and A1,
respectively. Despite the difference in the calcium-bound states of the proteins and that
the two annexin peptides are from different protein sources, both structures demonstrate
two annexin peptides per S100 dimer, located in near-identical binding sites on either side
of the S100 molecule (Figure 1.4). Each peptide makes contacts with both S100
protomers resulting in the bridging of the two monomers by the annexin protein. Gerke
and Moss proposed an elegant model in which calcium-binding by an annexin protein
promotes its association with a phospholipid membrane and facilitates interaction with
either S100A10 or Ca2+-S100A11, allowing two membrane surfaces to be brought within
close proximity during a fusion or vesiculation event (Gerke and Moss 2002).
Recently, a multiprotein complex was identified between S100A10, annexin A2
and AHNAK (Figure 1.8B) (Benaud et al. 2004; De Seranno et al. 2006). AHNAK is
important for cell membrane differentiation and membrane repair (Kouno et al. 2004), is
expressed in epithelial cells and localizes near the plasma membrane. In the absence of
annexin A2, a weak interaction between S100A10 and the C-terminal portion of AHNAK
exists. However, the strength of this interaction is increased more than 150-fold in the
presence of annexin A2. Further, in vitro binding assays demonstrated no detectable
interactions between annexin A2 and the C-terminus of AHNAK, in the absence of
S100A10, or S100A10 with AHNAK in the absence of annexin A2. These observations
suggest that S100A10-annexin A2 tetramer formation is likely a prerequisite for the
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interaction with AHNAK. Similar to S100A10 and annexin A2, AHNAK protein
localizes on the plasma membrane (Kouno et al. 2004), where the interaction between
dysferlin and this complex can mediate the docking and fusion of the patch and sealing of
the membrane. A high calcium concentration (extracellular, via the wound) causes
annexin A1 and A2 association with a dysferlin-containing vesicle and damaged plasma
membranes. The key protein in this process, dysferlin (Doherty and McNally 2003; Shao
et al. 2006; Glover and Brown 2007), co-localizes and co-immunoprecipitates with
annexins A1 and A2 (Lennon et al. 2003). In addition, recent experiments have shown
that the C-terminus of AHNAK is responsible for binding to the N-terminal C2A domain
of dysferlin. Calcium binding to the dysferlin C2A domain is not required for its
interaction with AHNAK. The exact mechanisms whereby AHNAK is recruited for
plasma membrane repair are not clear, however, S100A10 and annexin A2 co-localize
with AHNAK and dysferlin proteins at the plasma membrane, providing some evidence
for the function of this multiprotein complex in membrane repair.

5.3

Design of High-Affinity S100-Target Hybrid Proteins
Due to the presence of multiple proteins in larger complexes, studying the

arrangement, affinities and mechanisms used by multi-protein complexes is quite
challenging. This task could be achieved by devising a method in which the number or
the sizes of the proteins involved in the interactions are reduced. In order to study multiprotein complexes involved in membrane repair, chapter 2 focused on designing a hybrid
protein in which the S100A10 was linked in tandem to the N-terminal peptide of annexin
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A2 (residues 1-15). A similar hybrid molecule was also generated for S100B and the
central region of CapZ (TRTK12; residues 1-12). These two proteins were selected to test
this approach for one protein (S100B) that undergoes a calcium-induced conformational
change in order to interact with a target, and one protein (S100A10) that is calciuminsensitive. Further advantage of this method was protection of the target peptide from
degradation to proteases by the S100 protein, which was used as a carrier.
Analysis of the structures of S100A10 in complex with the N-terminus of
annexin A2 (1BT6) (Rety et al. 1999), and Ca2+-S100B complexed to a portion of the
CapZ (TRTK12) (1MWN, 1MQ1) (Inman et al. 2002; McClintock and Shaw 2003),
allowed determining the length of the linker connecting the S100 protein to the target
peptide. In both these structures (Figure 2.6), the C-termini of helix IV in the S100
protein are proximal to the N-terminus of the binding peptide. A nine-residue linker
comprised of a TEV protease cleavage site (ENLYFQ/G) was introduced to connect the
S100A10 protein to the N-terminal peptide of annexin A2 (A10A2). Similarly, an elevenresidue linker containing a PreScission protease cut site (LFQ/GP) and four glycine
residues were used to connect the S100B protein to the TRTK12 peptide (BT12). High
yields of isotopically labeled A10A2 and BT12 were purified to prepare the concentrated
samples required for the collection of heteronuclear NMR experiments. The resonance
assignments for nearly all of the atoms of each one of the hybrid proteins were completed.
In situ proteolytic cleavage monitored by 1H-15N HSQC spectra showed the linker did not
perturb the structures of the S100A10-annexin A2 or S100B-TRTK12 complexes.
Overall, these results indicated that the structures and interactions of the S100 proteins
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and the peptides in the A10A2 and BT12 hybrid proteins are nearly identical to those
obtained for the complexes formed between the individual S100 proteins and synthetic
peptides. Furthermore, analysis of the chemical shift assignments (1H,

15

N, and

13

C)

showed that residues T102-S108 of annexin A2 formed a well-defined α-helix in the
A10A2 hybrid while the TRTK12 region was unstructured at the N-terminus with a single
turn of α-helix from D108-K111 in the BT12 hybrid protein. The two S100 hybrid
proteins provide a simple yet extremely efficient method for obtaining high yields of
intact S100 target peptides. Since cleavage of the S100 hybrid protein is not necessary for
structural characterization, this approach may be useful as a scaffold for larger S100
complexes.

5.4

An Asymmetric Platform for AHNAK Recruitment
The availability of the A10A2 hybrid protein, designed in previous chapter,

allowed performing a series of experiments that assisted greatly in understanding the
arrangement of the novel multi-protein complex formed between the S100A10, annexin
A2 and AHNAK proteins. Peptide array analysis identified eight potential binding regions
within the C-terminus of AHNAK for the A10A2 protein. Important amino acids of
AHNAK for this interaction were characterized by +X+XPKφXφ consensus sequence,
whereby amino acids with smaller sidechains at the second and forth positions of this
sequence enhanced the interaction of A10A2. The sequence of AHNAK with the most
intense binding (residues 5654-5673, AHNAK5) that was consistent with previous GSTAHNAK pull-down assay (De Seranno et al. 2006), was utilized in NMR titration
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experiments. Using both the A10A2C82S hybrid protein and complex of S100A10C82S
with an N-terminal peptide of the annexin A2, a single AHNAK5 peptide was found to
coordinate in an asymmetric fashion to the S100A10-annexin A2 heterotetramer. Since
the annexin A2 portion of A10A2C82S was also 15N-labeled and visible in the spectrum, it
was clear that the binding of AHNAK5 affected both the S100A10C82S and annexin A2
regions of the hybrid protein. Significant chemical shift changes occurred mainly for
residues in helix IV of the S100A10C82S (Gly77, Ala81), as well as the N-terminus of the
annexin A2 (Leu112, G114) peptides. The plot of the change in peak intensities as a
function of AHNAK5 and A10A2C82S concentrations showed a stoichiometry of one
AHNAK5 peptide to one A10A2C82S dimer. Further, non-denaturing electrospray mass
spectrometry results corroborated the NMR titration experiments. The binding affinity
between AHNAK5 and A10A2C82S was measure to approximately 3 nM. Repeating
similar experiments using AHNAK5 and S100A10C82S showed a much poorer interaction
in the absence of annexin A2. Thus, confirming that both S100A10 and annexin A2 are
required for strong association with the C-terminal domain of AHNAK.
Consistent with the two-hybrid and co-immunoprecipitation experiments (van
de Graaf et al. 2003; Borthwick et al. 2008), possible formation of a ternary complex
involving S100A10, annexin A2 proteins and the transient receptor potential cation
channel protein, TRPV5 was examined by peptide array analysis. Both, S100A10C82S or
A10A2C82S associated to the same regions on multiple sites of the TRPV5 peptide array,
indicating that interaction of TRPV5 with S100A10C82S or annexin A2-bound
S100A10C82S differs from the complex formed with the AHNAK, where residues from

233

both S100A10C82S and annexin A2 are required for the strong interaction of the
peptide. Regardless, it is important to repeat these experiments at lower protein
concentrations in order to reduce the non-specific or weaker interactions.

5.5

Interactions between Other Proteins in the Membrane Repair Complex
With the aim of identifying secondary binding sites on annexin A2 (other than

the twelve-residue N-terminal region) by S100A10 protein, peptide array experiments of
full length annexin A2 were performed. Due to the sequence similarity of the helices
within each repeat unit of annexin A2 (Barton et al. 1991; Jost et al. 1994), different
potential binding sites corresponding to all four structural repeats were observed. Some of
these repeats are buried in the structure of annexin A2 and clearly are not available to
interact with S100A10. Similar to the TRPV5, the peptide array of annexin A2 was also
probed at higher protein concentrations and it is important to repeat them using lower
amount of protein to eliminate the non-specific or weaker interactions.
Lack of information on the arrangement or assembly of the proteins in the
membrane repair complex does not allow understanding the membrane repair mechanism.
To shed light into this, the possible interactions between pairs of proteins in the complex
were examined. Knowing the backbone assignment of some of these proteins would
provide the information on how some residues are affected by the binding to other
proteins in the complex. High yields of unlabeled and isotopically labeled S100A10,
AHNAK C-terminal domain and dysferlin C2A domain were purified and concentrated
samples for the collection of heteronuclear NMR experiments were prepared. The
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resonance assignments of S100A10 were determined. However, NMR spectroscopy of
S100A10 and dysferlin C2A domain did not indicate a direct interaction between these
two proteins in the presence or absence of calcium. This result was contradictory to the
interaction observed between S100A13 and synaptotagmin C2A domain (Mohan et al.
2009; Mohan et al. 2010). It will be very interesting to test whether optimizing the
experimental conditions such as the salt concentration in the buffer would change the
outcome.
Similarly, no interaction was identified between the C-terminus of AHNAK and
dysferlin C2A domain in the presence or absence of calcium by NMR spectroscopy,
contradicting the previous GST-pull down assay (Huang et al. 2007) and peptide array
experiment performed in this thesis. The AHNAK protein used in the NMR experiments
was much shorter than the AHNAK fragment used in the GST-pull down assay and it will
be exciting to repeat this experiment using a larger AHNAK construct in optimized
experimental conditions.
No structural information is available for dysferlin C2A domain to date.
Calcium titrations into the sample of dysferlin C2A domain showed sequential binding of
six calcium ions to this region. It is important to obtain apo- and calcium-bound structures
of dysferlin C2A domain to locate the interaction site formed between this protein and
others in the membrane repair complex.
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5.6

Structure of S100A10-Annexin A2-AHNAK5 Complex
The last chapter of this thesis was focused on determining the binding region of

AHNAK5 on A10A2 protein by NMR spectroscopy and X-ray crystallography methods.
The resonance assignments for A10A2C82S alone and in complex with the AHNAK5
peptide were completed. Chemical shift perturbation mapped the binding surface of
AHNAK5 on helices IV and IV’ of protomers a and b of the S100A10 region (D84a,
S82a, I80a, G77a-A76a, S73a, F72a/b, S73b, L74b, A76b-G77b, I80b), as well as some
residues from the annexin A2 peptide region (E113a-G114a, S108a-S111a, L110b-S111b
and E113b) of the A10A2C82S protein (Figure 4.10).
X-ray crystallography of the A10A2-AHNAK5 complex showed that the
backbone structure of A10A2-AHNAK5 complex is similar to that of S100A10 in
complex with the N-terminal peptide of annexin A2 (Rety et al. 1999). The symmetric
dimer contained four α-helices per subunit (I-IV), with helices I, I’, IV and IV’
comprising the dimer interface of the A10A2. The hydrophobic surface of the annexin A2
peptide region of the A10A2 hybrid protein in the A10A2-AHNAK5 complex was also
similar to that of the X-ray crystallographic structure of the S100A10 bound to individual
N-terminal peptide of annexin A2. Some of the important residues for the interaction with
the AHNAK5 peptide included I54, L58 and S111 of protomer a, and L78, S111 and
L112 of protomer b in the A10A2 protein. From the structure, it was clear that only one
AHNAK5 peptide was bound to a dimeric A10A2 protein. This result was in perfect
agreement with the results obtained by NMR spectroscopy, however, this mode of
interaction for AHNAK5 peptide differs from other interaction in S100-target complexes
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observed to date (Figure 5.1). For instance, in the Ca2+-S100B structures with
TRTK12 (1MWN, 1MQ1, 3IQO, Figure 5.1A) (Inman et al. 2002; McClintock and Shaw
2003; Charpentier et al. 2010), Ndr kinase (1PSB, Figure 5.1A) (Bhattacharya et al. 2003)
and p53 (1DT7) (Rustandi et al. 2000); and the Ca2+-S100A1 structure with TRTK12
(2KBM, Figure 5.1A) (Wright et al. 2009); the interaction occurs between the target
peptide and the exposed hydrophobic surface between helices III and IV of the calciumbound S100 protein. The second mode of interaction used by the S100 proteins is
observed in the structures of Ca2+-S100A11 (1QLS, Figure 5.1B) and apo-S100A10
(1BT6) in complexes with the N-terminal peptides from annexins A1 and A2,
respectively. In both structures the annexin peptide bridges the two S100 protomers such
that its C-terminus interacts with the linker and helix IV of one protomer while the
annexin N-terminus has contacts near the N-terminus of helix I’ of the partner protomer.
The third mode of interaction utilized by the S100 proteins involves the Ca2+-S100A6 and
the C-terminal domain from the Siah-1 Interacting Protein (2JTT) (Figure 5.1C). In this
structure the SIP peptide forms two distinct α-helices oriented nearly perpendicular to
each other. The first helix (Helix A) occupies the hydrophobic groove between helices III
and IV, while the second helix in SIP (helix B) lies across helix I’ of the adjacent
protomer. The binding surface of AHNAK5 on the A10A2 protein is unique, as the
peptide binds diagonally across helices IV and IV’ of the S100A10 region (Figure 5.1),
which is on the opposite face of the molecule with respect to other S100-target
complexes. In addition, AHNAK5 makes contacts with residues on the adjacent C-termini
of the annexin A2 peptide regions (Figure 5.1D) of the A10A2 hybrid protein.

237

Figure 5.1. Different modes for target protein interaction with S100 proteins.
(A) Binding to the helix III-IV hydrophobic displayed by TRTK12 (pink) bound to Ca2+S100A1 (2KBM) (Wright et al. 2009) and NDR kinase (cyan) bound to Ca2+-S100B
(1PSB) (Bhattacharya et al. 2003). (B) Binding near helix I’ at the dimer interface
displayed by the N-terminal region of annexin A1 (pink) and Ca2+-S100A11 (1QLS)
(Rety et al. 2000). (C) Two- site surface mode displayed by the C-terminal region of SIP
bound to Ca2+-S100A6 (2JTT) (Lee et al. 2008). (D) Binding to the helices IV and IV‘ as
well as the adjacent C-termini of annexin A2 peptides one face of the A10A2 hybrid
protein. The diagram in (D) is rotated by 180 alonge the y-axis with respect to (A-C).
Ribbon diagrams of the calcium-saturated S100 or apo-A10A2 proteins are presented
with one of the protomers shaded in black (helices labeled as I-IV for the S100 or as I-IV
and annexin A2 for the A10A2) and the other protomer shown in light grey (helices
labeled as I’-IV’ for the S100 or as I’-IV’ and annexin A2 for the A10A2). Calcium ions
are illustrated in yellow spheres.
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5.7

Membrane Repair mechanism
Membrane repair involves a complicated assembly of multiple proteins. Strong

in vivo evidence suggests that S100A10 is an important regulator of plasma membrane
repair and membrane receptor trafficking. One of the central proteins in these functions is
the calcium-sensitive annexin A2 protein. Many different experiments including coimmunoprecipitation and two-hybrid assays supporte the formation of a tight complex
with the S100A10 protein. The interaction between S100A10 and annexin A2 utilizes the
N-terminus of annexin A2 similar to that observed in the S100A10-annexin A2 tetramer
crystal structure (Rety et al. 1999) with a Kd of approximately 30 nM. An S100A10 dimer
can coordinate a pair of annexin A2 proteins, potentially bridging adjacent phospholipid
membranes into close proximity during a membrane fusion event (Gerke and Moss 2002).
This allows for the aggregation of vesicles and formation of an endomembrane patch
required for membrane repair during calcium flood through the disrupted membrane. The
endomembrane patch trafficking is facilitated by affixin. Meanwhile, calpain-3 cleaves
cytoskeletal proteins to mediate disassembly of the damaged actin cytoskeleton at the
damaged site. The next component involved in membrane repair is the AHNAK protein.
In this thesis, it was shown that despite the symmetric structure of dimeric S100A10annexin A2 complex, only one AHNAK5 peptide was bound asymmetrically to the
heterotetramer (Figure 5.1) with a Kd of about 3 nM. Simialr to the yeast triple-hybrid and
in vitro binding assays (De Seranno et al. 2006), it was also shown that both S100A10
and annexin A2 are required for strong association with the C-terminal domain of
AHNAK. This requirement indicates there are two calcium-regulated steps for AHNAK
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delivery to the membrane surface both mediated by annexin A2. The first is the
extrusion of N-terminus of annexin A2 upon calcium binding to the protein core domain
allowing formation of the heterotetramer and subsequent recruitment of AHNAK. The
second step is the localization of the entire complex to the phospholipid surface through
calcium bridging between annexin A2 and the membrane. Peptide array experiments
identified the possibility for eight binding regions in the C-terminus of AHNAK for the
S100A10-annexin A2 complex. This is consistent with a scaffolding role for AHNAK
where up to eight S100A10-annexin A2 heterotetramers could be assembled on the Cterminus of AHNAK. Since binding of the complex to the phospholipid surface is
governed by calcium binding to the annexin moiety, this would allow a highly
cooperative association of the complex with the membrane. Stronger association of only
one of the sequences in the array could also imply that some or the remaining binding
sites are masked by the AHNAK tertiary structure. Regardless of the number of
S100A10-annexin A2 complexes that could be recruited by one AHNAK onto the plasma
membrane, the AHNAK protein gets located on the plasma membrane (Kouno et al.
2004), where the interaction between dysferlin and this complex can mediate the docking
and fusion of the patch and sealing of the membrane.

5.8

Conclusion
The work in this thesis has provided valuable information regarding multi-

protein complexes involved in membrane repair. The details on the arrangement of the
proteins, stoichiometry and affinity of AHNAK for the S100A10-annexin A2 complex, as
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well as structural information on this ternary complex proposed a novel model for a
larger protein assembly during the membrane repair.

5.9

Future Work
The data presented in this thesis demonstrate an assembly of at least four

proteins involved in membrane repair. Given the essential role of membrane repair in cell
survival, it is important to invest on understanding the arrangement, affinities and
structural information of the proteins in the complex. Although the structures of S100
proteins bound to the target peptides are informative, they lack the overall architecture of
the proteins in the complex. Thus, it is exciting to obtain more structural information on
larger protein fragments alone or associated with other proteins in the complex. For
instance, the apo- and calcium-bound structures of dysferlin C2A domain must first be
solved in order to locate the binding sites of other members of the repair complex (ie.
S100A10, annexin A2, and AHNAK). Finally, this structural model and the identified
protein-protein interactions must be confirmed by site-directed mutation experiments.
The preliminary work on the association of some of the pair complexes (ie. S100A10 or
AHNAK with dysferlin) did not indicate an interaction, however, it is important to repeat
these experiments under optimized experimental conditions.
These structures could further be used in explaining some of the diseases caused
by impaired membrane repair. For example, single V67D point mutation in dysferlin C2A
domain is responsible for limb-girdle form of muscular dystrophy. Dysferlin has been
shown to co-localize and co-immunoprecipitate with annexins A2 and A1 (Lennon et al.

241

2003) as well as the C-terminal domain of AHNAK. Therefore, it is quite interesting
to study the effect of this mutation on the stability, structure and interactions of dysferlin
C2A domain and other proteins in the complex.
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